Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,mRNA processing (GO:0006397),0.7517786583038969,3.1291105021411276,0.0,0.0,0.0,58/99,12.75%,LSM5;SNRPG;LSM4;LSM6;NUDT21;SNRPD2;SF3B5;SNRPC;RALY;GTF2H5;HNRNPL;BCAS2;THOC7;AURKAIP1;POLR2J;SF3B6;SRSF11;TRA2B;ELAVL1;PABPN1;PUF60;PCBP2;CCNH;DNAJC8;POLR2K;CWC15;PAPOLA;ZCRB1;POLR2D;SNRNP27;POLR2G;SNRPB2;SF1;POLR2I;U2AF1L4;FIP1L1;CDC5L;CD2BP2;SNW1;ZMAT2;SF3B1;CHTOP;IK;AQR;TRA2A;PPIL3;CTNNBL1;PRPF4B;WBP4;RBM22;WDR83;SMNDC1;CRNKL1;PRKACA;WDR33;ZMAT5;FRG1;RNGTT
gsea,"mRNA splicing, via spliceosome (GO:0000398)",0.7616501775960102,3.115739051755064,0.0,0.0,0.0,55/88,13.24%,LSM5;SNRPG;LSM4;LSM6;NUDT21;SNRPD2;SF3B5;SNRPC;RALY;HNRNPL;BCAS2;POLR2J;SF3B6;SRSF11;TRA2B;ELAVL1;PABPN1;PUF60;PCBP2;DNAJC8;POLR2K;DCPS;CWC15;PAPOLA;ZCRB1;POLR2D;SNRNP27;POLR2G;SNRPB2;SF1;POLR2I;U2AF1L4;FIP1L1;CDC5L;CD2BP2;SNW1;ZMAT2;SF3B1;IK;AQR;TGS1;TRA2A;PPIL3;CTNNBL1;PRPF4B;GEMIN4;WBP4;RBM22;WDR83;SMNDC1;CRNKL1;WDR33;ZMAT5;FRG1;SCNM1
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.7657362096712184,3.0523792542791033,0.0,0.0,0.0,51/81,12.73%,LSM5;SNRPG;LSM4;LSM6;NUDT21;SNRPD2;SF3B5;SNRPC;RALY;HNRNPL;BCAS2;POLR2J;SF3B6;SRSF11;TRA2B;ELAVL1;PABPN1;PUF60;PCBP2;DNAJC8;POLR2K;CWC15;PAPOLA;ZCRB1;POLR2D;SNRNP27;POLR2G;SNRPB2;SF1;POLR2I;U2AF1L4;FIP1L1;CDC5L;CD2BP2;SNW1;ZMAT2;SF3B1;IK;AQR;TRA2A;PPIL3;CTNNBL1;PRPF4B;WBP4;RBM22;WDR83;SMNDC1;CRNKL1;WDR33;ZMAT5;FRG1
gsea,mitochondrial translation (GO:0032543),0.8489181977974407,3.0133704719460814,0.0,0.0,0.0,32/41,10.99%,MRPL23;MRPS15;MRPS14;MRPS36;MRPS26;AURKAIP1;MRPL57;MRPS33;MRPS24;MRPL33;MRPL27;MRPS17;MRPL21;MRPS18C;MRPL34;MRPL36;MRPL10;MRPS21;MRPL54;MRPL46;MRPS11;MRPL14;MRPS9;MRPS23;MRPL58;NDUFA7;MRPL41;MRPL48;MRPL43;MRPL32;MRPL4;MRPS34
gsea,translational elongation (GO:0006414),0.8501651195576513,3.006111523199662,0.0,0.0,0.0,32/40,11.47%,MRPL23;MRPS15;MRPS14;MRPS36;MRPS26;AURKAIP1;MRPL57;MRPS33;MRPS24;MRPL33;MRPL27;MRPS17;MRPL21;MRPS18C;MRPL34;MRPL36;MRPL10;MRPS21;MRPL54;MRPL46;MRPS11;MRPL14;MRPS9;MRPS23;MRPL58;MRPL41;MRPL48;MRPL43;MRPL32;MRPL4;MRPS34;GTPBP1
gsea,mitochondrial translational elongation (GO:0070125),0.8656213626562099,2.9755213095991215,0.0,0.0,0.0,31/37,10.99%,MRPL23;MRPS15;MRPS14;MRPS36;MRPS26;AURKAIP1;MRPL57;MRPS33;MRPS24;MRPL33;MRPL27;MRPS17;MRPL21;MRPS18C;MRPL34;MRPL36;MRPL10;MRPS21;MRPL54;MRPL46;MRPS11;MRPL14;MRPS9;MRPS23;MRPL58;MRPL41;MRPL48;MRPL43;MRPL32;MRPL4;MRPS34
gsea,double-strand break repair (GO:0006302),0.7915485472962669,2.9726900638529923,0.0,0.0,0.0,19/43,11.18%,HMGB2;HMGB1;SWI5;RAD21;MAD2L2;NSMCE2;BABAM1;RAD51B;MORF4L1;SUMO1;NABP2;SEM1;UBXN1;SMARCAD1;XRCC3;YY1;ERCC1;BABAM2;SFR1
gsea,mitochondrial translational termination (GO:0070126),0.848585503515749,2.9706211502167275,0.0,0.0,0.0,31/39,10.99%,MRPL23;MRPS15;MRPS14;MRPS36;MRPS26;AURKAIP1;MRPL57;MRPS33;MRPS24;MRPL33;MRPL27;MRPS17;MRPL21;MRPS18C;MRPL34;MRPL36;MRPL10;MRPS21;MRPL54;MRPL46;MRPS11;MRPL14;MRPS9;MRPS23;MRPL58;MRPL41;MRPL48;MRPL43;MRPL32;MRPL4;MRPS34
gsea,translational termination (GO:0006415),0.8440513660068937,2.9596627228331385,0.0,0.0,0.0,32/41,10.99%,MRPL23;MRPS15;MRPS14;MRPS36;MRPS26;AURKAIP1;MRPL57;MRPS33;MRPS24;MRPL33;MRPL27;MRPS17;MRPL21;MRPS18C;TRMT112;MRPL34;MRPL36;MRPL10;MRPS21;MRPL54;MRPL46;MRPS11;MRPL14;MRPS9;MRPS23;MRPL58;MRPL41;MRPL48;MRPL43;MRPL32;MRPL4;MRPS34
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.823223756139836,2.900305858698596,0.0,0.0,0.0,24/40,11.67%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;AP2S1;PSMB9;PSMD8;RAC1;PSMD5;PSMB10;PSMB1;PSMF1;AP2M1;PSMD4;RHOA;CDC42;PSMD9;AP2A1;ARRB2;PSME1
gsea,regulation of establishment of planar polarity (GO:0090175),0.8127368898332139,2.8950091626005294,0.0,0.0,0.0,24/42,11.67%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;AP2S1;PSMB9;PSMD8;RAC1;PSMD5;PSMB10;PSMB1;PSMF1;AP2M1;PSMD4;RHOA;CDC42;PSMD9;AP2A1;ARRB2;PSME1
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.8116637374815773,2.8533945424129405,0.0,0.0,0.0,28/41,12.70%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;MAPRE1;RBX1;SSNA1;PSMB9;PSMD8;RAD51B;PSMD5;PSMB10;PSMB1;DYNLL1;PSMF1;PSMD4;PPP2R1A;PSMD9;DCTN3;PAFAH1B1;BRD4;PSME1;PRKACA;CEP63
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),0.7979375706263291,2.8470322447662073,0.0,0.0,0.0,30/52,5.47%,NDUFB8;NDUFC2;NDUFC1;NDUFB6;NDUFV2;NDUFS5;NDUFS6;UQCC2;NDUFB9;NDUFB7;NDUFA2;NDUFS7;NDUFA11;NDUFA9;NDUFB4;NDUFA10;UQCRFS1;NDUFS3;NDUFB2;NDUFS8;NDUFB5;NDUFB3;NDUFA3;NDUFS2;NDUFA8;NDUFS4;COA3;NDUFB11;NDUFB10;NDUFAF8
gsea,regulation of primary metabolic process (GO:0080090),0.7868927131768687,2.843219006465002,0.0,0.0,0.0,23/45,11.67%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;EDF1;PSMD5;PSMB10;PSMB1;HDAC3;PSMF1;PSMD4;OAZ1;PSMD9;TGS1;CERS2;SIN3B;PSME1
gsea,regulation of stem cell differentiation (GO:2000736),0.8539861906867189,2.8365245396321104,0.0,0.0,0.0,21/32,7.98%,NUDT21;PSMA7;PSMA2;MYB;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;TCF3;PSMF1;CBFB;PSMD4;PSMD9;YTHDF2
gsea,proteasomal protein catabolic process (GO:0010498),0.6546827939063475,2.833690575917173,0.0,0.0,0.0,42/92,16.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PCBP2;PSMB9;PSMD8;PCNP;RNF187;PSMD5;PSMB10;PSMB1;UBE2K;PSMF1;PSMD4;UBE2A;UBXN1;BAG6;KCTD5;PSMD9;GSK3A;DERL1;GID8;MAEA;KBTBD6;ARRB2;SPOP;RNF4;PPP2R5C;PSME1;RBCK1;ATE1;PSMD10;TOPORS;CTNNB1;WWP2;UBE2G1
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),0.7498229848321407,2.8262957624206426,0.0,0.0,0.0,27/50,7.82%,ANAPC11;PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;MAPRE1;SSNA1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;DYNLL1;PSMF1;PSMD4;PPP2R1A;ANAPC16;CDC26;UBE2E1;ANAPC2;PSMD9;DCTN3;PAFAH1B1
gsea,regulation of immune response (GO:0050776),-0.8239728205784796,-2.81871513671825,0.0,0.0,0.0,16/37,4.92%,HCST;B2M;LAG3;CD3E;KLRD1;CD3D;CD3G;CD8A;KLRC1;PTPN22;PDCD1;KLRK1;CD247;ADCY7;FOXP1;ITGAL
gsea,non-canonical Wnt signaling pathway (GO:0035567),0.7466776247673076,2.816843693364307,0.0,0.0,0.0,23/54,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;CALM1;AP2S1;PSMB9;PSMD8;RAC1;PSMD5;PSMB10;PSMB1;PSMF1;AP2M1;GNB1;PSMD4;RHOA;CDC42;PSMD9
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.8012642360959888,2.812786889145091,0.0,0.0,0.0,17/36,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.825309080904906,2.808329080921645,0.0,0.0,0.0,38/53,4.82%,COX6A1;NDUFB8;COX5B;COX5A;NDUFC2;UQCR11;UQCR10;NDUFC1;NDUFB6;NDUFV2;NDUFS5;NDUFS6;NDUFB9;UQCRQ;NDUFB7;NDUFA2;NDUFS7;NDUFA11;UQCRB;NDUFA9;NDUFB4;NDUFA10;UQCRFS1;NDUFS3;NDUFB2;NDUFS8;SDHC;NDUFB5;NDUFB3;NDUFA3;COX7B;NDUFS2;NDUFA8;NDUFS4;UQCRC2;COX6B1;NDUFB11;NDUFB10
gsea,RNA processing (GO:0006396),0.7147391707937024,2.8021873292411863,0.0,0.0,0.0,26/59,13.24%,LSM5;SNRPG;LSM4;LSM6;NUDT21;SNRPD2;RBM3;HNRNPL;BCAS2;AURKAIP1;SRSF11;PABPN1;ZCRB1;PPP2R1A;PPP2CA;XRN2;RP9;SF3B1;LSM1;PRPF4B;WBP4;TENT2;PRKACA;ZMAT5;RNGTT;SCNM1
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),0.8758199517845752,2.800376550331307,0.0,0.0,0.0,20/27,7.98%,PSMA7;PSMA2;MYB;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;TCF3;PSMF1;CBFB;PSMD4;PSMD9;YTHDF2
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5962417735366963,2.7856294897919245,0.0,0.0,0.0,65/134,20.86%,ANAPC11;PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PCBP2;PSMB9;PSMD8;PCNP;RNF187;PSMD5;PSMB10;PSMB1;UBE2K;PSMF1;SEC61B;PSMD4;UBE2A;ANAPC16;CDC26;SGTA;UBE2E1;UBXN1;BAG6;KCTD5;UBE2J2;ANAPC2;PSMD9;GSK3A;FAF2;DERL1;CUL2;GID8;UBE2G2;MAEA;KBTBD6;ARRB2;SPOP;RNF4;PPP2R5C;PSME1;RBCK1;ANAPC10;PSMD10;PTTG1;TOPORS;RNF121;CTNNB1;UFD1;WWP2;UBE2G1;FBXO4;UBE2J1;RMND5B;UBXN8;AGAP3;UBE2D3;TRIM2;AMFR;FBXL6
gsea,RNA splicing (GO:0008380),0.7947021394197858,2.779481405481663,0.0,0.0,0.0,19/31,13.24%,SNRPG;LSM4;LSM6;SNRPD2;BCAS2;SRSF11;TRA2B;ZCRB1;PPP2R1A;PPP2CA;RP9;SF3B1;LSM1;PRPF4B;WBP4;WDR83;SMNDC1;ZMAT5;SCNM1
gsea,aerobic electron transport chain (GO:0019646),0.8267798110337468,2.7777315846308333,0.0,0.0,0.0,38/52,4.82%,COX6A1;NDUFB8;COX5B;COX5A;NDUFC2;UQCR11;UQCR10;NDUFC1;NDUFB6;NDUFV2;NDUFS5;NDUFS6;NDUFB9;UQCRQ;NDUFB7;NDUFA2;NDUFS7;NDUFA11;UQCRB;NDUFA9;NDUFB4;NDUFA10;UQCRFS1;NDUFS3;NDUFB2;NDUFS8;SDHC;NDUFB5;NDUFB3;NDUFA3;COX7B;NDUFS2;NDUFA8;NDUFS4;UQCRC2;COX6B1;NDUFB11;NDUFB10
gsea,NIK/NF-kappaB signaling (GO:0038061),0.8620225490576908,2.7761858067764678,0.0,0.0,0.0,16/26,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9
gsea,regulation of cell cycle phase transition (GO:1901987),0.8543860146493124,2.7633220867738,0.0,0.0,0.0,21/27,6.85%,ANAPC11;PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;ANAPC16;CDC26;UBE2E1;ANAPC2;PSMD9
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),0.8387683830196659,2.759840356768824,0.0,0.0,0.0,27/37,5.47%,NDUFB8;NDUFC2;NDUFC1;NDUFB6;NDUFV2;NDUFS5;NDUFS6;NDUFB9;NDUFB7;NDUFA2;NDUFS7;NDUFA11;NDUFA9;NDUFB4;NDUFA10;NDUFS3;NDUFB2;NDUFS8;NDUFB5;NDUFB3;NDUFA3;NDUFS2;NDUFA8;NDUFS4;NDUFB11;NDUFB10;NDUFAF8
gsea,NADH dehydrogenase complex assembly (GO:0010257),0.8387683830196659,2.759840356768824,0.0,0.0,0.0,27/37,5.47%,NDUFB8;NDUFC2;NDUFC1;NDUFB6;NDUFV2;NDUFS5;NDUFS6;NDUFB9;NDUFB7;NDUFA2;NDUFS7;NDUFA11;NDUFA9;NDUFB4;NDUFA10;NDUFS3;NDUFB2;NDUFS8;NDUFB5;NDUFB3;NDUFA3;NDUFS2;NDUFA8;NDUFS4;NDUFB11;NDUFB10;NDUFAF8
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.6887097896702308,2.751661149446794,0.0,0.0,0.0,21/64,7.76%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;MAD2L2;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;EMD;PSMD9;CSNK1A1;GSK3A
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.8541460523916219,2.7508419553929873,0.0,0.0,0.0,17/27,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9
gsea,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.877720451281617,2.7414070066726453,0.0,0.0,0.0,26/31,4.82%,NDUFB8;NDUFC2;NDUFC1;NDUFB6;NDUFV2;NDUFS5;NDUFS6;NDUFB9;NDUFB7;NDUFA2;NDUFS7;NDUFA11;NDUFA9;NDUFB4;NDUFA10;NDUFS3;NDUFB2;NDUFS8;NDUFB5;NDUFB3;NDUFA3;NDUFS2;NDUFA8;NDUFS4;NDUFB11;NDUFB10
gsea,Fc receptor signaling pathway (GO:0038093),0.7571657092228773,2.7364908225497264,0.0,0.0,0.0,19/42,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;CALM1;PSMB9;PSMD8;RAC1;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;GRB2;PSMD9
gsea,post-translational protein modification (GO:0043687),0.6175884957647725,2.7332833024195224,0.0,0.0,0.0,42/107,17.88%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;COPS6;COMMD1;RBX1;ELOB;PSMB9;RNF7;PSMD8;NEDD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;BTBD1;DDA1;PSMD9;CUL2;DNAJC3;COPS8;KBTBD6;RAB8A;FBXO22;PSME1;PNPLA2;FBXO7;ATG5;PTP4A2;ASB8;RAB2A;PSMD10;RAB1A;KBTBD8;FBXO4;CHML
gsea,protein-DNA complex assembly (GO:0065004),0.8181284750396474,2.721916922610154,0.0,0.0,0.0,19/31,4.30%,HMGB2;PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;GTF2H5;PSMD13;PSMC3;RBX1;PSMB9;CCNH;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.8577181033366934,2.721658386466054,0.0,0.0,0.0,23/28,11.67%,PSMA7;PSMA2;MYB;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;TCF3;PSMF1;CBFB;PSMD4;PSMD9;YTHDF2;DHX36;PDCD2;PSME1
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),0.7350480036218319,2.713923261521796,0.0,0.0,0.0,19/43,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;CALM1;PSMB9;PSMD8;RAC1;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;GRB2;PSMD9
gsea,regulation of mRNA catabolic process (GO:0061013),0.7410992139959952,2.6721882691027794,0.0,0.0,0.0,28/39,11.67%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;YWHAB;ELAVL1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;YWHAZ;PSMD9;YTHDF2;CNOT7;ZC3H14;CARHSP1;DHX36;DCP2;CNOT8;GTPBP1;PSME1
gsea,regulation of mRNA stability (GO:0043488),0.7467634327013545,2.6708937352405355,0.0,0.0,0.0,25/40,11.67%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;YWHAB;ELAVL1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;YWHAZ;PSMD9;YTHDF2;ZC3H14;CARHSP1;DHX36;DCP2;PSME1
gsea,protein modification by small protein removal (GO:0070646),0.6007528252512704,2.668672399923402,0.0,0.0,0.0,46/94,19.12%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;COPS6;TAF10;SNX3;PSMB9;PSMD8;BABAM1;NEDD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;RHOA;PSMD9;TOR1A;OTUB1;YY1;SUDS3;COPS8;BABAM2;SMAD2;ARRB2;USP4;PSME1;USP16;TFPT;USP50;RCE1;PSMD10;UFD1;SENP6;POLB;RHOT1;CYLD;USP49;JOSD2;USP21;SENP2
gsea,positive regulation of Wnt signaling pathway (GO:0030177),0.6754146260566484,2.6637497116688933,0.0,0.0,0.0,20/59,9.15%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;CSNK2A1;PSMB9;PSMD8;ILK;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;DAPK3;GID8
gsea,regulation of cellular ketone metabolic process (GO:0010565),0.8968817103958064,2.658745237699092,0.0,0.0,0.0,18/22,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PANK2;OAZ1;PSMD9
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.7803739089509035,2.652539209817726,0.0,0.0,0.0,19/31,9.08%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;ELOB;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;CUL2
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.8082645921489103,2.6364538365819574,0.0,0.0,0.0,21/28,6.85%,ANAPC11;PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;ANAPC16;CDC26;UBE2E1;ANAPC2;PSMD9
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.8532654007886937,2.6353791171537644,0.0,0.0,0.0,18/25,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;NABP2;PSMD9
gsea,negative regulation of Wnt signaling pathway (GO:0030178),0.655235111605615,2.6338357354763775,0.0,0.0,0.0,21/70,7.76%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;MAD2L2;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;EMD;PSMD9;CSNK1A1;GSK3A
gsea,regulation of cellular amino acid metabolic process (GO:0006521),0.8955481819038902,2.6248920351534673,0.0,0.0,0.0,17/21,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;OAZ1;PSMD9
gsea,regulation of cellular amine metabolic process (GO:0033238),0.8955481819038902,2.6248920351534673,0.0,0.0,0.0,17/21,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;OAZ1;PSMD9
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.6920132448575546,2.6237555054133566,0.0,0.0,0.0,19/53,9.15%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;ILK;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;DAPK3;GID8
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.6104147005773989,2.6206383807247158,0.0,0.0,0.0,45/93,17.79%,SEC13;YIF1B;TMED10;DYNLL1;CNIH1;TMED9;PDCD6;TRAPPC1;BCAP31;ACTR10;VAPA;TRAPPC5;CAPZB;TEX261;TMED3;DCTN3;SAR1A;SCFD1;TRAPPC6A;BET1;SEC22B;TFG;PREB;ERGIC2;IER3IP1;YIF1A;SAR1B;NAPA;COPB1;DCTN5;COPE;ARFGAP2;VTI1B;TRAPPC6B;RAB2A;TMED7;PEF1;YKT6;TMED5;DCTN2;RAB1A;COG8;CAPZA1;GOSR2;TRAPPC3
gsea,protein deubiquitination (GO:0016579),0.5872524509940286,2.6192594904748145,0.0,0.0,0.0,42/92,18.86%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;ENY2;TAF10;SNX3;PSMB9;PSMD8;BABAM1;NEDD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;RHOA;PSMD9;OTUB1;YY1;SUDS3;BABAM2;SMAD2;ARRB2;USP4;PSME1;USP16;TFPT;USP50;RCE1;PSMD10;UFD1;POLB;RHOT1;CYLD;USP49;JOSD2;USP21
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.761976648924444,2.601530757729011,0.0,0.0,0.0,18/35,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;ILK;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PYCARD;PSMD9
gsea,RNA metabolic process (GO:0016070),0.7176552211896523,2.595923490875518,0.0,0.0,0.0,18/39,12.75%,RNASEH2C;RBM3;HNRNPL;POLR2J;PABPN1;PCBP2;POLR2K;PAPOLA;LAGE3;POLR2D;POLR2G;POLR2I;XRN2;LSM1;DHX36;TENT2;ALKBH1;RNGTT
gsea,cellular response to tumor necrosis factor (GO:0071356),0.7221874441615721,2.5875592406734857,0.0,0.0,0.0,18/44,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;ILK;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PYCARD;PSMD9
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.8929543904398328,2.5693270219451954,0.0,0.0,0.0,17/20,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9
gsea,cellular response to lipid (GO:0071396),0.6865914774549274,2.56193222684608,0.0,0.0,0.0,10/42,9.54%,HMGB2;HMGB1;UBE2L3;PABPN1;PDK3;GSTP1;RHOA;PYCARD;SNW1;PAF1
gsea,"DNA-templated transcription, termination (GO:0006353)",0.8423970229543534,2.5516931655693007,0.0,0.0,0.0,10/18,5.60%,SNRPG;NUDT21;GTF2H5;SSU72;PABPN1;CCNH;MED18;POLR2K;PAPOLA;FIP1L1
gsea,T cell activation (GO:0042110),-0.7998674314627794,-2.5489497004231807,0.0,0.0,0.0,13/26,6.28%,CD3E;CD3G;CD8A;PTPRC;ITK;LFNG;CD2;PTPN22;CD28;MSN;ZAP70;LMBR1L;PPP3CA
gsea,cellular response to interferon-gamma (GO:0071346),-0.8220789724054078,-2.5391924985566514,0.0,0.0,0.0,8/20,4.00%,B2M;RPL13A;SP100;IFNGR1;IRF9;LGALS9;IRF2;JAK1
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.7473108966410937,2.5306401015471467,0.0,0.0,0.0,19/32,9.08%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;ELOB;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;CUL2
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),0.5796595030113795,2.5303700190295895,0.0,0.0,0.0,41/103,21.54%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PPP1CA;PSMC3;RBX1;MAD2L2;PSMB9;PSMD8;ILK;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;EMD;PSMD9;CSNK1A1;GSK3A;DAPK3;GID8;PSME1;SDHAF2;RNF220;PSMD10;CTNNB1;CSNK1G2;CYLD;UBAC2;NPHP3;PTPRU;DVL2;JRK;PPM1B;AMFR;STK11;PSEN1
gsea,COPII-coated vesicle budding (GO:0090114),0.6934809092336371,2.5275144498738094,0.0,0.0,0.0,22/37,17.79%,SEC13;TMED10;CNIH1;PDCD6;TRAPPC1;VAPA;TRAPPC5;SAR1A;SCFD1;TRAPPC6A;BET1;SEC22B;TFG;PREB;PPP6C;SAR1B;NAPA;TRAPPC6B;PEF1;RAB1A;GOSR2;TRAPPC3
gsea,cellular response to hypoxia (GO:0071456),0.7138368867975708,2.516224913016909,0.0,0.0,0.0,19/36,9.08%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;ELOB;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;CUL2
gsea,"DNA-templated transcription, elongation (GO:0006354)",0.793973058507522,2.5153269822121467,0.0,0.0,0.0,15/23,14.54%,GTF2H5;POLR2J;ELOB;CCNH;TCEA1;POLR2K;WDR61;POLR2D;POLR2G;POLR2I;CDK9;NELFA;PAF1;NELFB;MNAT1
gsea,transcription by RNA polymerase II (GO:0006366),0.5742611644104715,2.5028521606497227,0.0,0.0,0.0,43/103,16.95%,SNRPG;NUDT21;GTF2H5;POLR2J;TAF10;ELOB;SSU72;PABPN1;CCNH;TCEA1;MED18;POLR2K;GTF2A2;PAPOLA;WDR61;HDAC3;POLR2D;CBFB;POLR2G;TAF12;POLR2I;DRAP1;NABP2;FIP1L1;CDK9;SNW1;TAF11;NELFA;PAF1;MED27;ARRB2;WDR33;RNGTT;MED17;NELFB;ABT1;CPSF7;MNAT1;DEAF1;SNAPC1;SNAPC3;GTF2B;PHAX
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),0.7981785842663788,2.500987260262146,0.0,0.0,0.0,15/22,14.54%,GTF2H5;POLR2J;ELOB;CCNH;TCEA1;POLR2K;WDR61;POLR2D;POLR2G;POLR2I;CDK9;NELFA;PAF1;NELFB;MNAT1
gsea,regulation of mitotic cell cycle (GO:0007346),0.6306958752441323,2.5009851386738307,0.0,0.0,0.0,33/56,15.96%,ANAPC11;PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;ANAPC16;CDC26;RPS6KB1;UBE2E1;CDK9;ANAPC2;PSMD9;SRA1;DAPK3;MAEA;CDK5RAP3;PSME1;CCDC57;CDK11B;ANAPC10;PSMD10;ANGEL2
gsea,positive regulation of hydrolase activity (GO:0051345),0.690397503060511,2.499358945471942,0.0,0.0,0.0,6/36,4.80%,HMGB2;EZH2;CALM3;CALM1;ZC3H15;RHOA
gsea,chromatin organization (GO:0006325),0.698389399583088,2.4954861834993824,0.0,0.0,0.0,13/33,13.13%,HMGB2;EZH2;MYB;GATAD1;HDAC3;SMARCE1;SMARCAD1;SMARCD2;SMARCD1;SETD5;CHRAC1;FAM50A;DR1
gsea,cellular response to molecule of bacterial origin (GO:0071219),0.7461607078536945,2.4949308399172523,0.0,0.0,0.0,6/26,5.11%,HMGB2;HMGB1;PABPN1;GSTP1;RHOA;PYCARD
gsea,mRNA 3'-end processing (GO:0031124),0.7506305742994148,2.490358362933555,0.0,0.0,0.0,16/24,17.93%,NUDT21;THOC7;SRSF11;SSU72;PABPN1;PAPOLA;POLR2D;U2AF1L4;FIP1L1;CHTOP;PAF1;TENT2;WDR33;CPSF7;CDC40;MTPAP
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.8217411412866535,2.480790439910001,0.0,0.0,0.0,7/18,10.14%,HMGB2;HMGB1;NSMCE2;BABAM1;SUMO1;ERCC1;BABAM2
gsea,protein ubiquitination (GO:0016567),0.50012936588485,2.4787497360275204,0.0,0.0,0.0,84/206,25.65%,ANAPC11;PSMA7;PSMA2;UBE2L3;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;COMMD1;RBX1;ELOB;PSMB9;RNF7;PSMD8;PCNP;WDR61;NEDD8;RNF187;PSMD5;PSMB10;PSMB1;UBE2K;PSMF1;TRIM27;CBFB;PSMD4;UBE2A;ANAPC16;UBE2E1;DDA1;UBE2J2;PSMD9;RNF181;UBE3A;ATG3;DERL1;CUL2;PAF1;UBE2G2;TRAF7;TPP2;ARRB2;FBXO22;SPOP;RNF4;PSME1;UBE2V1;RBCK1;FBXO7;RNF220;RNF10;UBE2Z;PSMD10;RNF26;TOPORS;CTNNB1;PEX14;CAND2;LZTR1;WWP2;UBE2G1;KBTBD8;FBXO4;UBE2J1;UBE2D3;TRIM2;UBE2Q2;AMFR;TRIM69;RTF1;PPIL2;UBE3C;UBOX5;FBXO2;HECTD2;RNF20;DET1;ARRDC1;KLHL2;RNF115;FBXO17;FBXW2
gsea,vesicle coating (GO:0006901),0.6918588708075417,2.471703132408779,0.0,0.0,0.0,20/34,17.79%,SEC13;TMED10;CNIH1;PDCD6;TRAPPC1;TRAPPC5;SCFD1;TRAPPC6A;BET1;SEC22B;TFG;PREB;PPP6C;SAR1B;NAPA;TRAPPC6B;PEF1;RAB1A;GOSR2;TRAPPC3
gsea,COPII vesicle coating (GO:0048208),0.6918588708075417,2.471703132408779,0.0,0.0,0.0,20/34,17.79%,SEC13;TMED10;CNIH1;PDCD6;TRAPPC1;TRAPPC5;SCFD1;TRAPPC6A;BET1;SEC22B;TFG;PREB;PPP6C;SAR1B;NAPA;TRAPPC6B;PEF1;RAB1A;GOSR2;TRAPPC3
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.6918588708075417,2.471703132408779,0.0,0.0,0.0,20/34,17.79%,SEC13;TMED10;CNIH1;PDCD6;TRAPPC1;TRAPPC5;SCFD1;TRAPPC6A;BET1;SEC22B;TFG;PREB;PPP6C;SAR1B;NAPA;TRAPPC6B;PEF1;RAB1A;GOSR2;TRAPPC3
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.7374060983577074,2.4699038068604184,0.0,0.0,0.0,18/28,16.75%,LSM5;LSM4;LSM6;NT5C3B;DCPS;WDR61;POLR2D;CNOT6;CNOT11;LSM1;CNOT7;DCP2;CNOT8;CNOT3;EDC3;SKIV2L;PDE12;CNOT2
gsea,DNA-dependent DNA replication (GO:0006261),0.7314854105294575,2.4670383316011355,0.0,0.0,0.0,18/31,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;POLE4;PSMB9;PSMD8;PSMD5;PSMB10;SSBP1;PSMB1;PSMF1;PSMD4;PSMD9
gsea,protein polyubiquitination (GO:0000209),0.5233586879969967,2.4473149179191074,0.0,0.0,0.0,61/140,23.92%,ANAPC11;PSMA7;PSMA2;UBE2L3;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PSMB9;PSMD8;RNF187;PSMD5;PSMB10;PSMB1;UBE2K;PSMF1;TRIM27;CBFB;PSMD4;UBE2A;CDC26;UBE2E1;DDA1;ANAPC13;UBE2J2;ANAPC2;PSMD9;UBE3A;UBE2G2;KBTBD6;TPP2;FBXO22;SPOP;RNF4;PSME1;UBE2V1;RBCK1;FBXO7;ANAPC10;PSMD10;RNF26;TOPORS;CTNNB1;WWP2;UBE2G1;FBXO4;UBE2J1;UBE2D3;TRIM2;UBE2Q2;AMFR;TRIM69;PPIL2;UBE3C;UBOX5;FBXO2;HECTD2;RNF20
gsea,nucleic acid metabolic process (GO:0090304),0.7920064939406436,2.4408144124645874,0.0,0.0,0.0,9/19,7.89%,HNRNPL;POLR2J;PCBP2;POLR2K;POLR2D;POLR2G;POLR2I;XRN2;LSM1
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.8304790309099953,-2.4388481032366256,0.0,0.0,0.0,7/16,5.74%,TGFB1;DDX5;ETS1;EGR1;NR3C1;HIF1A;STAT3
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.6993259181326615,2.435620738925994,0.0,0.0,0.0,20/37,12.02%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;KRAS;PAK2;PSME1;PRKACA
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.6993259181326615,2.435620738925994,0.0,0.0,0.0,20/37,12.02%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;KRAS;PAK2;PSME1;PRKACA
gsea,cellular response to lectin (GO:1990858),0.6993259181326615,2.435620738925994,0.0,0.0,0.0,20/37,12.02%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;KRAS;PAK2;PSME1;PRKACA
gsea,protein modification by small protein conjugation (GO:0032446),0.5053901232318494,2.4234402494811995,0.0,0.0,0.0,55/143,24.09%,ANAPC11;UBE2L3;TPR;UBE2I;COMMD1;RBX1;ELOB;DCUN1D5;RNF7;NSMCE2;PCNP;WDR61;NEDD8;RNF187;UBE2K;TRIM27;SUMO1;UBE2A;ANAPC16;UFM1;UBE2E1;NUP50;UBE2J2;RNF181;UFC1;ATG3;DERL1;CUL2;PAF1;UBE2G2;TRAF7;ARRB2;CDK5RAP3;FBXO7;RNF220;UBA5;UBE2Z;RNF26;TOPORS;PEX14;CAND2;LZTR1;WWP2;UBE2G1;FBXO4;UBE2D3;UBE2Q2;AMFR;TRIM69;RTF1;URM1;FBXO2;RNF20;DET1;ARRDC1
gsea,mRNA export from nucleus (GO:0006406),0.7710237089988328,2.421394238570794,0.0,0.0,0.0,11/22,7.65%,TPR;THOC7;SEC13;ENY2;SRSF11;PABPN1;POLR2D;U2AF1L4;FIP1L1;NUP50;CHTOP
gsea,negative regulation of cell cycle (GO:0045786),-0.7634936278726648,-2.4146836814278734,0.0,0.0,0.0,13/21,14.10%,BTG1;TGFB1;CDKN1B;NR4A1;RNF167;BTG3;HECA;SLC9A3R1;CEBPA;PPP1R13B;APC;CHMP1A;RPS6KA2
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),-0.6629238436692145,-2.413767239608726,0.0,0.0,0.0,10/33,11.50%,CD3E;CD8A;FYN;ABI1;ZAP70;LCK;INSRR;SRC;JAK3;DDR1
gsea,regulation of cytokine production (GO:0001817),-0.6854443033886334,-2.407041552688084,0.0,0.0,0.0,12/31,7.17%,SRGN;PLD3;PTPRC;ITK;S100A13;TNFRSF1B;CD28;LGALS9;FOXP1;NPTN;ATP2B1;N4BP1
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),0.5086385161091658,2.4000109357538966,0.0,0.0,0.0,73/159,24.09%,ANAPC11;PSMA7;PSMA2;UBE2L3;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;UBE2I;PSMC3;RBX1;PCBP2;PSMB9;RNF7;PSMD8;PCNP;NEDD8;RNF187;PSMD5;PSMB10;PSMB1;UBE2K;PSMF1;TSG101;PSMD4;UBE2A;ANAPC16;CDC26;PPP1R11;UBE2E1;UBXN1;BAG6;KCTD5;ANAPC2;PSMD9;GSK3A;GID8;UBE2G2;MAEA;KBTBD6;ARRB2;FBXO22;SPOP;RNF4;PPP2R5C;PSME1;RBCK1;ATE1;NTAN1;MVB12A;FBXO7;ANAPC10;PSMD10;PTTG1;TOPORS;CTNNB1;UFD1;WWP2;UBE2G1;VPS4A;RMND5B;AGAP3;UBE2D3;TRIM2;AMFR;UBE3C;ARMC8;VPS4B;UBL7;UBQLN2;RNF20;ARRDC1
gsea,MAPK cascade (GO:0000165),0.5578875282423835,2.3993605726608687,0.0,0.0,0.0,36/96,15.41%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;YWHAB;RBX1;CALM1;PABPN1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;GRB2;PSMD9;ABHD17A;KRAS;PPP1CC;CCM2;MAP2K2;WDR83;PSME1;PTPRA;LAMTOR3;LAMTOR2;PTK2;FNTA;MAPK1;RCE1;PSMD10
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.8250440317664406,2.3967977545150156,0.0,0.0,0.0,12/16,11.34%,LSM5;LSM4;LSM6;NT5C3B;DCPS;WDR61;POLR2G;CNOT6;LSM1;CNOT7;DCP2;CNOT8
gsea,double-strand break repair via homologous recombination (GO:0000724),0.7385098016448738,2.3931208496390157,0.0,0.0,0.0,10/24,11.18%,SWI5;RAD21;NSMCE2;RAD51B;MORF4L1;NABP2;SEM1;XRCC3;YY1;SFR1
gsea,substantia nigra development (GO:0021762),0.8048155195496638,2.391944490198612,0.0,0.0,0.0,11/18,9.13%,YWHAH;CALM3;YWHAQ;CALM1;NDUFS3;DYNLL1;COX6B1;RHOA;CDC42;MAPKAP1;SUDS3
gsea,mitochondrion organization (GO:0007005),0.5932008033052304,2.3882455917386882,0.0,0.0,0.0,25/53,18.50%,COX7A2;DNAJC19;SLIRP;TIMM10B;RAB5IF;AIP;SSBP1;CHCHD2;TIMM22;TOMM22;FMC1;TOMM7;BCAP31;SLC25A4;CHCHD3;TOMM34;MFF;TMEM11;ATPAF1;DNM1L;FBXO7;TWNK;RHOT1;TIMM17B;TFB2M
gsea,pre-replicative complex assembly (GO:0036388),0.797598121860525,2.387332182244007,0.0,0.0,0.0,16/21,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9
gsea,cellular response to cytokine stimulus (GO:0071345),-0.5288673495064683,-2.386909585445164,0.0,0.0,0.0,43/108,13.88%,PTPN18;SELPLG;UBC;RPL13A;MCL1;IRAK2;CRLF2;TGFB1;TNFRSF1B;IFNGR1;CDKN1B;IL2RG;IL2RB;IL12RB2;FYN;EGR1;STAT4;UBA52;INPP5D;LGALS9;FOXO1;JAK1;IFNAR1;HIF1A;IL10RB;IL3RA;NDUFA13;GBA;STAT3;PTPN4;ITGB2;IRAK4;INPP5K;LDLRAP1;IL27RA;CEBPA;LCK;RPS3;RC3H1;JAK3;SLA2;IL18BP;IKBKB
gsea,"transcription, DNA-templated (GO:0006351)",0.5711838295391546,2.3806016261781964,0.0,0.0,0.0,38/69,21.44%,GTF2H5;POLR2J;TAF10;ELOB;CCNH;TCEA1;POLR2K;GTF2A2;WDR61;POLR2D;CBFB;POLR2G;TAF12;POLR2I;DRAP1;CDK9;TAF11;GTF3C6;NELFA;PAF1;ARRB2;RNGTT;NELFB;CRCP;TWNK;ABT1;MNAT1;DEAF1;TOPORS;SNAPC3;GTF2B;BRF1;TFB2M;SNAPC2;TBPL1;CCNT2;XAB2;RTF1
gsea,mitotic cell cycle phase transition (GO:0044772),0.5994051100953377,2.376549801206558,0.0,0.0,0.0,27/51,21.18%,ARPP19;FOXM1;MAPRE1;SSNA1;CCNH;KHDRBS1;DYNLL1;PPP2R1A;RPS6KB1;DCTN3;PAFAH1B1;CHMP2A;CUL2;PPP2R2A;LCMT1;PPP6C;PPP2R2D;PRKACA;CRLF3;CEP63;CCDC57;MNAT1;DCTN2;PPP1R12B;CEP131;FBXL6;CHMP7
gsea,snRNA transcription (GO:0009301),0.7353293169692576,2.3566583462684556,0.0,0.0,0.0,15/22,20.73%,POLR2J;POLR2K;GTF2A2;POLR2D;POLR2G;POLR2I;NABP2;CDK9;TAF11;SNAPC1;SNAPC3;GTF2B;PHAX;SNAPC2;CCNT2
gsea,snRNA transcription by RNA polymerase II (GO:0042795),0.7353293169692576,2.3566583462684556,0.0,0.0,0.0,15/22,20.73%,POLR2J;POLR2K;GTF2A2;POLR2D;POLR2G;POLR2I;NABP2;CDK9;TAF11;SNAPC1;SNAPC3;GTF2B;PHAX;SNAPC2;CCNT2
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.6536358974629968,2.3549849249689645,0.0,0.0,0.0,20/35,20.86%,ARPP19;FOXM1;MAPRE1;SSNA1;CCNH;KHDRBS1;DYNLL1;PPP2R1A;DCTN3;PAFAH1B1;PPP2R2A;LCMT1;PRKACA;CEP63;CCDC57;MNAT1;DCTN2;PPP1R12B;CEP131;FBXL6
gsea,mRNA metabolic process (GO:0016071),0.7061846116918072,2.351826852297181,0.0,0.0,0.0,11/25,12.02%,LSM5;SNRPG;LSM6;NUDT21;AURKAIP1;SRSF11;PCBP2;RNH1;YTHDF2;DCP2;PRKACA
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.8212385367155637,2.3495963710489973,0.0,0.0,0.0,11/15,11.34%,LSM5;LSM4;LSM6;NT5C3B;DCPS;WDR61;CNOT6;LSM1;CNOT7;DCP2;CNOT8
gsea,histone acetylation (GO:0016573),0.6872357446028631,2.340251516458758,0.0,0.0,0.0,11/23,14.53%,TAF10;MEAF6;MORF4L1;TAF12;YEATS4;MSL3;TADA1;BRD1;MRGBP;DR1;LEF1
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.7018649622826754,2.3373581772939116,0.0,0.0,0.0,17/30,8.21%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;SEC22B
gsea,positive regulation of translation (GO:0045727),0.6594733146405186,2.3361181991821622,0.0,0.0,0.0,18/34,17.57%,RBM3;UQCC2;ELAVL1;KHDRBS1;COA3;POLR2D;POLR2G;RPS6KB1;MPV17L2;RPL26;YTHDF2;DHX36;USP16;YTHDF1;NGRN;FXR1;UPF3A;UHMK1
gsea,cell cycle G2/M phase transition (GO:0044839),0.6373267225671565,2.3267059683739033,0.0,0.0,0.0,20/36,20.86%,ARPP19;FOXM1;MAPRE1;SSNA1;CCNH;KHDRBS1;DYNLL1;PPP2R1A;DCTN3;PAFAH1B1;PPP2R2A;LCMT1;PRKACA;CEP63;CCDC57;MNAT1;DCTN2;PPP1R12B;CEP131;FBXL6
gsea,hemopoiesis (GO:0030097),-0.6906793680420866,-2.324527264109202,0.0,0.0,0.0,12/26,9.64%,SELPLG;PTPRC;TGFB1;CD164;TGFBR2;PRKX;RUNX2;RRAS;ARIH2;FLCN;CEBPA;LCK
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.7117226339840064,2.3223845426423857,0.0,0.0,0.0,17/29,8.21%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;SEC22B
gsea,establishment of protein localization to mitochondrion (GO:0072655),0.7553910906540817,2.3168956770636244,0.0,0.0,0.0,14/18,13.55%,DNAJC19;PAM16;ROMO1;TIMM10B;AIP;TIMM22;TOMM22;TOMM7;BCAP31;DNLZ;TOMM34;MFF;GRPEL2;FBXO7
gsea,recombinational repair (GO:0000725),0.7244745057914009,2.309789072465993,0.0,0.0,0.0,9/20,11.18%,SWI5;NSMCE2;RAD51B;MORF4L1;NABP2;SEM1;XRCC3;YY1;SFR1
gsea,mitochondrial transport (GO:0006839),0.7205273063072815,2.3095809074395226,0.0,0.0,0.0,13/21,13.55%,TMEM14C;DNAJC19;TIMM10B;AIP;TIMM22;TOMM22;TOMM7;BCAP31;SLC25A4;TOMM34;MFF;MAIP1;FBXO7
gsea,protein targeting to mitochondrion (GO:0006626),0.734494287888676,2.304498512993842,0.0,0.0,0.0,15/20,13.55%,DNAJC19;PAM16;ROMO1;TIMM10B;AIP;TIMM22;TOMM22;TOMM7;BCAP31;DNLZ;TOMM34;MFF;IMMP1L;GRPEL2;FBXO7
gsea,cellular response to lipopolysaccharide (GO:0071222),0.6785383477966199,2.3040529280038093,0.0,0.0,0.0,6/27,5.11%,HMGB2;HMGB1;PABPN1;GSTP1;RHOA;PYCARD
gsea,protein insertion into ER membrane (GO:0045048),0.7433174457413495,2.297830432387827,0.0,1.2332762851471531e-05,0.001,12/20,10.86%,UBL4A;EMC7;SEC61B;EMD;EMC6;SGTA;VAPA;WDR83OS;BAG6;UBE2J2;SEC61G;EMC3
gsea,regulation of viral transcription (GO:0046782),0.7730586976343704,2.2943335793250057,0.0,1.2219618238155277e-05,0.001,10/16,16.38%,POLR2J;POLR2K;TRIM27;POLR2D;POLR2G;POLR2I;CDK9;NELFA;NELFB;UBP1
gsea,intracellular protein transmembrane transport (GO:0065002),0.7295288664579899,2.285585384944769,0.0,1.2108530799626593e-05,0.001,11/18,17.54%,DNAJC19;PAM16;ROMO1;SEC61B;DNLZ;SEC63;SEC61G;GRPEL2;PEX14;PEX16;TIMM17B
gsea,cellular response to interleukin-1 (GO:0071347),0.6138120442120416,2.285378353285789,0.0,1.1999444936566896e-05,0.001,18/49,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PYCARD;PSMD9
gsea,protein N-linked glycosylation (GO:0006487),0.6751582897071818,2.2791151927250897,0.0,1.1892307035347548e-05,0.001,16/25,20.47%,KRTCAP2;OSTC;OST4;TMEM258;DAD1;TMEM165;MGAT2;ALG5;TUSC3;DPM2;NUDT14;DPM1;ALG1;UBE2J1;DPM3;MGAT3
gsea,positive regulation of endothelial cell proliferation (GO:0001938),0.7831267588020042,2.277261785657832,0.0,1.178706538016748e-05,0.001,4/17,6.67%,HMGB2;HMGB1;PDCD6;PDCL3
gsea,amyloid fibril formation (GO:1990000),-0.765108434929789,-2.253340357127996,0.0,0.0002540915502482948,0.003,7/16,6.22%,B2M;UBC;ITM2B;UBA52;PSENEN;SORL1;TSPAN14
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),0.7426981131534665,2.2508730468908356,0.0,2.336734013963027e-05,0.002,12/19,19.38%,POLR2J;POLR2K;POLR2D;TIAL1;POLR2G;POLR2I;GRB2;TIA1;RAB14;MAPK1;FGFRL1;FIBP
gsea,negative regulation of cell cycle process (GO:0010948),0.7418301142483577,2.2504736343358425,0.0,2.3164145877546527e-05,0.002,6/16,9.33%,EZH2;AURKAIP1;UXT;YAF2;CHMP2A;WAPL
gsea,interleukin-1-mediated signaling pathway (GO:0070498),0.6283281552480968,2.250188026118531,0.0,2.2964454964809054e-05,0.002,17/41,6.85%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;PSMB9;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9
gsea,response to lipopolysaccharide (GO:0032496),0.6080937449774084,2.244107062254702,0.0,2.276817757194744e-05,0.002,6/42,5.11%,HMGB2;HMGB1;PABPN1;GSTP1;RHOA;PYCARD
gsea,mitotic nuclear membrane organization (GO:0101024),0.6790063044489901,2.243704859772808,0.0,2.238551912536009e-05,0.002,9/20,11.25%,UBE2I;SEC13;SUMO1;PPP2R1A;EMD;PPP2CA;CHMP2A;PPP2R2A;CHMP6
gsea,mitotic nuclear membrane reassembly (GO:0007084),0.6790063044489901,2.243704859772808,0.0,2.238551912536009e-05,0.002,9/20,11.25%,UBE2I;SEC13;SUMO1;PPP2R1A;EMD;PPP2CA;CHMP2A;PPP2R2A;CHMP6
gsea,positive regulation of binding (GO:0051099),0.6685672382527444,2.240815343043462,0.0,2.2198973132648753e-05,0.002,9/26,9.06%,HMGB2;HMGB1;EDF1;DPH3;NMD3;MED25;CEBPG;FKBP1A;DERL1
gsea,nuclear membrane reassembly (GO:0031468),0.6659313181293018,2.2309319622548394,0.0,2.2015510544775624e-05,0.002,9/21,11.25%,UBE2I;SEC13;SUMO1;PPP2R1A;EMD;PPP2CA;CHMP2A;PPP2R2A;CHMP6
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.7197223427652181,2.215826615032449,0.0,4.3315069527119516e-05,0.004,8/19,7.65%,TPR;THOC7;SEC13;SRSF11;U2AF1L4;FIP1L1;NUP50;CHTOP
gsea,mRNA transport (GO:0051028),0.7197223427652181,2.215826615032449,0.0,4.3315069527119516e-05,0.004,8/19,7.65%,TPR;THOC7;SEC13;SRSF11;U2AF1L4;FIP1L1;NUP50;CHTOP
gsea,cellular response to oxygen-containing compound (GO:1901701),0.5123195756879559,2.213994597198631,0.0,4.2965754450287914e-05,0.004,23/80,19.58%,HMGB2;HMGB1;PABPN1;ROMO1;PDK3;GSTP1;GNB1;RHOA;PYCARD;SNW1;LAMTOR4;LAMTOR1;PAF1;DHX36;LAMTOR5;LAMTOR3;LAMTOR2;MAPK1;P2RY12;TWF2;HCN2;AGAP3;P2RY1
gsea,RNA export from nucleus (GO:0006405),0.7075319359352135,2.2049275718048222,0.0,5.327753551835701e-05,0.005,8/20,7.65%,TPR;THOC7;SEC13;SRSF11;U2AF1L4;FIP1L1;NUP50;CHTOP
gsea,regulation of gene silencing by miRNA (GO:0060964),0.7538185739297623,2.1905745247141604,0.0,6.342563752185358e-05,0.006,9/17,6.75%,TPR;POLR2J;SEC13;ELAVL1;POLR2K;POLR2D;POLR2G;POLR2I;NUP50
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.6590028549649382,2.186228587401805,0.0,6.292622305317757e-05,0.006,7/26,5.89%,HMGB1;PDCD5;BEX3;CSNK2A1;PYCARD;PDCD6;BCAP31
gsea,DNA metabolic process (GO:0006259),0.5217387566874027,2.1839689466596046,0.0,8.324614924743284e-05,0.008,29/63,19.65%,HMGB2;HMGB1;RAD21;POLE4;RAD51B;SUMO1;UBE2A;NABP2;SMARCAD1;INIP;XRCC3;ERCC1;GLRX2;ALKBH1;ORC4;MPG;ALKBH3;MNAT1;NSMCE3;PNKP;POLB;REXO4;TERF1;POLL;NTHL1;TOP2B;RAD9B;STN1;TOP1
gsea,RNA 3'-end processing (GO:0031123),0.6813811036596592,2.1812260361544946,0.0020161290322580645,8.260083026101863e-05,0.008,13/22,17.93%,NUDT21;THOC7;SRSF11;PABPN1;PAPOLA;U2AF1L4;FIP1L1;CHTOP;TENT2;WDR33;CPSF7;CDC40;MTPAP
gsea,cellular respiration (GO:0045333),0.6947145543461157,2.18120525825936,0.0,8.196543925901079e-05,0.008,10/20,3.97%,UQCR10;SDHB;ETFA;NDUFS7;UQCRB;UQCRFS1;NDUFS8;SDHC;NDUFS4;UQCRC2
gsea,metal ion transport (GO:0030001),-0.6272659507050294,-2.175697473540993,0.0,0.0015591981492508998,0.019,4/28,2.41%,TPT1;NDFIP1;FYN;SELENOK
gsea,negative regulation of macromolecule metabolic process (GO:0010605),-0.5340734135923494,-2.1727656954368317,0.0,0.001429264970146658,0.019,13/57,8.35%,CD3E;NDFIP1;TGFB1;PTPN22;CD28;TNRC6B;SUB1;LGALS9;HIF1A;FOXP1;TNRC6C;FLCN;AGO3
gsea,positive regulation of T cell activation (GO:0050870),-0.7038365182235939,-2.1627926250506966,0.0,0.0014659127898940083,0.022,13/21,14.20%,CD3E;PTPRC;CD6;THY1;CD28;LGALS9;PRKCQ;ZAP70;NCK1;LCK;JAK3;NOD2;IL15
gsea,protein methylation (GO:0006479),0.723400795484693,2.1477756771666234,0.0,0.0001626794977659756,0.014,8/16,12.31%,EZH2;TRMT112;PCMT1;EEF1AKMT1;SETD3;LCMT1;EEF1AKMT2;NSD1
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.6226639859504371,2.143974963177265,0.0,0.0001816279619943989,0.016,15/30,21.60%,RBM3;HNRNPL;SAP18;TRA2B;PUF60;KHDRBS1;SF1;SNW1;TRA2A;TIA1;FXR1;RBM7;FAM172A;RBM4;WTAP
gsea,Golgi organization (GO:0007030),0.5576730715487651,2.1399619118609303,0.0,0.00018026233822000492,0.016,22/44,23.56%,TMED10;TMED9;CDC42;YWHAZ;TMED3;CSNK1A1;BET1;SEC22B;SURF4;VTI1B;RAB2A;TMED7;TMED5;RAB1A;VMP1;GOSR2;TJAP1;COG4;COG2;TANGO2;GOLGA5;OBSL1
gsea,regulation of endothelial cell proliferation (GO:0001936),0.7109595538031849,2.1282395979374704,0.0,0.00018885693560611626,0.017,5/17,8.50%,HMGB2;PDCD6;PDCL3;SYNJ2BP;AIMP1
gsea,positive regulation of lymphocyte proliferation (GO:0050671),-0.715368180536901,-2.117367385947427,0.0,0.002586288993598715,0.036,4/16,2.29%,CD3E;PTPRC;CD6;CD28
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),0.5863311636755506,2.11278177131601,0.0,0.0002565214673106078,0.021,12/37,11.11%,EZH2;CALM3;CALM1;CDC37;CCNH;SNF8;TSG101;RHOA;PYCARD;PPP2CA;MAP2K2;CDK5RAP3
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),0.7183341472166953,2.110336827575799,0.0,0.00027422260928566106,0.023,7/15,11.48%,CALM3;CALM1;PTPA;PPP1R2;PPP1R11;FKBP1A;CSNK2B
gsea,brain development (GO:0007420),0.5814506480254311,2.1082454620110322,0.0,0.0002722209844003643,0.023,13/38,14.92%,NDUFS4;UFM1;EOMES;TMX2;BAG6;PAFAH1B1;UBE3A;UFC1;PAFAH1B2;IER3IP1;CDK5RAP3;UGP2;HESX1
gsea,cellular protein modification process (GO:0006464),0.4124795179308475,2.10659918384991,0.0,0.00028955182346933155,0.025,136/349,30.07%,PSMA7;PSMA2;UBE2L3;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;UBE2I;PPP1CA;PSMC3;COPS6;UBL4A;COMMD1;RBX1;ELOB;CSNK2A1;PSMB9;RNF7;PSMD8;PDK3;ILK;NEDD8;PSMD5;PSMB10;GPAA1;PSMB1;PSMF1;PSMD4;ILKAP;PIGT;PPP2R1A;BTBD1;CTBP1;YWHAZ;DAD1;UBE2E1;DDA1;PHPT1;CDK9;PPP2CA;PSMD9;CSNK1A1;CSK;GSK3A;ATG3;PRPF4B;DAPK3;CUL2;SETD3;DNAJC3;PPP1CC;COPS8;PPP2R2A;KBTBD6;LCMT1;PPP6C;PRKAG1;ALG5;RAB8A;PAK2;FBXO22;PPP2R5C;PSME1;FASTK;TLK1;PRKACA;PTPRA;PGGT1B;ATE1;RUNX3;PNPLA2;FBXO7;ATG4B;ATG5;GRK6;PTP4A2;ASB8;SDHAF2;CDK11B;RAB2A;MTMR2;MAPK1;RCE1;WIPI2;PSMD10;ALG1;CSNK1G2;FNIP2;WWP2;RAB1A;KBTBD8;MORC3;FBXO4;CHML;PTPRU;APOA2;CDK10;UBE2D3;PPP2R5E;MBTPS1;PPM1B;SIRT7;STK26;PPM1D;STK11;ASB6;FBXO2;OBSL1;LIMK2;MAN2B1;TMEM132A;PPM1E;KLHL2;CDC42BPA;PTPRR;VWA1;FBXO17;PIGK;FBXW2;KCTD6;WFS1;CLK3;MAPK3;TNKS;PKN3;STK19;MSRA;STK25;PKN2;ART4;MACROD2;ARAF;ENGASE;CDC42BPG;CAMK4
gsea,chromosome organization (GO:0051276),0.6437374246413681,2.1057299298763534,0.0,0.0002874687168256673,0.025,8/24,11.74%,HMGB2;EZH2;COPS6;RBX1;GATAD1;HDAC3;COPS8;FAM50A
gsea,positive regulation of viral process (GO:0048524),0.6638627481007018,2.1051056556003305,0.0,0.00028541536884834116,0.025,12/21,17.60%,POLR2J;POLR2K;POLR2D;POLR2G;POLR2I;CDK9;CNOT7;NELFA;TYRO3;NELFB;PDE12;VPS4A
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),0.7248928357049419,2.105105519898623,0.0,0.0002833911463742394,0.025,9/15,16.03%,MAPRE1;SSNA1;DYNLL1;PPP2R1A;DCTN3;PAFAH1B1;PRKACA;CEP63;DCTN2
gsea,nucleotide-excision repair (GO:0006289),0.5979684236998604,2.1018125708152438,0.0,0.00030015512968088455,0.026,19/30,17.66%,GTF2H5;COPS6;POLR2J;COMMD1;RBX1;CCNH;TCEA1;POLR2K;POLR2D;POLR2G;POLR2I;AQR;ERCC1;COPS8;MNAT1;SLC30A9;PNKP;POLB;POLL
gsea,regulation of protein dephosphorylation (GO:0035304),0.7116549170183679,2.100211755552861,0.0,0.0003166846516825417,0.028,7/16,7.99%,CALM3;ARPP19;YWHAB;CALM1;PTPA;PPP1R2;CAMTA1
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",0.5485012059339769,2.0994709955768123,0.0,0.0003144854527125241,0.028,16/39,20.95%,SNX3;TRIM27;VPS29;TMED9;PLEKHJ1;SNX6;SNX1;SURF4;SNX8;VTI1B;YKT6;WASHC1;GOSR2;SNX12;GGA1;TBC1D10A
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.6717015456110513,-2.098106584803699,0.0,0.003260841561519783,0.043,1/18,0.07%,HCST
gsea,regulation of epithelial cell proliferation (GO:0050678),-0.7135784552940901,-2.0974397719288222,0.0,0.0030570389639247965,0.043,4/16,2.32%,B2M;TGFB1;NR4A3;NR4A1
gsea,negative regulation of autophagy (GO:0010507),-0.6892241958434049,-2.092633901306008,0.0,0.0031761443781036847,0.05,8/17,12.41%,CTSA;MCL1;PTPN22;SIRT2;STAT3;BMF;QSOX1;NRBP2
gsea,DNA repair (GO:0006281),0.5089736773921085,2.0817144278142123,0.0,0.00040417440738063935,0.036,29/62,18.48%,RAD21;CENPX;GTF2H5;COMMD1;MAD2L2;BABAM1;RAD51B;SUMO1;UBE2A;NABP2;UBXN1;INIP;XRCC3;ERCC1;FAAP20;BABAM2;ALKBH1;WDR33;UBE2V1;MPG;ALKBH3;MNAT1;SLC30A9;NSMCE3;PNKP;POLB;REXO4;POLL;RAD9B
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.6489200035889087,2.07700542880308,0.0,0.0004287746865347225,0.038,12/23,19.38%,POLR2J;POLR2K;POLR2D;TIAL1;POLR2G;POLR2I;GRB2;TIA1;RAB14;MAPK1;FGFRL1;FIBP
gsea,circulatory system development (GO:0072359),-0.5908362523838417,-2.0753781034340237,0.0021691973969631237,0.0038113732537244215,0.066,9/28,12.44%,TGFB1;CDKN1B;BORCS8;TGFBR2;AKAP13;MEF2A;PDLIM2;CXADR;TCF25
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),0.5385124715883612,2.0747094472247616,0.0,0.00045304026801323995,0.038,19/50,16.55%,GTF2H5;POLR2J;TAF10;CCNH;POLR2K;GTF2A2;HDAC3;POLR2D;POLR2G;TAF12;POLR2I;CDK9;SNW1;TAF11;MED27;DR1;MED17;MNAT1;GTF2B
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.44477669037998663,2.0742263428107095,0.0,0.00044997918512125853,0.038,49/154,20.01%,HMGB2;EZH2;MYB;FOXM1;UBE2I;SAP18;YWHAQ;KHDRBS1;EIF4E2;HDAC3;SMARCE1;SUMO1;MALSU1;YAF2;CTBP1;SNX6;SNW1;GSK3A;KDM1A;MBD2;DAPK3;NKAP;SUDS3;CNOT7;WAPL;DHX36;SMAD2;MPHOSPH8;CNOT8;LSM14A;BRMS1;THAP7;MLX;SP3;CCDC85B;GATAD2A;LEF1;LIMS1;DEAF1;FXR1;CTNNB1;PEX14;WWP2;TERF1;ID3;CAPN3;CDKN1C;DPF2;EIF2AK1
gsea,protein insertion into membrane (GO:0051205),0.7172836607967378,2.073344391255895,0.0,0.0004469591905902434,0.038,8/15,10.21%,SEC61B;EMD;SGTA;VAPA;WDR83OS;UBE2J2;SEC61G;MAIP1
gsea,response to ionizing radiation (GO:0010212),0.712495998466137,2.0722907057649333,0.0,0.0004439794626529751,0.038,6/17,10.14%,SWI5;BABAM1;NABP2;GRB2;INIP;BABAM2
gsea,lysosome localization (GO:0032418),-0.6894966372227244,-2.0652581568175132,0.0,0.004045404944742589,0.077,10/17,7.14%,S100A13;NR4A3;BLOC1S1;KXD1;SNAPIN;TMEM106B;SPAG9;BORCS6;NDEL1;FLCN
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),0.6402219307506323,2.0514212496299824,0.0,0.0005909925297566093,0.052,13/21,9.62%,GTF2H5;COPS6;POLR2J;RBX1;CCNH;TCEA1;POLR2K;POLR2D;POLR2G;POLR2I;AQR;ERCC1;COPS8
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6582810763107443,2.042665104250101,0.0,0.0006309181837700173,0.056,10/20,21.60%,HNRNPL;SAP18;TRA2B;PUF60;KHDRBS1;FXR1;RBM7;FAM172A;RBM4;WTAP
gsea,cell chemotaxis (GO:0060326),0.6924163169019532,2.0417283992492377,0.0,0.0006355000151699447,0.056,1/17,0.01%,HMGB2
gsea,ciliary basal body-plasma membrane docking (GO:0097711),0.6127372030820633,2.0412849647554427,0.0,0.0006313733916948151,0.056,17/25,28.71%,MAPRE1;SSNA1;DYNLL1;PPP2R1A;DCTN3;PAFAH1B1;PRKACA;CEP63;DCTN2;NPHP1;CEP131;NPHP4;TCTN2;B9D2;MKS1;TMEM67;TUBB4A
gsea,regulation of DNA binding (GO:0051101),0.6962285264555018,2.0365590101642272,0.0,0.0006702657694244914,0.061,6/18,8.01%,HMGB2;HMGB1;EDF1;SUMO1;CEBPG;KDM1A
gsea,chromatin remodeling (GO:0006338),0.6040712893231498,2.0345798429045945,0.0,0.0007001214603373838,0.065,10/26,15.09%,MYB;GATAD1;SMARCE1;SMARCAD1;SMARCD2;MBD2;SMARCD1;CHRAC1;DR1;MPND
gsea,histone H3 acetylation (GO:0043966),0.6839075364459495,2.0324312891978185,0.0,0.0007295968239775005,0.068,10/15,25.85%,TAF10;MEAF6;TAF12;TADA1;BRD1;DR1;LEF1;PHF14;SUPT7L;LDB1
gsea,positive regulation of cell death (GO:0010942),-0.6990394728404106,-2.0316107765876517,0.0020325203252032522,0.005653536993024559,0.116,9/15,16.06%,CDKN1B;FYN;EGR1;ITGB2;LRP1;TRIM13;MARK4;APC;SARM1
gsea,protein-containing complex assembly (GO:0065003),0.4512672811411607,2.029749442687733,0.0,0.0007839890511403801,0.072,48/98,24.84%,RBX1;SEC13;ELOB;TMED10;GPAA1;AP2M1;CNIH1;PPP2R1A;DBNL;PDCD6;TRAPPC1;TCF7;TRAPPC5;CSNK1A1;SCFD1;TRAPPC6A;BET1;SEC22B;TFG;PREB;PPP6C;SAR1B;NAPA;CSNK2B;FERMT3;DNM1L;TRADD;TRAPPC6B;LEF1;MNAT1;PEF1;TAPBP;CTNNB1;PEX14;CAND2;RAB1A;CAPZA1;GOSR2;TRAPPC3;CAPN3;CASP8;DLG4;WAS;TCF7L1;DET1;AIM2;TRAPPC4;BAD
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.551250324457766,2.028174706148699,0.0022026431718061676,0.0008041892153714266,0.074,17/36,20.36%,RER1;TMED10;TMED9;TMED3;SCFD1;SEC22B;SURF4;ERGIC2;NAPA;COPB1;COPE;ARFGAP2;TMED7;TAPBP;RAB1A;COG4;COPZ1
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),0.44460175859437157,2.023981335330307,0.0,0.0008407861073990717,0.078,40/140,19.39%,HMGB2;YWHAH;MYB;FOXM1;ENY2;MAD2L2;PCBD2;ILK;EDF1;RNF187;TCF3;YAF2;YEATS4;EOMES;PSMD9;SETD3;BRD4;SMAD2;MAP2K2;LHX2;RNF4;SFR1;USP16;NSD1;UBE2V1;CRLF3;RUNX3;MED17;SP3;LEF1;RNF10;DEAF1;CTNNB1;CAND2;CXXC1;ELF2;CAPN3;CDKN1C;USP21;LRP5
gsea,ribonucleoprotein complex assembly (GO:0022618),0.5535845425178605,2.01578054819872,0.0,0.0010092949275216701,0.091,21/41,15.18%,SNRPG;LSM4;NUDT21;SNRPD2;SNRPC;RPS19;PUF60;LUC7L2;POLR2D;MRPS11;SF1;MCTS1;SF3B1;TGS1;GEMIN4;TRAF7;RPS5;CRNKL1;ABT1;CPSF7;GEMIN7
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),0.44615107440539076,2.0154366785684728,0.0,0.0010030647119196844,0.091,38/133,19.28%,HMGB2;EZH2;MYB;FOXM1;UBE2I;SAP18;YWHAQ;KHDRBS1;HDAC3;SMARCE1;SUMO1;YAF2;CTBP1;SNX6;SNW1;KDM1A;MBD2;NKAP;SUDS3;CNOT7;SMAD2;MPHOSPH8;BRMS1;THAP7;MLX;SP3;CCDC85B;GATAD2A;LEF1;LIMS1;DEAF1;CTNNB1;PEX14;WWP2;ID3;CAPN3;CDKN1C;DPF2
gsea,positive regulation of macromolecule metabolic process (GO:0010604),-0.4441336192804347,-2.010437507599105,0.0,0.007199260590368351,0.15,32/101,19.48%,CD3E;LAPTM5;RPS7;TGFB1;IFNGR1;ETS1;PTPN22;CD28;EGR1;MSN;TNRC6B;RBPJ;RPL23;LGALS9;HIF1A;PTPN1;GBA;STAT3;TNRC6C;AGO3;ATF2;RPS3;SRPK2;RPL11;ITCH;TICAM1;PDE2A;TGFBR1;ZBTB7B;BRAF;RAB29;INSR
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.5429150129992666,-2.00846526999532,0.0,0.006987517631828108,0.151,9/33,12.49%,CD6;CD164;TGFBR2;CD84;ITGAL;NPTN;ITGB2;CXADR;CDH24
gsea,"DNA-templated transcription, initiation (GO:0006352)",0.5090119007005702,2.008134503669381,0.0,0.0010867963533652582,0.098,22/57,19.43%,GTF2H5;POLR2J;TAF10;CCNH;POLR2K;GTF2A2;HDAC3;POLR2D;POLR2G;TAF12;POLR2I;CDK9;SNW1;TAF11;MED27;MED17;CRCP;MNAT1;GTF2B;BRF1;TFB2M;TBPL1
gsea,response to metal ion (GO:0010038),0.6331252332705325,2.0036222306126654,0.0,0.0011857500283048968,0.105,11/23,21.08%,CALM3;PPP1CA;CALM1;PDCD6;PPP2CA;SLC30A5;PEF1;SNCB;CAPN3;MTF1;SLC25A12
gsea,positive regulation of intracellular protein transport (GO:0090316),0.49412647348866445,2.0030619272977885,0.0,0.001186636018363406,0.106,27/62,24.84%,YWHAH;UBE2L3;TPR;YWHAQ;YWHAB;HDAC3;EMD;YWHAZ;TOMM7;OAZ1;UBE2J2;SAR1A;GSK3A;MFF;SAR1B;RBM22;SH3GLB1;PPP3R1;HCLS1;UBE2D3;CASP8;CEP131;PSEN1;LEPROT;MIEF1;CIB1;BAD
gsea,regulation of translational initiation (GO:0006446),0.5762903651184025,2.0005245381355365,0.0020408163265306124,0.0012276299599862383,0.11,18/28,25.35%,TPR;KHDRBS1;POLR2D;POLR2G;RPS6KB1;YTHDF2;EIF2B2;CSDE1;DNAJC3;EIF1B;ALKBH1;YTHDF1;UHMK1;EIF4EBP2;PPP1R15B;RBM4;BOLL;RPS6KB2
gsea,RNA transport (GO:0050658),0.6694429593547369,1.9998714011382934,0.003861003861003861,0.0012282545613513443,0.111,6/16,7.65%,TPR;THOC7;SRSF11;RTRAF;U2AF1L4;CHTOP
gsea,JNK cascade (GO:0007254),-0.6329823501583408,-1.9992454334656597,0.0,0.007484653273618249,0.164,4/21,3.79%,UBC;IRAK2;UBA52;NOD1
gsea,regulation of cell cycle process (GO:0010564),0.5967938816602641,1.998524928059543,0.0,0.0012447281363663766,0.114,13/26,24.46%,CALM3;CALM1;CSNK2A1;CDC42;YTHDF2;DAPK3;SH3GLB1;CTNNB1;MYO19;ENTR1;USP51;OBSL1;BECN1
gsea,extrinsic apoptotic signaling pathway (GO:0097191),-0.5947210943243927,-1.997240522421983,0.0,0.0073845356790910675,0.168,7/27,7.01%,GABARAP;MCL1;TGFB1;TNFRSF1B;CD27;ITGAV;DEDD2
gsea,protein complex oligomerization (GO:0051259),0.5907012034342184,1.997237970571823,0.0,0.0012373628811216052,0.114,16/31,25.05%,NUDT21;ELAVL1;G3BP2;PYCARD;CHMP2A;PDCD6IP;DNM1L;TWNK;MPP2;CPSF7;MICU1;UGDH;PRMT8;PKD2;CUTC;SPAST
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),-0.6261160986669966,-1.996244369977206,0.0,0.007114563406952254,0.169,9/21,14.20%,ITK;FYN;ABI1;ZAP70;LCK;SRC;JAK3;DDR1;IL15
gsea,autophagy of mitochondrion (GO:0000422),-0.6179963278653586,-1.9954646532397633,0.0,0.006914221992333406,0.17,7/23,5.21%,SQSTM1;GABARAP;MAP1LC3B;RB1CC1;GABARAPL2;MAP1LC3A;ATG12
gsea,regulation of JNK cascade (GO:0046328),0.5980926903166409,1.989971679633989,0.0017152658662092624,0.0013319383879589254,0.119,3/28,5.11%,HMGB1;HDAC3;PYCARD
gsea,cellular protein localization (GO:0034613),0.43530228417655714,1.9871505617701692,0.0,0.0013864621816180626,0.124,50/123,23.43%,YWHAH;SEC13;TMED10;VPS29;TMED9;ARF1;PDCD6;TM9SF1;ERP29;SNX6;TMED3;ABHD17A;SAR1A;ARL6;SNX1;TM9SF3;SCFD1;AP2A1;TM9SF2;LAMTOR1;SAR1B;NAPA;SNX17;USP4;TLK1;ARF6;RAB14;LAMTOR3;LAMTOR2;SNX8;TBC1D15;TMED7;WIPI2;RAB5C;CTNNB1;TMED5;RAB21;RAB1A;NPHP1;CAPN3;PTPRU;GGA1;UNC50;COPZ1;STXBP2;STX12;TBC1D10A;CROCC;ARFIP1;ARL5A
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5488515454366047,-1.9826776564584878,0.0,0.007599219512055483,0.195,13/32,19.48%,HCST;NOP53;SLC9A3R1;PPP1R16B;LIME1;SRC;PIP5K1A;PIP4K2A;SEMA4D;IL18;PPP2R5B;FBXL2;INSR
gsea,peptide metabolic process (GO:0006518),0.5910004051255857,1.9739271242418435,0.0,0.0016494353292747157,0.144,12/26,21.54%,SEC11C;GSTP1;SPCS1;LTA4H;SOD1;SEC11A;GLRX2;ETHE1;DNPEP;MGAT3;APEH;PSEN1
gsea,mitochondrion disassembly (GO:0061726),-0.6236844316789155,-1.9709060273464896,0.0,0.008235288637511698,0.219,7/22,5.21%,SQSTM1;GABARAP;MAP1LC3B;RB1CC1;GABARAPL2;MAP1LC3A;ATG12
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),0.5036216794635566,1.9697898218024388,0.0,0.0017014935476238294,0.15,20/42,28.26%,TAF10;CSNK2A1;RPS20;MEAF6;PAK1IP1;TAF12;TAF11;MAPKAP1;PRKAG1;CDK5RAP3;CSNK2B;PPP2R5C;RAD9B;RMI1;STK11;TTC5;ATRIP;TAF13;KAT5;PRDM1
gsea,cellular response to light stimulus (GO:0071482),0.6261149283650298,1.9672161967013262,0.0,0.0017529533956470915,0.155,9/21,16.23%,GNB1;COPS9;RPL26;KDM1A;YY1;DHX36;TMEM161A;TRIAP1;NSMCE3
gsea,import into nucleus (GO:0051170),0.6494371307116611,1.9661615608221752,0.001893939393939394,0.0017733808251110263,0.158,11/19,19.29%,SNRPG;SNRPD2;TPR;SEC13;NUP50;GEMIN4;APPL1;GEMIN7;IPO13;RANBP17;NXT2
gsea,regulation of heart contraction (GO:0008016),0.6660347444669917,1.9659332872943174,0.0,0.0017708726294453892,0.159,6/19,13.76%,CALM3;CALM1;ATP1B3;GSK3A;PRKACA;SRI
gsea,regulation of neuron differentiation (GO:0045664),0.656377420359661,1.949613100492587,0.0,0.0022274223889030614,0.203,4/19,11.11%,YWHAH;TCF3;RHOA;CDK5RAP3
gsea,regulation of TOR signaling (GO:0032006),0.5711012158825263,1.9487857109634663,0.0,0.0022523227796384074,0.206,9/30,13.27%,SEC13;HDAC3;PDCD6;LAMTOR4;GSK3A;LAMTOR1;LAMTOR5;LAMTOR3;LAMTOR2
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.6220253828445934,1.9479439443867714,0.0,0.002276944953717492,0.209,11/19,24.84%,HMGB1;PDCD5;PYCARD;PDCD6;BCAP31;USP50;CYFIP2;CASP8;TBC1D10A;AIM2;BAD
gsea,mitotic sister chromatid segregation (GO:0000070),0.5805752191021085,1.9452384713034854,0.0,0.0023308921789281195,0.212,13/26,24.46%,RAD21;CSNK2A1;CHMP2A;EML4;CHMP6;CSNK2B;PDCD6IP;DCTN2;TUBG2;VPS4A;CHMP7;VPS4B;BECN1
gsea,histone modification (GO:0016570),0.5459829609221096,1.9438524797394767,0.0,0.0023400906484582224,0.215,16/37,22.74%,EZH2;ENY2;TAF10;MORF4L1;UBE2A;MSL3;SUDS3;SIN3B;MRGBP;USP16;NSD1;BRMS1;USP21;PRMT8;SIRT7;USP51
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3924187074121699,1.9436429829373467,0.0,0.002341869693114594,0.216,92/247,33.20%,HMGB2;HMGB1;EZH2;MYB;FOXM1;TPR;UBE2I;SAP18;YWHAQ;MAD2L2;KHDRBS1;HDAC3;TCF3;TRIM27;CBFB;SMARCE1;SUMO1;UXT;DRAP1;YAF2;CTBP1;EOMES;SNX6;MED25;SNW1;KDM1A;CBX2;VPS72;YY1;MBD2;NKAP;SUDS3;CNOT7;PAF1;SMAD2;MPHOSPH8;SIN3B;PHF6;CGGBP1;NSD1;BRMS1;THAP7;RUNX3;MLX;DR1;SP3;CCDC85B;GATAD2A;LEF1;HESX1;LIMS1;DEAF1;PSMD10;CTNNB1;PEX14;FNIP2;WWP2;HSBP1;CNOT2;MAP2K5;ID3;CAPN3;THAP11;CDKN1C;DPF2;UBE2D3;SIRT7;RTF1;PSEN1;PHF12;SCML2;LDB1;DPF3;ZFP69;TBR1;WFS1;NCOR1;THRA;KAT5;PRDM1;NR2C1;ZBTB5;CPEB3;BEND5;SUFU;HMGA2;RING1;MAP3K10;HSF4;GPS2;CBFA2T2;ZMYND11
gsea,cellular protein-containing complex assembly (GO:0034622),0.49088680335497675,1.939009676961079,0.0,0.0024600829242082886,0.226,22/56,20.03%,COX7A2;TPR;PSMD13;SRP19;POMP;AP2S1;RAB5IF;GPX4;AP2M1;PSMD4;FKBP1A;FCHO1;ARL6;CHMP2A;SMAD2;CSNK2B;TBCD;TBCC;GTF2B;TBCE;COG4;TBCA
gsea,positive regulation of epithelial cell proliferation (GO:0050679),0.5972434368933969,1.9378283313950622,0.0,0.0024756680906627853,0.228,3/24,6.67%,HMGB2;PDCD6;PDCL3
gsea,protein targeting (GO:0006605),0.4800656447818632,1.9374080399617524,0.0,0.0024766854349074076,0.229,27/55,28.08%,DNAJC19;CDC37;YIF1B;TIMM10B;AIP;SPCS1;TIMM22;TOMM22;TOMM7;BCAP31;ZDHHC3;ARL6;ATG3;SEC63;TOMM34;MFF;SEC61G;FBXO7;PEX16;TIMM17B;ZDHHC4;AP4S1;SPCS2;ZDHHC7;ZFAND6;NACA;PEX19
gsea,regulation of ATP metabolic process (GO:1903578),0.66426052690042,1.9332929080996095,0.00199203187250996,0.0025994281442424188,0.237,6/15,10.07%,COX7A2;TPR;UQCC2;SEC13;NUP50;PRKAG1
gsea,positive regulation of cellular component biogenesis (GO:0044089),0.5832085267865227,1.9319325617012173,0.0,0.0026282634500365957,0.24,11/24,17.60%,TPR;SNF8;TSG101;SUMO1;CHMP2A;ERCC1;PDCD6IP;SH3GLB1;BRK1;FNIP2;VPS4A
gsea,regulation of cell adhesion (GO:0030155),-0.5131956136542559,-1.9271741565899632,0.0,0.01305504861620549,0.332,12/35,17.41%,RAC2;PPP1R12A;CD164;ITGAV;CYTIP;PRKX;ARHGDIB;PPP3CA;FLCN;SRC;SEMA4D;IL18
gsea,positive regulation of cytokine production (GO:0001819),-0.4642839058728403,-1.925556744424973,0.0,0.012873971879246935,0.337,29/72,14.20%,LAPTM5;TIGIT;PTPRC;ITK;CRLF2;TGFB1;S100A13;CD2;CD6;IL12RB2;PTPN22;CD28;EGR1;LGALS9;PRKCQ;NOD1;PDE4D;HIF1A;SORL1;FOXP1;STAT3;FZD5;BCL10;TNFRSF14;EP300;RPS3;TICAM1;NOD2;IL15
gsea,cellular response to peptide (GO:1901653),-0.612263795236854,-1.918257216346169,0.002398081534772182,0.012991455069146686,0.346,9/18,14.51%,FYN;PTPN22;RPL23;NOD1;LRP1;CDK5;SRC;NOD2;CACNB1
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.526865614019102,-1.915924750698317,0.0,0.012473585194007198,0.354,8/30,15.32%,CD3G;FYN;CD247;GNG2;ADCY7;SRC;HRH2;PRKACB
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.526865614019102,-1.915924750698317,0.0,0.012473585194007198,0.354,8/30,15.32%,CD3G;FYN;CD247;GNG2;ADCY7;SRC;HRH2;PRKACB
gsea,endoplasmic reticulum organization (GO:0007029),0.535361038864512,1.9118208724884382,0.0038684719535783366,0.003400693756490873,0.284,15/29,29.16%,SEC61B;EMD;SGTA;VAPA;WDR83OS;UBE2J2;SEC61G;RAB10;DNM1L;MOSPD3;RTN4;CYB5A;VAPB;ATL1;TRAM2
gsea,stress-activated MAPK cascade (GO:0051403),-0.5475182921750227,-1.9089116248864768,0.001949317738791423,0.012891409534656133,0.372,8/29,17.37%,UBC;IRAK2;UBA52;LGALS9;NOD1;NOD2;IKBKB;MAP4K3
gsea,spindle assembly (GO:0051225),0.6256741908970517,1.9054266481827873,0.006382978723404255,0.0036575450970935566,0.303,6/17,12.70%,MAPRE1;HDAC3;RHOA;LSM14A;MZT1;CEP63
gsea,regulation of cytokinesis (GO:0032465),0.5858278979353813,1.903129787299294,0.001976284584980237,0.0037294274862849906,0.309,14/21,32.36%,CALM3;CALM1;RHOA;CDC42;SH3GLB1;VPS4A;MYO19;ENTR1;BECN1;SPAST;PKN2;GIT1;CDC14B;RAB11A
gsea,"regulation of transcription, DNA-templated (GO:0006355)",0.3664907107153136,1.9022088836234377,0.0,0.0037447691849944657,0.31,182/483,32.55%,HMGB2;HMGB1;EZH2;RAD21;YWHAH;UBE2L3;MYB;FOXM1;UBE2I;SAP18;YWHAQ;ENY2;MAD2L2;CCNH;KHDRBS1;PCBD2;MED18;POLR2K;ILK;EDF1;RNF187;SNF8;HDAC3;TCF3;TIAL1;CBFB;SMARCE1;SUMO1;PPP2R1A;UXT;DRAP1;YAF2;CTBP1;MED21;YEATS4;CDC5L;EOMES;TCF7;SNX6;MLF2;MED29;PPP2CA;PSMD9;BRD9;CEBPG;SRA1;SNW1;MSL3;SMARCD2;CAMTA1;KDM1A;YY1;MBD2;DAPK3;NKAP;TADA1;SUDS3;CNOT7;SMARCD1;SETD3;BRD4;SETD5;DHX36;MED27;GLRX2;SMAD2;MAP2K2;LHX2;RNF4;MPHOSPH8;SFR1;PHF6;MRGBP;POLR3C;USP16;NSD1;ATF6B;UBE2V1;CRLF3;BRMS1;THAP7;RUNX3;MLX;MED17;SP3;CCDC85B;SBNO1;CDK11B;GATAD2A;LEF1;MNAT1;MED31;RNF10;MED6;HESX1;LIMS1;SREBF1;DEAF1;CTNNB1;PEX14;CAND2;CXXC1;WWP2;UBP1;BBS7;ELF2;CNOT2;SP9;REXO4;ID3;SAP30L;HCLS1;PQBP1;CAPN3;THAP11;CDKN1C;USP21;BATF;DVL2;DPF2;LRP5;FOXJ3;CREG1;ZFP82;PHF14;ZIK1;RFXAP;MTF1;CCNT2;ARNTL2;ZBTB3;ZFX;PSEN1;KLF5;TCF7L1;PHF12;DNM2;ZFPL1;ZKSCAN8;MED12L;RNF20;USF2;MED20;RPL6;SCML2;LDB1;HTATIP2;DPF3;ZFP69;TBR1;NCOR1;THRA;CCNQ;KAT5;PRKAR1A;ACTR8;IRF3;NR3C2;PRDM1;NR2C1;GPBP1;RXRB;RPS6KA1;GRHL2;ZBTB5;BEND5;CAMK4;ZFP92;MESP2;SUFU;SPIN1;TRIM45;MAP2K7;HMGA2;RING1;DVL1;WTIP;MAP3K10;TOX;HSF4;SIX5;HAS3
gsea,regulation of protein localization (GO:0032880),0.6121769860420128,1.8967299077677793,0.002136752136752137,0.003995815163876776,0.332,8/18,17.60%,TPR;TRIM27;SUMO1;FKBP1A;KDM1A;RAB14;WDPCP;VPS4A
gsea,organonitrogen compound biosynthetic process (GO:1901566),0.49302901158401874,1.8940571609512618,0.0,0.004106234926609122,0.341,28/52,33.95%,SPTSSA;CSNK2A1;AKR1A1;GSTP1;ESD;VAPA;CERS2;NFS1;CSNK2B;MOCS2;CEPT1;CSNK1G2;DEGS1;ELOVL1;ELOVL5;APOA2;SPTLC1;PCYT1B;GSTO2;PEMT;VAPB;GSTM4;PHOSPHO1;SPNS2;SGPP1;LPCAT3;CERS5;PLA2G4C
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.583334265062853,1.8880879353101874,0.0,0.0043047699445888975,0.349,13/24,21.56%,YWHAH;UBE2L3;YWHAQ;YWHAB;YWHAZ;TOMM7;UBE2J2;GSK3A;SH3GLB1;PPP3R1;UBE2D3;CASP8;LEPROT
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5830764159075099,1.8875365749911899,0.0016339869281045752,0.004316846467641235,0.349,6/28,10.34%,EZH2;CALM3;CALM1;RHOA;PPP2CA;MAP2K2
gsea,positive regulation of JNK cascade (GO:0046330),0.6483148226259013,1.8866949053351634,0.0033613445378151263,0.0043084129488059125,0.35,2/17,5.11%,HMGB1;PYCARD
gsea,defense response to bacterium (GO:0042742),0.617632818677438,1.8863896586464044,0.0035842293906810036,0.00429330394088283,0.351,5/21,6.07%,HMGB2;RPS19;ROMO1;PYCARD;PPP1R11
gsea,negative regulation of cell population proliferation (GO:0008285),-0.4178413904876723,-1.884480731164579,0.0,0.01613481344076672,0.438,32/92,23.86%,B2M;BTG1;TGFB1;CDKN1B;VGLL4;ETS1;CD164;SIRT2;BTG3;ABI1;FTH1;SLC9A3R1;TES;FLCN;CEBPA;RBM5;RNF139;ING4;B4GALT7;APC;RPS6KA2;ATP8A2;NACC2;ZBTB49;TMEM115;IRF6;ADORA3;TNFRSF8;MYO16;TGFB1I1;NOS3;VHL
gsea,ephrin receptor signaling pathway (GO:0048013),0.5456258140412222,1.8795166510823829,0.0,0.0045945147423027575,0.375,14/34,24.67%,AP2S1;RAC1;AP2M1;RHOA;CDC42;ACTR3;ARPC4;ARPC1A;AP2A1;PTK2;ARPC5;PSEN1;NCSTN;CHN1
gsea,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.6472412520177121,-1.8788765921487878,0.00390625,0.017027662915944757,0.456,6/15,13.19%,UBC;IRAK2;UBA52;NOD1;ITCH;NOD2
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5317656604385891,1.8781392561678278,0.0038535645472061657,0.004618711723419756,0.382,16/34,16.84%,SEC13;AP1S1;AP2S1;DYNLL1;AP2M1;ARF1;ACTR10;CAPZB;DCTN3;AP2A1;SAR1B;DCTN5;OSBPL1A;ACTR1B;DCTN2;CAPZA1
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5317656604385891,1.8781392561678278,0.0038535645472061657,0.004618711723419756,0.382,16/34,16.84%,SEC13;AP1S1;AP2S1;DYNLL1;AP2M1;ARF1;ACTR10;CAPZB;DCTN3;AP2A1;SAR1B;DCTN5;OSBPL1A;ACTR1B;DCTN2;CAPZA1
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5317656604385891,1.8781392561678278,0.0038535645472061657,0.004618711723419756,0.382,16/34,16.84%,SEC13;AP1S1;AP2S1;DYNLL1;AP2M1;ARF1;ACTR10;CAPZB;DCTN3;AP2A1;SAR1B;DCTN5;OSBPL1A;ACTR1B;DCTN2;CAPZA1
gsea,response to cytokine (GO:0034097),-0.5054574708504026,-1.8748087299029814,0.0,0.017082506249800896,0.462,12/38,13.43%,PTPN18;MCL1;SP100;IRAK2;LGALS9;STAT3;PTPN4;LDLRAP1;SRC;JAK3;IGBP1;IL18BP
gsea,positive regulation of protein ubiquitination (GO:0031398),0.5114426101169793,1.8745849958191143,0.004347826086956522,0.004793659445772964,0.395,19/33,19.12%,UBE2L3;CENPX;COMMD1;RBX1;DCUN1D5;HDAC3;PDCD6;FKBP1A;GSK3A;UBE3A;KDM1A;DERL1;CDK5RAP3;PEF1;PSMD10;TOPORS;NSMCE3;FBXO4;SENP2
gsea,cilium assembly (GO:0060271),0.42769333278567667,1.8713288100607992,0.0,0.0049143933624691384,0.402,62/108,38.29%,MAPRE1;SSNA1;CFAP20;DYNLL1;PPP2R1A;ACTR3;DCTN3;DYNLRB1;ARL6;PAFAH1B1;RAB8A;NUDCD3;PRKACA;ARL3;CEP63;CCDC57;BBS5;WDPCP;DCTN2;RAB1A;BBS7;NPHP1;NPHP3;TTC26;SNAP29;TTC8;EXOC5;EXOC3;CEP131;TMEM17;EXOC1;WDR35;TTC36;INTU;NPHP4;TCTN2;ATAT1;EXOC7;B9D2;IFT122;MKS1;TMEM67;TUBB4A;PKD1;CCDC96;RSPH1;CDC14B;WDR19;CPLANE2;RAB11A;IFT52;IFT172;ARMC9;VANGL2;GALNT11;TXNDC15;TTC30B;NINL;BBIP1;BBS2;BBOF1;DYNC2LI1
gsea,regulation of translation (GO:0006417),0.49058221278332786,1.8677340154354711,0.002188183807439825,0.0050992347107643166,0.414,22/45,22.29%,RBM3;ELAVL1;EIF4E2;MALSU1;RPS6KB1;MTPN;RPL26;DAPK3;EIF2B2;CNOT7;CSDE1;EIF1B;DHX36;CNOT8;LSM14A;ALKBH1;YTHDF1;FXR1;UPF3A;MTRF1;RBM4;POLDIP3
gsea,regulation of proteasomal protein catabolic process (GO:0061136),0.6285833145541115,1.8610465968561185,0.003861003861003861,0.005451201499987992,0.436,5/17,12.02%,PSMC3;COMMD1;PSMF1;PSME1;PRKACA
gsea,regulation of Wnt signaling pathway (GO:0030111),0.5330971413501995,1.8604886816333113,0.0038314176245210726,0.005463533678763553,0.439,12/33,22.85%,PPP1CA;SNX3;CSNK2A1;CBFB;PPP2R1A;EMD;PPP2CA;CTNNB1;SENP2;PSEN1;TCF7L1;DACT3
gsea,peptidyl-lysine modification (GO:0018205),0.5516661514177322,1.8556079324857833,0.0038684719535783366,0.005726691619726779,0.459,11/29,20.91%,TPR;UBE2I;NSMCE2;SUMO1;NUP50;EEF1AKMT1;EEF1AKMT2;TOPORS;SENP6;SENP2;SIRT7
gsea,positive regulation of mitochondrion organization (GO:0010822),0.6319220832659113,1.8553869381646964,0.004319654427645789,0.0057119665483623145,0.46,9/16,24.84%,PDCD5;PYCARD;GSK3A;MFF;DNM1L;FBXO7;RALBP1;MIEF1;BAD
gsea,intracellular protein transport (GO:0006886),0.40466186603099447,1.8548329373839296,0.0,0.005722874030560358,0.462,48/124,23.43%,YWHAH;TPR;SEC13;CDC37;TMED10;VPS36;SNF8;VPS29;TMED9;ARF1;PDCD6;ERP29;SNX6;NUP50;TMED3;SAR1A;ARL6;SNX1;SCFD1;AP2A1;PREB;SURF4;SAR1B;NAPA;MAIP1;SNX17;TLK1;ARF6;RAB14;SNX8;APPL1;TBC1D15;TMED7;RAB5C;TMED5;RAB21;RAB1A;IPO13;RANBP17;GGA1;NXT2;COPZ1;STXBP2;STX12;TBC1D10A;ARFIP1;AP4S1;ARL5A
gsea,negative regulation of growth (GO:0045926),-0.5182416622721319,-1.8544312702701748,0.0021321961620469083,0.02022702472371294,0.521,13/33,15.73%,BTG1;TGFB1;CDKN1B;VGLL4;NDUFA13;SERTAD2;FLCN;PPT1;SERTAD3;ING4;SMAD4;CDKN2AIP;ACVR1B
gsea,tRNA processing (GO:0008033),0.6224808501458008,1.852897773275976,0.002004008016032064,0.00582247352450616,0.471,8/16,22.23%,RTRAF;RPP21;RTCB;ZBTB8OS;ADAT1;POP7;DTWD2;URM1
gsea,mesenchymal cell differentiation (GO:0048762),-0.592460702771206,-1.8514668601458732,0.0048543689320388345,0.020164444820986473,0.525,5/19,7.89%,TGFB1;DDX5;RBPJ;HIF1A;FBXL17
gsea,activation of GTPase activity (GO:0090630),-0.5195217559818975,-1.849810287403155,0.0,0.020025590303943734,0.532,13/32,17.78%,ARHGAP45;RABGAP1L;TBC1D10C;RHOG;SIPA1L3;PIP5K1A;RAP1GAP2;TBC1D2;RUNDC1;RAP1GAP;TBC1D12;TBC1D22A;TBC1D17
gsea,antigen receptor-mediated signaling pathway (GO:0050851),0.46560435021206503,1.843675731844619,0.0,0.006527129351419568,0.503,24/57,15.41%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;KHDRBS1;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;SPG21;CSK;EIF2B2;PAK2;PSME1;RBCK1;PSMD10
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),0.38471721122156616,1.842810484999817,0.0,0.006596864657343734,0.508,64/175,30.31%,HMGB1;EZH2;MYB;FOXM1;TPR;UBE2I;MAD2L2;HDAC3;TCF3;TRIM27;CBFB;SUMO1;UXT;DRAP1;CTBP1;EOMES;MED25;SNW1;KDM1A;CBX2;VPS72;YY1;MBD2;NKAP;SUDS3;PAF1;SMAD2;SIN3B;PHF6;CGGBP1;NSD1;BRMS1;THAP7;RUNX3;MLX;DR1;GATAD2A;HESX1;DEAF1;PSMD10;FNIP2;WWP2;HSBP1;CNOT2;MAP2K5;ID3;THAP11;DPF2;UBE2D3;SIRT7;RTF1;PSEN1;PHF12;LDB1;ZFP69;WFS1;NCOR1;THRA;KAT5;PRDM1;NR2C1;ZBTB5;CPEB3;SUFU
gsea,organelle organization (GO:0006996),0.3933482125317109,1.8392931959033905,0.0,0.006878555055186938,0.524,52/134,28.74%,TMED10;SSBP1;CHCHD2;TMED9;CDC42;VAPA;CAPZB;TMED3;SAR1A;TOR1A;CSNK1A1;CHMP2A;YTHDF2;FAF2;SURF4;TMEM11;SAR1B;CHMP6;PDCD6IP;RAB14;DNM1L;TWNK;WDPCP;RAB2A;YTHDF1;TMED7;PEX14;TMED5;PEX16;RAB1A;VMP1;RHOT1;PEX11B;VPS4A;TFB2M;TJAP1;COG4;ABCA3;CHMP7;COG2;PKD2;TANGO2;GOLGA5;VPS4B;CSPG5;OBSL1;STRIP2;VAPB;ATL1;FAM161B;PEX19;UBXN2A
gsea,cellular response to metal ion (GO:0071248),-0.5379537230823315,-1.8375001915716973,0.0022271714922048997,0.022248504033936054,0.582,4/23,8.61%,B2M;CDKN1B;ADCY7;MEF2A
gsea,positive regulation of protein modification process (GO:0031401),0.4678122738627262,1.837190730290561,0.0,0.0070144605758397606,0.532,20/53,24.20%,CALM3;CALM1;PTPA;RAC1;ILK;HDAC3;ERP29;CAMTA1;KRAS;BRMS1;PTK2;FXR1;CNEP1R1;RALBP1;DVL2;P2RY1;CRKL;PIK3R3;LIMK2;CIB1
gsea,nucleus organization (GO:0006997),0.5654897486368599,1.8359661960088252,0.00211864406779661,0.007068566049586668,0.537,10/22,24.22%,TPR;RPS19;TOR1A;CHMP2A;CHMP6;PDCD6IP;VPS4A;CHMP7;VPS4B;SUN1
gsea,T cell receptor signaling pathway (GO:0050852),0.4684971275639584,1.833816451736174,0.0,0.00720849988668511,0.544,23/53,15.41%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;PSMB9;KHDRBS1;PSMD8;PSMD5;PSMB10;PSMB1;PSMF1;PSMD4;PSMD9;CSK;EIF2B2;PAK2;PSME1;RBCK1;PSMD10
gsea,neuron projection development (GO:0031175),0.46754401386802724,1.8331276828899317,0.0,0.00720597081780543,0.545,16/56,23.07%,HMGB1;ATXN10;DBNL;CDC42;DTNBP1;VAPA;TOR1A;UHMK1;PQBP1;WHRN;DLG4;RAB35;DNM2;TBC1D24;NRTN;LRP12
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.6205859820296769,1.8326114982573796,0.00392156862745098,0.007215684569630691,0.547,6/16,16.20%,TSG101;CDC42;GRB2;PTPN2;MVB12A;EPN1
gsea,calcium ion transport (GO:0006816),-0.5036577430697742,-1.828806207746764,0.0,0.023579090883160212,0.609,15/33,28.73%,TPT1;FYN;SELENOK;ITGAV;ORAI3;TRPM6;TRPM4;NMUR1;CACNG7;PANX1;ATP2A1;SLC24A1;STIM1;CHRNB2;CRACR2B
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),0.5638726812367184,1.828343946782005,0.003669724770642202,0.007541568954653276,0.564,8/24,15.86%,EZH2;MAD2L2;PPP2CA;SMAD2;MCRIP1;SDHAF2;LEF1;CTNNB1
gsea,regulation of transcription by RNA polymerase II (GO:0006357),0.34972405306620846,1.827457542353222,0.0,0.007561777484366807,0.567,179/490,32.39%,HMGB2;HMGB1;EZH2;RAD21;MYB;GTF2H5;FOXM1;TPR;UBE2I;PSMC3;SAP18;ENY2;MAD2L2;SSU72;CCNH;TCEA1;MED18;LAGE3;SNF8;CHCHD2;HDAC3;TCF3;TRIM27;TIAL1;CBFB;SMARCE1;SUMO1;RTRAF;UXT;DRAP1;CTBP1;MED21;YEATS4;CDC5L;BCL2L12;EOMES;TCF7;MED29;ACTR3;MED25;CDK9;BRD9;CEBPG;SRA1;SNW1;SMARCD2;CAMTA1;KDM1A;CBX2;VPS72;YY1;MBD2;NKAP;TADA1;SUDS3;SMARCD1;SETD3;BRD4;PAF1;MED19;DHX36;MED27;SMAD2;SSBP4;LHX2;RNF4;SIN3B;PHF6;CGGBP1;MRGBP;USP16;NSD1;ATF6B;CRLF3;BRMS1;THAP7;RUNX3;MLX;DR1;MED17;SP3;TRIAP1;PPIL4;GATAD2A;LEF1;MNAT1;MED31;RNF10;MED6;SLC30A9;HESX1;MPND;SREBF1;DEAF1;PSMD10;CTNNB1;FNIP2;WWP2;HSBP1;UBP1;BBS7;ELF2;CNOT2;MAP2K5;SP9;ID3;PPP3R1;HCLS1;THAP11;KANSL3;BATF;DVL2;DPF2;LRP5;MED15;FOXJ3;UBE2D3;CREG1;ZFP82;PHF14;ZIK1;RFXAP;MTF1;CCNT2;CRTC2;SIRT7;ARNTL2;ZBTB3;PPM1D;ZFX;RTF1;MED10;WAS;PSEN1;PKD2;KLF5;TCF7L1;PHF12;ZKSCAN8;CAPRIN2;MED12L;USF2;MED20;LDB1;HTATIP2;DPF3;ZFP69;TBR1;WFS1;NCOR1;THRA;CCNQ;KAT5;PRKAR1A;MAPK3;IRF3;TNKS;NR3C2;PRDM1;NR2C1;RXRB;PKD1;RPS6KA1;GRHL2;GALR3;ZBTB5;CPEB3;ASXL2;ZFP92;MESP2;SUFU;EFCAB7;HMGA2;DVL1;BCL9;TOX;HSF4;ITGB1BP1;SIX5
gsea,positive regulation of growth (GO:0045927),0.6025154952693939,1.8262016665810707,0.006048387096774193,0.007642071836796007,0.572,8/16,32.48%,CSNK2A1;CDC42;MTPN;PSMD10;CIB1;WFS1;RPS6KA1;TRIM32
gsea,nitrogen compound transport (GO:0071705),-0.48511461580223064,-1.8245087548778127,0.0,0.024035287921742768,0.623,16/39,15.99%,CD3G;ARL6IP5;VAMP2;CHMP1B;PPT1;SLC36A1;SCAMP3;SLC44A2;SCAMP2;TOM1;ATP11B;SLC29A4;SLC18A1;SLC25A29;CHMP1A;SLC18A2
gsea,regulation of cell differentiation (GO:0045595),0.48175708472992707,1.8233268093014847,0.0,0.007763640873958781,0.58,13/49,15.57%,YWHAH;UQCC2;CBFB;PPP2R1A;CDK9;PPP2CA;CDK5RAP3;PDCD2;PRKACA;MCRIP1;RUNX3;PTK2;OCIAD1
gsea,selective autophagy (GO:0061912),-0.5867677802380987,-1.8232463141486195,0.0037735849056603774,0.023748897736275282,0.625,8/20,6.64%,SQSTM1;UBC;MAP1LC3B;RB1CC1;UBA52;NBR1;ACBD5;TEX264
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5280382521209918,1.8215449071651044,0.0,0.007943847784687761,0.592,10/29,13.16%,HMGB1;PDCD5;MTCH1;BEX3;PYCARD;PDCD6;BCAP31;PDCD2;DIABLO;TRADD
gsea,positive regulation of protein kinase activity (GO:0045860),0.47750340430451754,1.8214750176244567,0.0038461538461538464,0.007920276485541467,0.592,9/46,13.35%,EZH2;CALM3;CALM1;RHOA;PPP2CA;PRKAG1;MAP2K2;PAK2;PTK2
gsea,positive regulation of intracellular signal transduction (GO:1902533),-0.38246647580678605,-1.8207271770222515,0.0,0.023602281778619384,0.631,67/151,33.34%,HCST;SHISA5;LAPTM5;NDFIP1;RAC2;PTPRC;LITAF;TGFB1;S100A13;RPL37;CD27;PELI1;FYN;CD28;ITGAV;RPL23;LGALS9;AKAP13;NOD1;CFLAR;RNF13;SLC9A3R1;GOLPH3;MIER1;BMF;FLCN;RHOG;TMEM9B;IRAK4;LCK;BCL10;EP300;SLC44A2;SRC;RPS3;TRIM13;TICAM1;RNF31;NOD2;SEMA4D;IKBKB;RUNDC3A;SHARPIN;TRIM62;TGFBR1;IL18;FIS1;ZDHHC17;INSR;CARD9;FRS2;SASH1;GAB2;GPR62;TRIP6;TBK1;AKT2;AGER;TREM2;MIB2;ESR1;NDFIP2;TLR6;FGFR1;IL11;IFI35;NTRK1
gsea,plasma membrane bounded cell projection organization (GO:0120036),0.48108672630405375,1.8157781163479227,0.0018726591760299626,0.00836457307638205,0.603,15/43,25.41%,HMGB1;RAC1;ATXN10;DTNBP1;VAPA;TOR1A;WDPCP;UHMK1;PQBP1;PKD2;RAB35;TBC1D24;NRTN;LRP12;MAPT
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.47199802689218756,-1.8152776108156758,0.0,0.02419393456712024,0.645,15/39,17.20%,UBC;TGFB1;ZYX;DDX5;UBA52;TGFBR2;RUNX2;PXN;SRC;SMAD4;RNF111;SMURF1;ACVR1B;SMURF2;TGFBR1
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),0.49632512955345787,1.8100768776330047,0.0,0.008787257240914855,0.615,11/35,16.49%,PSMC3;RBX1;ELOB;SUMO1;DDA1;BAG6;CSNK1A1;GSK3A;FBXO22;PSMD10;BBS7
gsea,negative regulation of cell growth (GO:0030308),-0.48999692501592473,-1.809506044362827,0.004098360655737705,0.024922596737119978,0.661,13/35,15.73%,BTG1;TGFB1;CDKN1B;VGLL4;NDUFA13;SERTAD2;FLCN;PPT1;SERTAD3;RNF6;SMAD4;CDKN2AIP;ACVR1B
gsea,regulation of cellular component size (GO:0032535),0.5946105872115237,1.800381474347089,0.00390625,0.009728431045092063,0.647,7/17,17.33%,PPP1CA;RAC1;AP2M1;MTPN;LAMTOR4;LAMTOR5;PEX11B
gsea,positive regulation of cell growth (GO:0030307),0.5342210165276965,1.7974083224323913,0.005952380952380952,0.010071323600180647,0.656,12/26,32.48%,CSNK2A1;DBNL;CDC42;MTPN;PSMD10;TWF2;NTN1;CIB1;MAPT;RPS6KA1;RASAL1;TRIM32
gsea,positive regulation of angiogenesis (GO:0045766),-0.5632553463849195,-1.792884243522272,0.0025380710659898475,0.02854559759820687,0.711,5/20,5.63%,BTG1;ETS1;JAK1;HIF1A;RRAS
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4725862381085445,1.7927152920423337,0.004158004158004158,0.010579894880774168,0.674,12/40,16.49%,COMMD1;RBX1;ELOB;SUMO1;UBXN1;DDA1;BAG6;CSNK1A1;GSK3A;FBXO22;PSMD10;BBS7
gsea,response to calcium ion (GO:0051592),0.5765809106415365,1.7891692497327276,0.0035778175313059034,0.010829238197753001,0.679,7/21,21.82%,CALM3;CALM1;PDCD6;PEF1;CAPN3;SLC25A12;PKD2
gsea,histone deacetylation (GO:0016575),0.6034199621437234,1.7880375526527794,0.002066115702479339,0.010932273521948583,0.682,7/16,12.91%,HDAC3;MORF4L1;SMARCAD1;MSL3;SUDS3;SIN3B;BRMS1
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),0.5000791062384554,1.7872623565613237,0.006423982869379015,0.010954045018213919,0.683,18/31,27.76%,SEC61B;SGTA;BAG6;UBE2J2;EDEM2;FAF2;DERL1;UBE2G2;RNF121;UFD1;UBE2J1;UBXN8;AMFR;FBXO2;UBQLN2;FBXO17;WFS1;TMEM67
gsea,external encapsulating structure organization (GO:0045229),-0.4753817935740761,-1.7868909729412932,0.0035842293906810036,0.02959648006208454,0.726,15/36,26.43%,ITGAV;LAMB3;ITGAL;ITGB2;ITGA2;ATP7A;DDR1;ADAMTS10;RECK;ADAMTSL5;AGRN;ITGAD;COL8A2;ITGB5;COL9A3
gsea,positive regulation of cellular biosynthetic process (GO:0031328),0.47555735755707357,1.7866715323694355,0.0,0.010935614318306542,0.685,17/47,22.29%,ARPP19;RBM3;ELAVL1;RPS6KB1;RPL26;NMD3;PTPN2;APPL1;YTHDF1;SREBF1;FXR1;UPF3A;CNEP1R1;ELOVL5;STN1;PKD2;POLDIP3
gsea,organic substance transport (GO:0071702),-0.4937086572653105,-1.7828697117304033,0.0022675736961451248,0.029703302224025663,0.731,14/33,15.99%,CD3G;ARL6IP5;VAMP2;CHMP1B;PPT1;SCAMP3;SCAMP2;SLC50A1;TOM1;SLC29A4;SLC18A1;CHMP1A;ABCA5;SLC18A2
gsea,negative regulation of cytokine production (GO:0001818),-0.44844782157559754,-1.7732392912164054,0.0,0.03168671097214029,0.749,21/52,14.80%,LAPTM5;SRGN;TIGIT;PTPRC;RNF125;TBX21;PTPN22;LGALS9;NLRC5;CD84;UBA7;ADCY7;GBA;NPTN;ATP2B1;N4BP1;TAX1BP1;JAK3;ITCH;OTUD5;ILRUN
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5810973594790867,1.770970785577021,0.007905138339920948,0.01281848397300641,0.738,10/19,26.61%,RAC1;ILK;CDC42;PTK2;LIMS1;AP1AR;CRKL;CSPG5;CIB1;LIMS2
gsea,positive regulation of TOR signaling (GO:0032008),0.5558607199012584,1.770776882588168,0.007366482504604052,0.012763937232695746,0.738,7/22,13.27%,SEC13;HDAC3;LAMTOR4;LAMTOR1;LAMTOR5;LAMTOR3;LAMTOR2
gsea,nuclear export (GO:0051168),0.5777429985483925,1.7705438333512078,0.01016260162601626,0.012721140366353464,0.739,8/18,17.83%,TPR;THOC7;SRSF11;U2AF1L4;CHTOP;PHAX;CDC40;RANBP17
gsea,regulation of receptor internalization (GO:0002090),0.6134960161028061,1.7683528302468359,0.012320328542094456,0.012903504382926973,0.745,7/15,20.34%,ARF1;ATAD1;ARRB2;MTMR2;MKLN1;ANKRD13A;DLG4
gsea,fatty acid biosynthetic process (GO:0006633),0.6120542710475919,1.7675144584714564,0.00796812749003984,0.012978004712927512,0.75,8/15,18.93%,GPX4;TECR;LTA4H;DEGS1;ELOVL1;ELOVL5;ACSF3;ACOT7
gsea,purine ribonucleotide biosynthetic process (GO:0009152),0.6228454586139656,1.7669141155283312,0.0018214936247723133,0.012990579005574288,0.753,9/16,21.47%,ACAT1;PANK2;NUDT2;SLC35B2;PAPSS1;ACOT7;AK5;SLC25A16;ADCY9
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5761574030784097,1.7662500983611262,0.005639097744360902,0.013025247485581655,0.755,10/19,26.61%,RAC1;ILK;CDC42;LIMS1;CRKL;CAPRIN2;CSPG5;OBSL1;CIB1;LIMS2
gsea,sensory perception of mechanical stimulus (GO:0050954),0.6039514390299587,1.7630176696987725,0.009693053311793215,0.013347017456102924,0.762,3/19,6.91%,NDUFB9;WDR1;SOD1
gsea,negative regulation of response to stimulus (GO:0048585),-0.5857263225024292,-1.7629294566681348,0.008733624454148471,0.03382593762680424,0.779,5/17,12.47%,THY1;PDCD1;UBASH3B;PTPN1;NR1H2
gsea,post-Golgi vesicle-mediated transport (GO:0006892),0.4457752147160292,1.762043714311274,0.00425531914893617,0.013401942044132161,0.763,19/45,23.76%,COMMD1;AP1S1;ARF1;DTNBP1;CHMP2A;SCFD1;AP2A1;NAPA;RAB10;VPS13A;ARL3;RAB14;PUM1;ACBD3;EXOC5;EXOC1;DNM2;AP4S1;GOPC
gsea,ncRNA processing (GO:0034470),-0.592245567098603,-1.7611377830028359,0.03300970873786408,0.033631174056448825,0.781,27/59,5.97%,RPS27;RPS24;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPL19;RPS7;RPL13A;RPL24;RPL17;RPL37;RPL9;RPL27A;RPL27;RPL38;NOP53;UBA52;TUT4;RPL23;RPS16;RPS14;RPL21;RPL36;TUT7;RPS28
gsea,cell morphogenesis involved in differentiation (GO:0000904),0.5679122496981532,1.759444501093595,0.00922509225092251,0.01375788211430824,0.77,8/20,13.20%,RAC1;ILK;RHOA;YTHDF2;TYRO3;FERMT3;TBCD;PARVG
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.5190827640479739,-1.7577427357839839,0.006711409395973154,0.03392592735722603,0.784,11/22,23.40%,UBC;TGFB1;UBA52;TGFBR2;IL17RD;SMURF1;SMURF2;TGFBR1;DAND5;ZBTB7A;TGFB1I1
gsea,peptidyl-tyrosine modification (GO:0018212),-0.5930019139645389,-1.7576154737301748,0.004629629629629629,0.0333437411621285,0.784,6/16,11.31%,FYN;ABI1;ZAP70;LCK;SRC;JAK3
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5750151634057736,1.755221875627642,0.009689922480620155,0.014214621156741974,0.779,11/19,29.89%,BEX3;CSNK2A1;BCL2L12;PAK2;LAMTOR5;TRIAP1;MAP2K5;LAMP3;SIAH2;RPS6KA1;RAF1
gsea,regulation of protein localization to plasma membrane (GO:1903076),-0.5329695704055768,-1.7534264598341227,0.010940919037199124,0.033996088218488374,0.795,9/24,10.89%,SQSTM1;TGFB1;TMEM59;PRKCH;RHOG;LDLRAP1;LRP1;CDK5;PPP2R5A
gsea,supramolecular fiber organization (GO:0097435),-0.4054145388077263,-1.7519978917199182,0.0,0.033823151535244504,0.798,29/79,26.43%,B2M;UBC;ITM2B;RAC2;UBA52;LAMB3;PSENEN;SORL1;DNAJB6;TSPAN14;RHOG;CRIPT;ARHGAP17;ATP7A;RAC3;B4GALT7;RND2;APH1B;BIN3;WHAMM;TGFBR1;APH1A;MYO1D;DLG1;CEP126;MTM1;CORO1B;COL8A2;COL9A3
gsea,sensory perception of sound (GO:0007605),0.5947739118575641,1.7515440893730025,0.008012820512820512,0.014602393918602748,0.785,3/20,6.91%,NDUFB9;WDR1;SOD1
gsea,positive regulation of transferase activity (GO:0051347),0.5021214329199576,1.7510543454669973,0.0,0.014629664732784617,0.786,10/35,16.71%,UBE2L3;UBE2I;PABPN1;DCUN1D5;GSK3A;TYRO3;MAPK1;TOPORS;CTNNB1;PNKP
gsea,regulation of stress fiber assembly (GO:0051492),0.5738396588278184,1.7509638987988405,0.0,0.014586612710238433,0.786,5/20,11.89%,RAC1;RHOA;CDC42;PAK2;WASF2
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5385082567484213,-1.7508611722504324,0.033073929961089495,0.03359046485394483,0.799,38/89,11.35%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;DDX5;RPL27A;RPL27;RPL38;RPS10;UBA52;TUT4;RPL23;RPS16;RPS14;RPL21;RPL36;TUT7;RPS28;PNRC2;RPL22;RPS3;RC3H1;RPS9;RPL11
gsea,protein import (GO:0017038),0.5044695778516247,1.7497181201484475,0.005681818181818182,0.01468891730269218,0.79,12/28,19.29%,TPR;SEC13;TOMM22;NUP50;ATAD1;APPL1;PEX14;PEX16;PEX11B;IPO13;RANBP17;NXT2
gsea,cellular amide metabolic process (GO:0043603),0.5083663542780347,1.749622947125701,0.011472275334608031,0.014645973117395733,0.79,12/28,27.10%,PPP2R1A;ORMDL2;PANK2;PPP2CA;ACOT13;ACBD6;ORMDL1;DNPEP;ACOT7;ACOT6;ACOT8;SLC5A6
gsea,regulation of interleukin-6 production (GO:0032675),0.5749119251223265,1.7489032861837035,0.003683241252302026,0.01467263328175552,0.79,2/20,5.11%,HMGB1;PYCARD
gsea,inositol phosphate metabolic process (GO:0043647),0.5773958085634786,1.746570824565113,0.005964214711729622,0.014846884649907226,0.797,5/18,6.36%,CALM1;MINPP1;IMPA1;IMPA2;NUDT3
gsea,polyol metabolic process (GO:0019751),0.5773958085634786,1.746570824565113,0.005964214711729622,0.014846884649907226,0.797,5/18,6.36%,CALM1;MINPP1;IMPA1;IMPA2;NUDT3
gsea,regulation of calcium ion transport (GO:0051924),-0.585556098470218,-1.7461425221576645,0.006818181818181818,0.03429159269240758,0.809,5/15,8.07%,SARAF;CD84;SLC8B1;ATP2B1;INPP5K
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4926459953266921,1.7451464028904033,0.010395010395010396,0.014935609512408975,0.797,11/30,16.49%,RBX1;ELOB;SUMO1;SGTA;BCAP31;DDA1;CSNK1A1;GSK3A;FBXO22;PSMD10;BBS7
gsea,positive regulation of protein phosphorylation (GO:0001934),0.41166040398241865,1.7449979001507137,0.0,0.014903027159760888,0.799,26/86,24.20%,CALM3;CALM1;MAD2L2;RAC1;ILK;HDAC3;UBE2K;ERP29;CDK9;KRAS;PRKAG1;PAK2;CSNK2B;PTK2;MAPK1;FXR1;FNIP2;HCLS1;RALBP1;DVL2;P2RY1;CRKL;CAPRIN2;PIK3R3;LIMK2;CIB1
gsea,extracellular structure organization (GO:0043062),-0.4622480280689242,-1.744063202143464,0.0036900369003690036,0.03436588217108187,0.81,16/37,26.43%,ITGAV;LAMB3;ITGAL;ITGB2;ITGA2;ATP7A;DDR1;ADAMTS10;RECK;TGFBR1;ADAMTSL5;AGRN;ITGAD;COL8A2;ITGB5;COL9A3
gsea,mRNA catabolic process (GO:0006402),0.5914798308831294,1.7425589629272138,0.008048289738430584,0.01522066063730317,0.803,8/17,17.52%,LSM5;LSM6;XRN2;RNH1;YTHDF2;DCP2;PDE12;NUDT16L1
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4934386755193335,1.7399011481944262,0.005802707930367505,0.015504595297334365,0.809,14/32,22.78%,RAC1;CDC42;CAPZB;ATG3;ARF6;ATG5;TBC1D15;FXR1;CYLD;TWF2;TBC1D19;TBC1D10A;WAS;TBC1D24
gsea,response to endoplasmic reticulum stress (GO:0034976),0.4953348394735628,1.7396267207120035,0.007936507936507936,0.015470179330962614,0.809,16/32,26.63%,TMCO1;TMX1;UFM1;BCAP31;BAG6;UFC1;DERL1;ERP44;CDK5RAP3;ATF6B;UBA5;MBTPS1;PPP1R15B;TMEM259;SCAMP5;WFS1
gsea,positive regulation of interleukin-1 production (GO:0032732),0.5672956653242065,1.7393534885893225,0.006012024048096192,0.01545668036259311,0.809,3/18,5.11%,HMGB1;TMED10;PYCARD
gsea,epithelium development (GO:0060429),-0.5313128708311361,-1.7373881648670062,0.010101010101010102,0.03571860726851029,0.826,4/21,5.47%,TGFB1;SLC9A3R1;TPP1;CTSB
gsea,"positive regulation of transcription, DNA-templated (GO:0045893)",0.34692360933747984,1.7362911995607624,0.0,0.015864980412560944,0.813,119/314,32.77%,HMGB2;HMGB1;YWHAH;MYB;FOXM1;PSMC3;ENY2;MAD2L2;PCBD2;TCEA1;ILK;EDF1;RNF187;LAGE3;CHCHD2;HDAC3;TCF3;RTRAF;DRAP1;YAF2;MED21;YEATS4;CDC5L;BCL2L12;EOMES;ACTR3;MED25;CDK9;PSMD9;CEBPG;SNW1;SMARCD2;KDM1A;YY1;SMARCD1;SETD3;BRD4;MED19;DHX36;SMAD2;MAP2K2;SSBP4;LHX2;RNF4;SFR1;USP16;NSD1;ATF6B;UBE2V1;CRLF3;RUNX3;MLX;DR1;MED17;SP3;TRIAP1;LEF1;RNF10;MED6;SLC30A9;MPND;SREBF1;DEAF1;CTNNB1;CAND2;CXXC1;UBP1;ELF2;MAP2K5;PPP3R1;HCLS1;CAPN3;KANSL3;CDKN1C;USP21;DVL2;DPF2;LRP5;FOXJ3;RFXAP;MTF1;CCNT2;CRTC2;SIRT7;ARNTL2;MED10;WAS;PSEN1;PKD2;KLF5;DNM2;CAPRIN2;RNF20;USF2;LDB1;HTATIP2;DPF3;THRA;KAT5;MAPK3;IRF3;TNKS;RXRB;PKD1;RPS6KA1;GRHL2;GALR3;ASXL2;CAMK4;SPIN1;TRIM45;MAP2K7;EFCAB7;HMGA2;DVL1;BCL9;ITGB1BP1;HAS3;GPS2
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5854435285530886,1.7356874654230916,0.014799154334038054,0.015870558176525964,0.816,7/16,16.20%,TSG101;CDC42;GRB2;SNX6;CHMP6;PTPN2;EPN1
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.5254252470087126,-1.733865151953916,0.004975124378109453,0.0361568177752513,0.838,9/24,17.41%,PTPRC;TGFB1;PTPN1;STAT3;TNFRSF14;SRC;SEMA4D;IL15;IL18
gsea,negative regulation of mitotic cell cycle (GO:0045930),-0.5780394460564265,-1.7338629518227033,0.02142857142857143,0.035582900032786996,0.838,7/17,6.68%,BTG1;TGFB1;CDKN1B;BTG3;HECA;SLC9A3R1;CHFR
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.4091467945996611,-1.7315491269747698,0.010309278350515464,0.035612518839487566,0.844,28/78,20.55%,SHISA5;SQSTM1;NDFIP1;LITAF;S100A13;PELI1;LGALS9;AKAP13;NOD1;CFLAR;CARD19;MIER1;TMEM9B;IRAK4;PPM1N;BCL10;LIME1;SLC44A2;TRIM13;TICAM1;RNF31;NOD2;IKBKB;SHARPIN;TRIM62;NR1D1;ZDHHC17;CARD9
gsea,mitotic cytokinetic process (GO:1902410),0.5883762930530223,1.72954359169228,0.010548523206751054,0.016677297516665777,0.825,8/16,23.13%,RHOA;CHMP2A;CHMP6;MITD1;PDCD6IP;VPS4A;CHMP7;VPS4B
gsea,generation of neurons (GO:0048699),0.477346262329908,1.7293662142568722,0.0030911901081916537,0.01662381117796063,0.825,10/44,15.86%,HMGB2;RAC1;MTPN;PAFAH1B1;YTHDF2;DTNB;LHX2;RUNX3;NGRN;CTNNB1
gsea,ceramide metabolic process (GO:0006672),0.5376907682682093,1.7278459628223795,0.006289308176100629,0.01683408061435539,0.833,8/20,19.92%,SPTSSA;PPP2R1A;ORMDL2;PPP2CA;CERS2;ORMDL1;DEGS1;SPTLC1
gsea,positive regulation of endothelial cell migration (GO:0010595),0.5594264884651633,1.72697079329326,0.005008347245409015,0.016906536128978633,0.835,3/21,5.53%,HMGB1;RAC1;PDCD6
gsea,regulation of neuron death (GO:1901214),-0.543353055830696,-1.7227378516214746,0.011627906976744186,0.037410094398095096,0.858,9/22,10.85%,TNFRSF1B;FYN;EGR1;SORL1;GBA;ITGB2;INPP5A;CDK5;NSMF
gsea,cellular response to UV (GO:0034644),0.5283794052051347,1.7222121395241214,0.00927643784786642,0.017486089251732454,0.841,11/24,23.24%,COPS9;RPL26;KDM1A;YY1;ERCC1;DHX36;TMEM161A;TRIAP1;NSMCE3;STK11;OPN1SW
gsea,modification-dependent protein catabolic process (GO:0019941),0.39312938182639084,1.7218867271572313,0.0022271714922048997,0.017485446807340477,0.841,37/84,30.46%,ANAPC11;UBE2L3;PSMD13;UBE2I;RBX1;RNF7;NEDD8;UBE2K;PSMF1;UBE2A;ANAPC16;CDC26;PPP1R11;UBE2E1;BAG6;ANAPC2;PSMD9;UBE2G2;FBXO22;NTAN1;FBXO7;ANAPC10;PTTG1;TOPORS;UFD1;UBE2G1;AMFR;UBE3C;UBL7;UBQLN2;RNF20;ARRDC1;KCTD6;SIAH2;ZNRF3;KLHL8;WDR91
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6304412915405023,-1.7201318738555926,0.04423076923076923,0.037661372580362784,0.866,30/63,6.87%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;RPL27A;RPL27;RPL38;RPS10;UBA52;RPL23;RPS16;RPS14;RPL21;RPL36;RPS28;PNRC2
gsea,regulation of cellular response to stress (GO:0080135),0.5379737435292395,1.7139761513539056,0.008492569002123142,0.01862718329827201,0.856,12/20,27.73%,TPR;SEC13;BAG1;CHCHD2;NUP50;ARMT1;MAPK1;HSBP1;AMFR;USP51;MAPT;MAPK3
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),0.5102908037969848,1.7118595866359547,0.0,0.01889563339932774,0.861,11/30,22.29%,RBM3;ELAVL1;RPS6KB1;MTPN;RPL26;NMD3;YTHDF1;FXR1;UPF3A;STN1;POLDIP3
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.5571908008403167,-1.7114673471431194,0.01694915254237288,0.03948848159642342,0.888,9/19,14.90%,UBC;IRAK2;UBA52;BCL10;NKIRAS1;TICAM1;RNF31;IKBKB;SHARPIN
gsea,neutrophil degranulation (GO:0043312),0.37813455538690804,1.7106970603673586,0.0,0.019003641386566378,0.864,56/140,28.51%,HMGB1;PSMA2;NDUFC2;PSMD13;PSMC3;COMMD3;RAC1;PSMB1;DYNLL1;DERA;GSTP1;RHOA;DBNL;PNP;PYCARD;LTA4H;TRAPPC1;ACTR10;VAPA;FAF2;PAFAH1B2;SURF4;GDI2;LAMTOR1;DNAJC3;ERP44;COTL1;KCMF1;COPB1;CSNK2B;RAB10;CYB5R3;RAB14;LAMTOR3;LAMTOR2;ACTR1B;MAPK1;RAB5C;DNAJC5;HEXB;DEGS1;SNAP29;CREG1;STXBP2;UNC13D;APEH;ARPC5;PSEN1;ARMC8;CANT1;MAN2B1;NCSTN;FUCA1;DYNC1LI1;CYBA;ATP6AP2
gsea,G1/S transition of mitotic cell cycle (GO:0000082),0.5729755308611876,1.7093117864864853,0.014583333333333334,0.019135514840343225,0.866,8/15,14.54%,CCNH;KHDRBS1;RPS6KB1;CUL2;BRD4;PPP6C;CRLF3;MNAT1
gsea,negative regulation of translation (GO:0017148),0.501824804327555,1.7083666684648826,0.013422818791946308,0.019276244861900018,0.87,14/27,21.19%,TPR;EIF4E2;MALSU1;YTHDF2;DAPK3;CNOT7;DHX36;CNOT8;LSM14A;YTHDF1;FXR1;PUM1;EIF4EBP2;RBM4
gsea,response to molecule of bacterial origin (GO:0002237),0.5338546062789037,1.7083426461198468,0.007547169811320755,0.019205376314613623,0.87,1/24,0.01%,HMGB2
gsea,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5927607862603729,1.708178827616303,0.011627906976744186,0.019164300321987758,0.87,8/15,26.61%,RAC1;ILK;CDC42;LIMS1;CRKL;CSPG5;CIB1;LIMS2
gsea,response to interleukin-1 (GO:0070555),-0.5421552452750579,-1.7067701304750886,0.016666666666666666,0.04041176641081336,0.896,7/18,17.65%,IRAK2;LGALS9;HIF1A;SRC;RC3H1;IGBP1;NR1D1
gsea,cellular response to organic cyclic compound (GO:0071407),-0.4623689320597112,-1.7021782073128482,0.011312217194570135,0.041253052052993074,0.9,13/38,17.41%,TGFB1;NR4A3;RAP1B;EGR1;MSN;FAM210B;ARL6IP5;NR3C1;GNG2;GOLPH3;INPP5K;PDE2A;IL18
gsea,neutrophil activation involved in immune response (GO:0002283),0.3766192146520555,1.7016908709775584,0.0,0.02022213026974135,0.88,57/141,28.51%,HMGB1;PSMA2;NDUFC2;PSMD13;PSMC3;COMMD3;RAC1;PSMB1;DYNLL1;DERA;GSTP1;RHOA;DBNL;PNP;PYCARD;LTA4H;TRAPPC1;ACTR10;VAPA;FAF2;PAFAH1B2;SURF4;GDI2;LAMTOR1;DNAJC3;ERP44;COTL1;KCMF1;COPB1;CSNK2B;RAB10;CYB5R3;RAB14;LAMTOR3;LAMTOR2;ACTR1B;MAPK1;RAB5C;DNAJC5;HEXB;DEGS1;SNAP29;CREG1;STXBP2;UNC13D;APEH;ARPC5;PSEN1;ARMC8;CANT1;MAN2B1;NCSTN;DNASE1;FUCA1;DYNC1LI1;CYBA;ATP6AP2
gsea,positive regulation of vasculature development (GO:1904018),-0.5557795195033697,-1.700857248241132,0.019801980198019802,0.04114468174377745,0.902,4/17,5.63%,BTG1;ETS1;HIF1A;RRAS
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5419303268334055,1.7000613142939773,0.011784511784511785,0.020376235629611633,0.882,3/24,9.21%,HMGB1;PYCARD;KLHDC10
gsea,regulation of fat cell differentiation (GO:0045598),-0.5325179625783213,-1.6999748692917342,0.008639308855291577,0.04083358575116963,0.903,11/20,21.04%,TGFB1;SIRT2;FOXO1;CREBL2;CCDC71L;TAF8;AAMDC;SYAP1;NR1D1;TRPM4;TRIO
gsea,organelle assembly (GO:0070925),0.35066952183700184,1.6999090532260794,0.0,0.0203168862800981,0.883,97/169,40.86%,LSM4;MAPRE1;CFAP20;VPS36;SNF8;HDAC3;DYNLL1;TSG101;DBNL;EMC6;ACTR3;ARL6;CHMP2A;YTHDF2;ATG3;TRAPPC6A;VTA1;TMEM41B;CSDE1;RAB8A;CHMP6;NUDCD3;LSM14A;ARL3;PDCD6IP;CEP63;MVB12A;CCDC57;TMOD3;ATG5;BBS5;WDPCP;YTHDF1;EDC3;WIPI2;RAB1A;BBS7;VMP1;HPS1;VPS4A;CAPN3;NPHP3;TTC26;SNAP29;TTC8;EXOC5;EXOC3;CEP131;STX12;ABCA3;CHMP7;TMEM17;EXOC1;WDR35;TTC36;INTU;VPS4B;UBQLN2;BECN1;TCTN2;ATAT1;MAPT;RPS23;EXOC7;B9D2;NCOR1;IFT122;MKS1;TMEM67;TNKS;UBXN2A;PKD1;CCDC96;CDC14B;WDR19;CPLANE2;RAB11A;IFT52;IFT172;ARMC9;PLA2G4C;GALNT11;TXNDC15;FITM2;VPS25;BBIP1;BBS2;ATG16L1;CDS2;AUP1;RAB1B;BIN2;CHMP4B;STX7;CHMP3;EXOC6;RILPL1
gsea,fatty acid beta-oxidation (GO:0006635),0.5529531973189729,1.6995262373761832,0.008830022075055188,0.02032047518958274,0.884,10/20,24.77%,ETFA;ACAT1;ECHS1;HADHA;AMACR;ACAA2;HADHB;AUH;ACOT8;ACADVL
gsea,protein modification process (GO:0036211),0.48616046546406444,1.69821583931324,0.006085192697768763,0.020458190347426658,0.887,14/31,29.58%,UBE2L3;UBE2I;UBL4A;NEDD8;ATG3;LCMT1;FBXO22;WWP2;UBE2D3;FBXO2;MAN2B1;FBXW2;MSRA;ARAF
gsea,lymphocyte differentiation (GO:0030098),-0.5636219973548047,-1.69750250046883,0.014256619144602852,0.040998730347355065,0.907,8/18,11.31%,PTPRC;LFNG;PTPN22;DNAJB9;ZAP70;LMBR1L;LCK;JAK3
gsea,autophagosome organization (GO:1905037),-0.4851040961129616,-1.693127539378273,0.011235955056179775,0.041672754593804234,0.913,10/31,13.63%,GABARAP;MAP1LC3B;RB1CC1;GABARAPL2;RAB43;RAB19;MAP1LC3A;ATG12;ATG9A;WDR45
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5046683726374547,-1.6926899302390839,0.004282655246252677,0.04127270856735815,0.913,13/25,19.52%,CTSW;UBC;UBA52;CTSC;CTSB;CHFR;FBXL17;CTSO;UBE2W;ZRANB1;NR1D1;RNF123;CHMP4C
gsea,ERAD pathway (GO:0036503),0.46479886965300804,1.6918311189618267,0.016736401673640166,0.021420815579826873,0.895,19/35,27.76%,SEC61B;SGTA;BAG6;UBE2J2;TOR1A;FAF2;DERL1;UBE2G2;RNF121;UFD1;UBE2J1;UBXN8;AMFR;FBXO2;UBQLN2;FBXO17;WFS1;UGGT2;TMEM67
gsea,positive regulation of autophagy (GO:0010508),0.5052426965913354,1.6902988312938394,0.018140589569160998,0.021701081878102206,0.898,6/24,14.85%,HMGB1;TRIM27;GSK3A;PAFAH1B2;FBXO7;SH3GLB1
gsea,neuron development (GO:0048666),0.455407990645213,1.6901423119245267,0.005357142857142857,0.021652293794293134,0.898,16/43,25.41%,HMGB1;ATXN10;DTNBP1;VAPA;TOR1A;TBCD;ARL3;RUNX3;UGDH;UHMK1;PQBP1;RAB35;TBC1D24;NRTN;LRP12;MAPT
gsea,innate immune response (GO:0045087),-0.43049517367792495,-1.6899090384196547,0.004618937644341801,0.04160325649398747,0.915,19/50,16.03%,B2M;KLRD1;RPL39;SP100;FYN;NLRC5;ZAP70;CYBC1;IRAK4;LCK;BCL10;SRC;TRIM13;SRPK2;CLEC4D;NOD2;IKBKB;TRIM62;F12
gsea,positive regulation of cytoskeleton organization (GO:0051495),0.5466754133443049,1.688105619378716,0.014678899082568808,0.021891966057409992,0.9,8/19,22.13%,PFDN2;CDC42;PYCARD;WDR1;ARF6;KATNBL1;HCLS1;BAIAP2L2
gsea,positive regulation of catalytic activity (GO:0043085),0.5507443855225405,1.6853310936449306,0.010141987829614604,0.022346443342858575,0.906,9/18,27.73%,YWHAB;SSBP1;SOD1;CHTOP;PSEN1;CIB1;NCSTN;NHEJ1;MAPK3
gsea,cellular amino acid catabolic process (GO:0009063),0.5564799740408716,1.6839927364784237,0.013333333333333334,0.022525704497770135,0.909,9/17,30.08%,ACAT1;QDPR;ECHS1;HMGCL;ALDH5A1;AUH;HYKK;PRODH;SLC25A44
gsea,regulation of proteolysis (GO:0030162),0.5077061559826151,1.6825395969146866,0.014925373134328358,0.022713054615720624,0.91,13/22,32.74%,AURKAIP1;NEDD8;BAG6;SPOP;CYFIP2;DNAJC1;CAPN3;CASP8;TBC1D10A;BAD;LTBP4;TRIM32;F2
gsea,cellular response to BMP stimulus (GO:0071773),-0.5764130796180379,-1.6824485330087293,0.01141552511415525,0.04290682314420069,0.924,5/15,14.76%,TGFB1;DDX5;RUNX2;SMAD4;SMURF1
gsea,BMP signaling pathway (GO:0030509),-0.5764130796180379,-1.6824485330087293,0.01141552511415525,0.04290682314420069,0.924,5/15,14.76%,TGFB1;DDX5;RUNX2;SMAD4;SMURF1
gsea,autophagosome assembly (GO:0000045),-0.47264993805561284,-1.6809780928219744,0.005535055350553505,0.042853517224568184,0.927,12/32,18.74%,GABARAP;MAP1LC3B;RB1CC1;GABARAPL2;RAB43;RAB19;MAP1LC3A;ATG12;ATG9A;WDR45;SMURF1;ATG13
gsea,regulation of MAP kinase activity (GO:0043405),0.5445119684948215,1.6802739377125293,0.012195121951219513,0.02310866531836429,0.913,5/22,11.11%,EZH2;SNF8;GSTP1;TSG101;CDK5RAP3
gsea,cellular response to chemical stress (GO:0062197),0.5126496280229833,1.6782001767321473,0.01768172888015717,0.023431905647402836,0.917,11/24,28.54%,PRDX2;CHCHD2;GSTP1;NUDT2;SOD1;NCF4;TMEM161A;MGAT3;PKD2;CYBA;MSRA
gsea,small GTPase mediated signal transduction (GO:0007264),0.4669541297948922,1.6778584417203224,0.01364522417153996,0.023419916654944438,0.917,19/36,35.38%,RAC1;G3BP2;GNB1;GRB2;RGS19;KRAS;ARHGAP33;ARL3;USP50;RALBP1;CRKL;NTN1;TIAM2;SIAH2;RRAGC;RHEB;RAB18;ARHGAP1;USP28
gsea,epithelial to mesenchymal transition (GO:0001837),-0.5293486738260794,-1.6772565341751535,0.03349282296650718,0.04353328015962873,0.932,4/19,4.52%,TGFB1;DDX5;RBPJ;HIF1A
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4327916251385729,1.6768414325537564,0.002074688796680498,0.023573926831868177,0.919,26/47,31.89%,COMMD1;MAD2L2;SUMO1;PYCARD;EOMES;CEBPG;KDM1A;ARRB2;CDK5RAP3;RBCK1;BRMS1;PSMD10;PEX14;WWP2;MAP2K5;CYLD;ID3;COMMD6;PKD2;AIM2;WFS1;NFKBIL1;PKD1;CTNNBIP1;SUFU;MAP3K10
gsea,positive regulation of cell population proliferation (GO:0008284),0.3826111878962633,1.6766766065977678,0.0,0.02352938055694336,0.919,32/102,32.13%,EZH2;RPS6;FOXM1;CSNK2A1;ROMO1;RNF187;NDUFS4;SSR1;UBE2A;COPS9;CNOT6;GNAI2;MCTS1;CHTOP;KDM1A;KRAS;GID8;CNOT7;CNOT8;PTK2;LEF1;HCLS1;LRP5;CEP131;EAPP;CRKL;CIB1;BAD;FGF20;HMGA2;TOX;ITGB1BP1
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.4544208484930747,-1.6766217856643375,0.009216589861751152,0.04319556354221011,0.933,17/34,23.40%,UBC;TGFB1;UBA52;TGFBR2;SORL1;LEMD2;UBE2D1;SMAD4;IL17RD;SMURF1;SMURF2;TGFBR1;ACVR2A;FSTL3;DAND5;ZBTB7A;TGFB1I1
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.5690682630463323,-1.6759278110066096,0.021739130434782608,0.04289755493389421,0.934,6/15,10.42%,TPT1;MCL1;NDUFA13;PTTG1IP;TMBIM6;SRC
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.4125107686913917,-1.6758842484157228,0.011406844106463879,0.04239765410088162,0.934,23/61,20.55%,SHISA5;NDFIP1;LITAF;S100A13;PELI1;LGALS9;AKAP13;NOD1;CFLAR;MIER1;TMEM9B;IRAK4;BCL10;SLC44A2;TRIM13;TICAM1;RNF31;NOD2;IKBKB;SHARPIN;TRIM62;ZDHHC17;CARD9
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),-0.42616086524073316,-1.6745548945409483,0.004796163069544364,0.04239961410769739,0.934,22/53,21.04%,SQSTM1;RAC2;ARHGAP45;ITGAV;ARHGAP15;AKAP13;GNA13;ARHGDIB;FLCN;RHOG;ARHGAP17;ARHGAP9;ARHGAP4;SRC;FAM13B;RAC3;ARHGAP30;RASGRF2;ARHGEF4;FGD4;RHOV;TRIO
gsea,cytokine-mediated signaling pathway (GO:0019221),0.36533037861634937,1.6738797309211868,0.0,0.02396115965967345,0.924,48/142,27.83%,PSMA7;PSMA2;PSMA1;PSMB4;PSMB3;PSMB8;PSMD13;PSMC3;RBX1;BOLA2;PSMB9;PSMD8;ILK;PSMD5;PSMB10;AIP;PSMB1;PSMF1;PSMD4;ARF1;CDC42;PYCARD;TALDO1;YWHAZ;GRB2;PSMD9;SOD1;PITPNA;CSK;PAK2;TXNDC17;CSNK2B;PSME1;PRKACA;ADIPOR2;UBE2V1;TRADD;APPL1;LIMS1;PSMD10;CAPZA1;BATF;CRKL;AIM2;VAV1;IL20RA;MAPK3;IRF3
gsea,regulation of cell population proliferation (GO:0042127),0.3566976906259979,1.6723543344347307,0.0,0.02419840119219897,0.926,73/168,47.93%,HMGB2;EZH2;RPS6;PDCD5;FOXM1;CSNK2A1;ROMO1;RNF187;SSR1;UBE2A;RHOA;COPS9;CNOT6;CTBP1;GNAI2;MCTS1;CHTOP;KRAS;GID8;CNOT7;COPS8;CNOT8;CSNK2B;NMI;PPP2R5C;PTPN2;PTK2;LEF1;LIMS1;CTNNB1;HCLS1;PTPRU;LRP5;CDK10;CEP131;PPM1D;STK11;EAPP;PKD2;CRKL;CIB1;BEX4;RAF1;FGF20;PTPN14;ITGB1BP1;KCNH1;CADM4;DLG3;AQP11;JAG1;TENM1;BCL6B;EGF;CNTF;SETD4;MAP2K1;MINAR1;TFAP2A;CDK13;MEAK7;PDF;SSTR3;GNRH1;SIX1;SOX4;DDRGK1;MAGI2;CACUL1;FER;TNFRSF11A;RPS4X;ERBB3
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.49181101044740466,1.670917194244941,0.016260162601626018,0.024447660923013995,0.93,11/25,17.69%,COMMD1;G3BP2;PYCARD;ARRB2;CDK5RAP3;RBCK1;BRMS1;PSMD10;MAP2K5;CYLD;COMMD6
gsea,regulation of protein phosphorylation (GO:0001932),0.41039014535676444,1.6680803890073794,0.0,0.024826606687125545,0.932,31/68,27.73%,RAC1;ILK;NDUFS4;HDAC3;ERP29;FKBP8;PDCL3;PPP2CA;SOD1;KRAS;BRD4;CDK5RAP3;ANKRD54;PPP2R5C;NSD1;PTK2;PPIL4;FXR1;FNIP2;RALBP1;DVL2;P2RY1;PPP2R5E;PPP1R15B;CRKL;PIK3R3;LIMK2;CIB1;MOB1B;TWF1;MAPK3
gsea,central nervous system development (GO:0007417),0.4127391637480674,1.6672248001437584,0.006644518272425249,0.024936595649820828,0.933,31/66,29.53%,COX7B;NDUFS4;GSTP1;UFM1;EOMES;TMX2;BAG6;UBE3A;UFC1;PAFAH1B2;EIF2B2;IER3IP1;SH3GL1;CDK5RAP3;UGP2;TAGLN3;HESX1;ALDH5A1;MTF1;JRKL;PKD2;ADAM22;SEMA6B;NHEJ1;TBR1;SZT2;SMO;ATP6AP2;PKD1;MAP1S;GRHL2
gsea,neutrophil mediated immunity (GO:0002446),0.36811545446852545,1.666883765829663,0.0,0.024901848104610446,0.934,56/143,28.51%,HMGB1;PSMA2;NDUFC2;PSMD13;PSMC3;COMMD3;RAC1;PSMB1;DYNLL1;DERA;GSTP1;RHOA;DBNL;PNP;PYCARD;LTA4H;TRAPPC1;ACTR10;VAPA;FAF2;PAFAH1B2;SURF4;GDI2;LAMTOR1;DNAJC3;ERP44;COTL1;KCMF1;COPB1;CSNK2B;RAB10;CYB5R3;RAB14;LAMTOR3;LAMTOR2;ACTR1B;MAPK1;RAB5C;DNAJC5;HEXB;DEGS1;SNAP29;CREG1;STXBP2;UNC13D;APEH;ARPC5;PSEN1;ARMC8;CANT1;MAN2B1;NCSTN;FUCA1;DYNC1LI1;CYBA;ATP6AP2
gsea,negative regulation of programmed cell death (GO:0043069),-0.37553255183580575,-1.6657950284970886,0.0020964360587002098,0.0448592582164549,0.946,97/97,98.17%,TPT1;LAPTM5;SQSTM1;UBC;MCL1;CD27;IL2RB;BNIP3L;CD28;UBA52;FOXO1;ARF4;CFLAR;HIGD2A;TMBIM6;GOLPH3;PPT1;TAX1BP1;PRDX5;SRC;EVI2B;ITCH;SEMA4D;IKBKB;KRT18;DSTYK;BRAF;SON;TAF9B;BCL2L2;VHL;AKT2;GSK3B;TREM2;IL7;POU4F1;NTRK1;MYD88;TRAF6;ADAM10;RNF144B;LTK;BFAR;IGF1R;PDCD10;XIAP;NOL3;RELA;HGF;HPN;DDRGK1;OPN3;TFAP2A;COMP;PRDM9;IRAK1;TMEM14A;CAT;NCKAP1L;HMGA2;RAF1;ARAF;RPS6KA1;SIAH2;WFS1;ZFAND6;HTATIP2;CASP2;CIB1;MIEN1;PSEN1;CAPN3;HYPK;CTNNB1;TOPORS;PSMD10;UBE2Z;LEF1;TRIAP1;PTK2;PAK2;BABAM2;TMBIM4;DNAJC3;CIAPIN1;YWHAZ;RPS6KB1;UFM1;BNIP2;GLO1;GSTP1;GPX4;HDAC3;NAA38;BAG1;DCPS;PRDX2
gsea,regulation of cell-matrix adhesion (GO:0001952),-0.5427849647570749,-1.6650951993018044,0.015625,0.04453328082145849,0.946,4/18,8.18%,CD3E;THY1;SKAP1;PLEKHA2
gsea,protein polymerization (GO:0051258),0.5494256474688244,1.6624638691715827,0.028056112224448898,0.02580462452631534,0.942,7/18,14.72%,RAC1;UBE2K;GPX4;ARL6;CHMP2A;MSRB1;WASHC3
gsea,cellular response to oxidative stress (GO:0034599),0.44882734733407437,1.6611993327826957,0.008888888888888889,0.02600408570854036,0.945,17/35,28.54%,PRDX2;ROMO1;CHCHD2;GSTP1;NUDT2;SOD1;NCF4;TMEM161A;MAPK1;AGAP3;WNT16;MGAT3;PKD2;MAPT;CYBA;MAPK3;MSRA
gsea,extracellular matrix organization (GO:0030198),-0.4129920388289635,-1.657114957039876,0.003484320557491289,0.046401253449412434,0.952,20/50,27.70%,TGFB1;ITGAV;LAMB3;ITGAL;ITGB2;ITGA2;CAPN1;ATP7A;QSOX1;DDR1;ADAMTS10;RECK;TGFBR1;ADAMTSL5;AGRN;ITGAD;COL8A2;ITGB5;COL9A3;NOXO1
gsea,cellular response to peptide hormone stimulus (GO:0071375),-0.4709609772832649,-1.655917289357953,0.012658227848101266,0.046203773849747394,0.952,15/32,21.57%,NR4A2;NR4A3;NR4A1;FOXO1;VAMP2;ADCY7;RAB8B;INPP5K;RAB31;INSIG2;SRC;PRKACB;SYAP1;INSR;RAB12
gsea,regulation of programmed cell death (GO:0043067),-0.4459452951010764,-1.6552191587543814,0.0039447731755424065,0.04586641222379731,0.952,16/40,22.97%,TPT1;CD3E;BNIP3L;NOP53;IKZF3;CTSB;PPP1R13B;CDK5;RPS3;JAK3;MARK4;CRADD;RABGGTA;TMEM219;ZBTB7A;HS1BP3
gsea,positive regulation of organelle assembly (GO:1902117),0.5781174649718346,1.654166101856146,0.014705882352941176,0.027440603578016656,0.948,7/15,22.31%,G3BP2;CNOT6;PDCD6IP;SH3GLB1;CNOT2;ENTR1;CROCC
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4851164259973336,-1.6524298494522405,0.01939655172413793,0.0463146086955389,0.954,9/28,13.19%,LAPTM5;CD27;PTPN22;LGALS9;NOD1;LIME1;EP300;RPS3;NOD2
gsea,negative regulation of immune response (GO:0050777),-0.42204167916800306,-1.6512648034314144,0.0029850746268656717,0.04621642975071762,0.956,14/45,15.32%,CD3G;SAMSN1;FYN;PDCD1;SIRT2;CD247;GNG2;ADCY7;SRC;HRH2;RC3H1;ITCH;ILRUN;PRKACB
gsea,positive regulation of supramolecular fiber organization (GO:1902905),0.515979636402938,1.650553632234822,0.016697588126159554,0.028068381628921085,0.952,9/23,25.41%,MAPRE1;RAC1;PYCARD;WDR1;ARF6;PSEN1;BAIAP2L2;SLAIN2;MAPT
gsea,proteolysis (GO:0006508),-0.38650904229157884,-1.6505043990385524,0.0024630541871921183,0.04598777838010346,0.957,35/75,32.22%,SRGN;CTSW;CTSA;OGT;CTSC;PSENEN;TPP1;CTSB;LNPEP;CTSE;FBXO6;LONP2;SVBP;CTSO;DPP7;CAPN1;HGFAC;APH1B;USP25;F12;FBXL2;CAPN7;RNF123;PCSK7;APH1A;SPPL3;VHL;RNPEPL1;CAPN5;MME;SDE2;CASP6;CELA1;CTSF;BACE1
gsea,substrate adhesion-dependent cell spreading (GO:0034446),0.5712280128424232,1.6497254892361777,0.013539651837524178,0.02816983314865953,0.953,6/15,13.20%,RAC1;ILK;RHOA;TYRO3;FERMT3;PARVG
gsea,cellular response to nutrient levels (GO:0031669),-0.5217170624959465,-1.6477685712305359,0.019880715705765408,0.046489087169069805,0.96,6/20,13.63%,MAP1LC3B;FOXO1;MAP1LC3A;LAMP2;FLCN;WDR45
gsea,sulfur compound biosynthetic process (GO:0044272),0.4698519291819506,1.647528246118705,0.006611570247933884,0.028632264949103786,0.955,20/36,35.88%,GCLM;AKR1A1;GSTP1;ESD;SLC35B2;CNDP2;B4GALT2;PAPSS1;UGDH;MPST;SLC10A7;OMD;GSTO2;CSPG5;GSTM4;OGN;GLCE;CHST14;B4GALT3;B3GNT4
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.5417139345553893,-1.646715497085703,0.020642201834862386,0.04628291248608724,0.961,9/19,14.20%,PTPRC;TGFB1;SAMSN1;FYN;ITGB2;TNFRSF14;SRC;SEMA4D;IL15
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),0.33654247918388464,1.6455361242999764,0.0,0.02900812350541567,0.957,90/242,32.77%,HMGB2;HMGB1;MYB;FOXM1;PSMC3;TCEA1;LAGE3;CHCHD2;HDAC3;TCF3;RTRAF;DRAP1;MED21;YEATS4;CDC5L;BCL2L12;EOMES;ACTR3;MED25;CDK9;CEBPG;SNW1;SMARCD2;KDM1A;YY1;SMARCD1;SETD3;BRD4;MED19;DHX36;SMAD2;SSBP4;RNF4;USP16;ATF6B;CRLF3;MLX;DR1;MED17;SP3;TRIAP1;LEF1;RNF10;MED6;SLC30A9;MPND;SREBF1;CTNNB1;UBP1;MAP2K5;PPP3R1;HCLS1;KANSL3;DVL2;DPF2;LRP5;FOXJ3;RFXAP;MTF1;CCNT2;CRTC2;SIRT7;ARNTL2;EAPP;MED10;WAS;PKD2;KLF5;CAPRIN2;USF2;LDB1;HTATIP2;DPF3;THRA;KAT5;MAPK3;IRF3;TNKS;RXRB;PKD1;RPS6KA1;GRHL2;GALR3;ASXL2;EFCAB7;HMGA2;DVL1;BCL9;ITGB1BP1;GPS2
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4744399970765677,-1.6450757477743547,0.011928429423459244,0.046277099364370286,0.964,10/26,17.20%,UBC;TGFB1;ZYX;UBA52;TGFBR2;PXN;SRC;SMAD4;SMURF1;TGFBR1
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4533563970207552,1.6429512349350857,0.00819672131147541,0.0294297044471056,0.959,14/31,19.12%,UBE2L3;CENPX;COMMD1;DCUN1D5;HDAC3;FKBP1A;GSK3A;UBE3A;DERL1;CDK5RAP3;PSMD10;NSMCE3;FBXO4;SENP2
gsea,calcium ion transmembrane transport (GO:0070588),0.49594025823636023,1.6413576515005421,0.015957446808510637,0.029730611623686436,0.959,12/27,30.15%,SMDT1;TMCO1;TMEM165;FKBP1A;MICU2;MAIP1;MICU1;PKD2;ATP2C1;TRPM7;PKD1;SLC25A23
gsea,mitotic nuclear division (GO:0140014),0.5601187893020725,1.6398959400766118,0.02301255230125523,0.03001214112737513,0.961,8/15,25.05%,RHOA;CHMP2A;PPP2R2D;LSM14A;MZT1;TUBG2;CHMP7;SPAST
gsea,positive regulation of cellular amide metabolic process (GO:0034250),0.4980220548625079,1.6392906756017855,0.023206751054852322,0.03006189280184819,0.962,8/24,16.51%,RBM3;ELAVL1;RPS6KB1;RPL26;GSK3A;YTHDF1;FXR1;UPF3A
gsea,endocytic recycling (GO:0032456),0.47453716547642383,1.637395983272095,0.018140589569160998,0.030405385732919493,0.963,14/28,30.50%,SNX3;SNF8;VPS29;SNX17;ARF6;RAB14;WASHC1;SNX12;SNX4;ENTR1;RAB35;DENND1A;VPS39;VPS53
gsea,rRNA metabolic process (GO:0016072),-0.6031139619975057,-1.6356853324624239,0.0670611439842209,0.04893268328202688,0.97,26/51,7.01%,RPS27;RPS24;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPL19;RPS7;RPL13A;RPL24;RPL17;RPL37;RPL9;RPL27A;RPL27;RPL38;NOP53;UBA52;RPL23;RPS16;RPS14;RPL21;RPL36;RPS28;DEDD2
gsea,response to UV (GO:0009411),0.4727803793350339,1.6356202341853607,0.01,0.0306647562845948,0.963,9/26,16.23%,UBE2A;COPS9;RPL26;KDM1A;YY1;DHX36;TMEM161A;TRIAP1;NSMCE3
gsea,positive regulation of protein-containing complex assembly (GO:0031334),0.4981836891355328,1.635524381315477,0.015717092337917484,0.030587320593159967,0.963,11/25,17.59%,GTF2H5;PSMC3;RBX1;SUMO1;MED25;ERCC1;USP50;SH3GLB1;BRK1;FNIP2;TERF1
gsea,rRNA processing (GO:0006364),-0.5933813944129814,-1.63517351652681,0.06420233463035019,0.04859500898498637,0.97,26/52,5.97%,RPS27;RPS24;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPL19;RPS7;RPL13A;RPL24;RPL17;RPL37;RPL9;RPL27A;RPL27;RPL38;NSA2;NOP53;UBA52;RPL23;RPS16;RPS14;RPL21;RPL36;RPS28
gsea,vesicle organization (GO:0016050),-0.5455395701877538,-1.6346311798686441,0.02240325865580448,0.04825774829329084,0.97,5/16,12.51%,SQSTM1;SRGN;WASL;SNX33;RAB22A
gsea,positive regulation of protein localization to nucleus (GO:1900182),0.5284821029918578,1.6333997599382852,0.018867924528301886,0.031011465810966487,0.966,9/17,23.62%,TPR;HDAC3;NMD3;RBM22;CDK5RAP3;LAMTOR5;HCLS1;PSEN1;LIMK2
gsea,receptor-mediated endocytosis (GO:0006898),0.48719456466211897,1.6321035543449014,0.01079136690647482,0.031193826284666243,0.966,13/30,31.58%,AP1S1;AP2S1;AP2M1;GRB2;FCHO1;SNX1;AP2A1;ARRB2;DNM2;AMN;SCARB2;GPR107;CLTA
gsea,positive regulation of endocytosis (GO:0045807),-0.5399673609314435,-1.6312382220330714,0.02517162471395881,0.04894503305930801,0.971,6/16,10.13%,B2M;PPT1;LDLRAP1;LRP1;RAB31;VPS28
gsea,protein targeting to ER (GO:0045047),-0.608189631638508,-1.6311626209179986,0.06031128404669261,0.04849555395900536,0.971,30/63,5.97%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;RPL27A;RPL27;RPL38;RPS10;UBA52;RPL23;RPS16;SRP14;RPS14;RPL21;RPL36;RPS28
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.41281668978411884,-1.6287060685024768,0.013972055888223553,0.048906271134040544,0.971,22/50,22.46%,UBC;IRAK2;UBA52;LGALS9;PRKCH;PRKCQ;NOD1;CFLAR;STAT3;BCL10;EP300;RPS3;TRIM13;TICAM1;RNF31;NOD2;IKBKB;TRIM62;IL18;CARD9;ZBTB7A;RPS6KA4
gsea,protein localization to nucleus (GO:0034504),0.46958318436866375,1.6275265811285486,0.0199203187250996,0.032149503262075656,0.968,16/30,31.55%,TPR;SEC13;NUP50;TOR1A;PAF1;APPL1;TOPORS;CNEP1R1;MORC3;IPO13;RANBP17;NXT2;SUPT7L;NUP62CL;FAM53A;DVL1
gsea,regulation of RNA splicing (GO:0043484),0.4955611795779077,1.626769971477056,0.03138075313807531,0.032216789989006483,0.97,13/23,29.03%,HNRNPL;TRA2B;KHDRBS1;SF1;RBM22;PTBP3;FASTK;FAM50A;TIA1;PQBP1;CLK3;PRX;HNRNPH2
gsea,protein K48-linked ubiquitination (GO:0070936),0.45981308015272143,1.6239865345462814,0.026915113871635612,0.032664203323754595,0.971,14/31,20.55%,RBX1;RNF187;UBE2K;UBE2A;UBE2E1;UBE3A;UBE2G2;KBTBD6;RNF4;TOPORS;UBE2G1;UBE2D3;UBE2Q2;AMFR
gsea,negative regulation of protein modification process (GO:0031400),0.5091463531539154,1.6226649208078552,0.016697588126159554,0.03287696020911272,0.971,11/24,25.57%,ARPP19;YWHAB;PTPA;FKBP8;CDK5RAP3;PNKP;PPP1R15B;CRKL;CIB1;MAPT;BEX4
gsea,positive regulation of cellular process (GO:0048522),0.3551996167565833,1.6225740722559134,0.001694915254237288,0.03279425589280572,0.971,44/134,32.48%,EZH2;RPS6;FOXM1;RPS19;CSNK2A1;ROMO1;RAC1;RNF187;SSR1;UBE2A;CDC42;COPS9;PYCARD;CNOT6;MTPN;GNAI2;MCTS1;CHTOP;KRAS;GID8;CNOT7;DHX36;CNOT8;PTK2;LEF1;RNF10;PSMD10;FXR1;HCLS1;APOA2;DVL2;LRP5;CEP131;EAPP;CRKL;CIB1;MAPT;PRODH;CYBA;RPS6KA1;FGF20;HMGA2;ITGB1BP1;TRIM32
gsea,positive regulation of gene expression (GO:0010628),-0.34912487551676136,-1.622479744960626,0.0,0.05058560244175829,0.972,120/120,99.42%,CD3E;RPS7;ITK;TGFB1;S100A13;IFNGR1;DDX5;ETS1;PTPN22;CD28;EGR1;MSN;TNRC6B;RBPJ;RPL23;LGALS9;HIF1A;STAT3;TNRC6C;AGO3;ATF2;EEF2;EP300;RPS3;SRPK2;RPL11;TICAM1;IL15;YTHDF3;PDE2A;TGFBR1;ZBTB7B;BRAF;CARD9;DGKQ;NOS3;ID2;PLD1;TFR2;GSK3B;TREM2;AVPR2;STOX1;POU4F1;TLR6;SLC2A10;CD46;SLC24A3;MAPK11;MYD88;ANK3;WBP2;TAF1C;EMILIN1;FGF23;PRKAB1;PDCD10;STAP1;HEY1;GATA2;AGO4;MBIP;FOXD1;EIF3E;HPN;RPS4X;POU3F1;MED26;DDRGK1;SOX4;MAPK14;CITED1;TTBK1;CIRBP;TFAP2A;MAP2K1;CNTF;EGF;MAPK9;OCLN;PCIF1;HMGA2;FGF20;CPEB3;SMO;MAPK3;SCAMP5;EPHX2;PIK3R3;LURAP1;POLDIP3;LAMP3;PSEN1;WNT16;BATF;UPF3A;FXR1;LIMS1;MAPK1;LEF1;YTHDF1;LAMTOR5;RBM22;MAP2K2;PRKAG1;DHX36;KRAS;GSK3A;SF3B1;SOD1;PDCL3;ERP29;DTNBP1;RPL26;RPS6KB1;SNF8;POLR2K;ELAVL1;RBM3;PDCD5
gsea,cotranslational protein targeting to membrane (GO:0006613),-0.6238535484073886,-1.6221548815630158,0.06862745098039216,0.05023913078071064,0.973,30/59,5.97%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;RPL27A;RPL27;RPL38;RPS10;UBA52;RPL23;RPS16;SRP14;RPS14;RPL21;RPL36;RPS28
gsea,regulation of macromolecule metabolic process (GO:0060255),0.4320739248630249,1.6217409685323922,0.007984031936127744,0.0329256844897645,0.971,18/42,25.09%,PCBP2;RNF187;TRIM27;C1D;ARF1;NKAP;LAMTOR1;CGGBP1;MTMR2;TAPBP;MKLN1;MTMR9;CIAO3;ADNP;PSEN1;DHH;SCARB2;PCBP3
gsea,gene expression (GO:0010467),0.4141021842699286,1.6177626099353515,0.04430379746835443,0.03386630803992114,0.977,61/127,25.55%,MRPL23;RPS6;RPL28;RBM3;MRPS15;MRPS14;TPR;MRPS36;HNRNPL;RPS19;THOC7;POLR2J;MRPS33;SEC13;SRSF11;PABPN1;RPL35;MRPL27;MRPS17;RPS20;RPL36A;MRPS18C;POLR2K;MRPL34;RPL12;MRPL36;MRPL10;MRPS21;POLR2D;MRPS11;POLR2G;POLR2I;U2AF1L4;FIP1L1;RPL26;RPLP2;NUP50;XRN2;CHTOP;RPS12;MRPL41;MRPL43;MRPL32;RPS5;WDR33;RNGTT;RPL29;TOPORS;CDC40;MRPS16;SMG5;EIF4EBP2;RPL32;XAB2;RBM4;POLDIP3;MED20;MRPL52;RPL6;RPS6KB2;RPS23
gsea,apical junction assembly (GO:0043297),0.5440950288714445,1.6150707252146763,0.01639344262295082,0.03453050270783514,0.979,5/19,12.39%,RHOA;WDR1;PAK2;TBCD;PDCD6IP
gsea,regulation of apoptotic process (GO:0042981),0.32792386582096766,1.6088249315462102,0.003780718336483932,0.03601627790493293,0.982,76/188,36.14%,HMGB1;RPS6;PDCD5;MTCH1;SAP18;PTPA;PRDX2;BAG1;NAA38;HDAC3;GSTP1;GLO1;BNIP2;PYCARD;UFM1;RPS6KB1;YWHAZ;SOD1;SRA1;CIAPIN1;CTNNBL1;DAPK3;SUDS3;IER3IP1;DNAJC3;LCMT1;TMBIM4;BABAM2;PAK2;PDCD2;DIABLO;BRMS1;DNM1L;TRADD;PTK2;TRIAP1;TFPT;LEF1;UBE2Z;PSMD10;TOPORS;CTNNB1;HYPK;CAPN3;SPTLC1;CASP8;TRIM2;STK26;PSEN1;MIEN1;DNM2;RTN4;CIB1;CASP2;VAV1;NCSTN;BAD;HTATIP2;ZFAND6;WFS1;TIAM2;SIAH2;IRF3;RPS6KA1;ARAF;RAF1;HMGA2;ACTN3;NCKAP1L;MAP3K10;CAT;EGLN2;TMEM14A;IRAK1;PRDM9;COMP
gsea,sphingolipid metabolic process (GO:0006665),0.41478967190588656,1.6085067849285473,0.010224948875255624,0.035999564566479895,0.982,19/47,25.78%,GLTP;SPTSSA;TECR;PPP2R1A;ORMDL2;VAPA;PPP2CA;CERS2;ORMDL1;CSNK1G2;HEXB;ESYT1;DEGS1;ELOVL1;ELOVL5;SPTLC1;B4GALNT1;ARV1;VAPB
gsea,mitotic metaphase plate congression (GO:0007080),0.5152308736759225,1.6066287119560594,0.031042128603104215,0.03639531954218413,0.985,11/18,32.36%,CHMP2A;EML4;CHMP6;PDCD6IP;DCTN2;VPS4A;CHMP7;VPS4B;BECN1;BOD1;RAB11A
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6279350139295011,-1.6065630232180343,0.07269155206286837,0.05564111568786687,0.977,30/58,5.97%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;RPL27A;RPL27;RPL38;RPS10;UBA52;RPL23;RPS16;SRP14;RPS14;RPL21;RPL36;RPS28
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5053760936092131,-1.6064123468231295,0.0262582056892779,0.05517329262963574,0.977,7/21,13.19%,LAPTM5;CD27;LGALS9;NOD1;EP300;RPS3;NOD2
gsea,ribosome biogenesis (GO:0042254),-0.5719914251682747,-1.6062647239268137,0.08349514563106795,0.054726480084430346,0.977,25/54,5.97%,RPS27;RPS24;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPL19;RPS7;RPL13A;RPL24;RPL17;RPL37;RPL9;RPL27A;RPL27;RPL38;NOP53;UBA52;RPL23;RPS16;RPS14;RPL21;RPL36;RPS28
gsea,response to lipid (GO:0033993),0.4468197449332164,1.6055718435594706,0.003676470588235294,0.036632416589820936,0.985,16/37,47.22%,HMGB2;TMEM161A;CTNNB1;VPS4B;RXRB;TIRAP;OVCA2;SRR;PALM3;LY96;IRAK1;CITED1;TAB2;GGT1;FER;TNFRSF11A
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5408828089496459,1.6055017258833804,0.02952755905511811,0.03653199627774111,0.985,8/15,16.75%,CNOT6;CNOT11;RPL26;CNOT7;CNOT8;CNOT3;TRIAP1;CNOT2
gsea,regulation of glycolytic process (GO:0006110),0.5207392932532572,1.6038426567999158,0.02464788732394366,0.036902047607500044,0.985,9/20,31.70%,TPR;SEC13;NUP50;PRKAG1;PSEN1;JMJD8;NCOR1;GIT1;ACTN3
gsea,regulation of protein secretion (GO:0050708),0.48296438398855485,1.5984055303802884,0.009124087591240875,0.03823518546718786,0.99,11/29,22.39%,UQCC2;TMED10;DPH3;ERP29;IER3IP1;ARF6;SERGEF;DNM1L;DNAJC1;EXOC1;ARFIP1
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4134399673195732,1.597640857900317,0.007366482504604052,0.03834601889480528,0.99,18/49,32.13%,HMGB1;GSTP1;PYCARD;YWHAZ;SYNJ2BP;TRAF7;ARRB2;PTPN2;DDT;P2RY1;CRKL;CIB1;PTPRR;MAPK3;TIRAP;STYX;MAP2K7;ITGB1BP1
gsea,membrane organization (GO:0061024),0.36772424452876457,1.5944449009051276,0.006147540983606557,0.03919299554355731,0.993,43/95,26.69%,GLTP;MTCH1;SNX3;AP2S1;AP2M1;EMD;GRB2;VAPA;ACTR3;SAR1A;TOR1A;ARPC4;ARPC1A;FCHO1;CHMP2A;AP2A1;SAR1B;NAPA;ARRB2;CHMP6;MITD1;PDCD6IP;DNM1L;VTI1B;SH3GLB1;EPN1;FNBP1;MOSPD3;VPS4A;DVL2;SNAP29;ARPC5;CHMP7;BAIAP2L2;DNM2;VPS4B;SUN1;ATP2C1;SCARB2;SPAST;VAPB;VAMP4;RABEP1
gsea,positive regulation of synaptic transmission (GO:0050806),-0.5322166983638827,-1.5921351563236157,0.02088167053364269,0.05985533971415019,0.981,3/15,6.26%,SQSTM1;VAMP2;NPTN
gsea,regulation of RNA metabolic process (GO:0051252),0.5078080870375841,1.5916175236331542,0.03420523138832998,0.039869355746237164,0.993,12/20,29.03%,HNRNPL;TRA2B;PCBP2;YTHDF2;PTBP3;FASTK;FAM50A;PQBP1;PCBP3;CLK3;PRX;HNRNPH2
gsea,calcium ion homeostasis (GO:0055074),-0.521812610074661,-1.5915432614922354,0.02869757174392936,0.059557159628291896,0.982,4/17,7.16%,TPT1;NPTN;SLC8B1;ATP2B1
gsea,regulation of anatomical structure morphogenesis (GO:0022603),-0.44814123733170586,-1.5891630842215918,0.036072144288577156,0.059999720001917944,0.985,10/30,16.06%,SP100;LFNG;TGFB1;ETS1;CDK5;NSMF;RC3H1;ZRANB1;SEMA4D;SARM1
gsea,membrane lipid biosynthetic process (GO:0046467),0.5206567173286061,1.5886140861417288,0.015873015873015872,0.04056979706163712,0.993,12/18,33.14%,SPTSSA;VAPA;CERS2;CSNK1G2;DEGS1;ELOVL1;ELOVL5;SPTLC1;VAPB;SPNS2;SGPP1;CERS5
gsea,negative regulation of cellular catabolic process (GO:0031330),-0.5059200043655573,-1.5872082735412,0.018947368421052633,0.06032343203257109,0.986,7/20,13.14%,MCL1;PTPN22;SIRT2;SORL1;STAT3;BMF;RIC1
gsea,establishment of protein localization to organelle (GO:0072594),0.5092742089048451,1.5839119509942163,0.03063063063063063,0.04181965589181879,0.993,13/20,32.36%,TPR;SEC13;NUP50;APPL1;IPO13;RANBP17;NXT2;NEURL1B;LAMP3;NUP62CL;PEX19;FAM53A;RAB11A
gsea,negative regulation of cell adhesion (GO:0007162),-0.4810273102691813,-1.5838897626826762,0.023923444976076555,0.06121296437799829,0.987,5/23,13.87%,PTPRC;TGFB1;CD164;ARHGDIB;SEMA4D
gsea,negative regulation of cellular process (GO:0048523),-0.33009712015607473,-1.5826912500002719,0.002369668246445498,0.061187992235467746,0.988,143/143,99.42%,BTG1;SP100;TGFB1;TNFRSF1B;CDKN1B;VGLL4;ETS1;BNIP3L;CD164;NR4A1;RNF167;SIRT2;BTG3;ABI1;ARHGDIB;FTH1;SLC9A3R1;TES;NDUFA13;SERTAD2;TMBIM6;FLCN;PPT1;SERTAD3;NCK1;CEBPA;RBM5;PPP1R13B;RNF139;ING4;CTTNBP2NL;SMAD4;NR1H2;APC;CDKN2AIP;SEMA4D;CHMP1A;RPS6KA2;ATP8A2;ACVR1B;NACC2;ZBTB49;TMEM115;IRF6;ADORA3;TNFRSF8;MYO16;TGFB1I1;NOS3;VHL;PDE8A;PARP16;TREM2;AVPR2;GPLD1;IGFBP6;COL18A1;NDRG3;IFI35;NTRK1;MDK;BMPR2;PRDM11;INCA1;PTEN;PODXL;ADAM15;ADAM10;SIPA1;HYAL1;PIWIL4;PLXNB1;EMILIN1;APBB2;NOTCH4;RNF41;TNS2;ADARB1;MUL1;ERBB3;NAIF1;MAGI2;CASK;SOX4;GNRH1;VAMP3;SSTR3;TFAP2A;MINAR1;PLXNA3;CBLL1;CHMP4B;MAP2K1;UBR2;SPEF1;TENM1;AQP11;DLG3;PIP4P2;ITGB1BP1;LPCAT3;PTPN14;RAF1;WFS1;LRPAP1;BECN1;CIB1;CAPRIN2;ADAM22;VPS4B;DACT3;RTN4;PKD2;STK11;PPM1D;SIRT7;RND1;WNT16;CDK10;PTPRU;PDE12;CTNNB1;ATG5;CCDC85B;RUNX3;ANXA6;CRLF3;PTPN2;PPP2R5C;NMI;CSNK2B;COPS8;TXNDC12;CNOT7;CHMP2A;PPP2CA;CTBP1;MALSU1;PPP2R1A;NDUFS3;SNX3;FOXM1;PDCD5
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.5222159119847968,1.5812098593131365,0.02982107355864811,0.04253003267017193,0.993,8/17,16.75%,CNOT6;CNOT11;RPL26;CNOT7;CNOT8;CNOT3;TRIAP1;CNOT2
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),0.5332712385234782,1.5806823242644172,0.020676691729323307,0.04255423514344219,0.993,6/17,9.31%,FOXM1;ROMO1;PDK3;RAC1;GRB2;DHRS4
gsea,regulation of cell division (GO:0051302),0.4930807741431576,1.5772159742294927,0.03,0.04349673422170341,0.993,8/21,24.46%,CALM3;CALM1;CDK2AP2;SH3GLB1;MYO19;ENTR1;CIB1;BECN1
gsea,regulation of cytoskeleton organization (GO:0051493),0.4288835359981637,1.5770481980635884,0.014311270125223614,0.04342674119074413,0.993,14/39,27.73%,PFDN2;RAC1;RHOA;PAK2;CDK2AP2;PTK2;KATNBL1;MAPK1;CYLD;TWF2;CDK10;RND1;MAPT;MAPK3
gsea,regulation of protein kinase B signaling (GO:0051896),-0.39685857322594453,-1.575283612287988,0.014861995753715499,0.06354557430763158,0.988,20/49,26.95%,RAC2;TGFB1;FYN;CD28;NOP53;SLC9A3R1;RRAS;FLCN;RHOG;INPP5K;LCK;SRC;TGFBR1;IL18;PPP2R5B;INSR;FRS2;OTUD3;GAB2;AKT2
gsea,inflammatory response (GO:0006954),0.44018127352810693,1.5704181375052193,0.013490725126475547,0.04555071193242319,0.995,8/39,37.50%,HMGB1;RAC1;TUSC2;TAC4;CYBA;PTGER3;PLA2G4C;MGLL
gsea,regulation of autophagy (GO:0010506),0.35886458200270827,1.5688830155490499,0.01026694045174538,0.04584941758550916,0.995,32/92,28.58%,HMGB1;TRIM27;VPS29;SNX6;ATP6V1G1;LAMTOR4;GSK3A;DAPK3;LAMTOR1;ATP6V1C1;PRKAG1;RAB8A;CISD2;LAMTOR5;PRKACA;ATP6V1A;LAMTOR3;DNM1L;LAMTOR2;SH3GLB1;SREBF1;MTMR9;WASHC1;STK11;LAMP3;EXOC1;UBQLN2;BAD;MAPT;EXOC7;KAT5;RRAGC
gsea,regulation of cellular component organization (GO:0051128),0.4306181292608125,1.568649615278842,0.03206412825651302,0.04582025215450438,0.995,11/33,21.35%,MAD2L2;AP2S1;DCUN1D5;LAMTOR1;SETD5;SNX17;LAMTOR2;CDK11B;RAB5C;SNX12;STK11
gsea,mitotic spindle organization (GO:0007052),0.45653183385282803,1.5681159159212799,0.026584867075664622,0.04590094732857273,0.995,17/27,28.06%,MAPRE1;SEC13;PTPA;DYNLL1;RHOA;PAFAH1B1;EML4;PPP1CC;LSM14A;MZT1;DCTN2;TUBG2;TBCE;SPAST;B9D2;DYNC1LI1;TNKS
gsea,protein stabilization (GO:0050821),0.3845688818625761,1.5635022192810686,0.012875536480686695,0.04740685106937676,0.995,20/55,28.08%,CDC37;CCNH;BAG1;PPIB;SUMO1;ATP1B3;BAG6;PDCL3;DNLZ;SUGT1;A1CF;RAB21;HYPK;MTMR9;MORC3;APOA2;STX12;RTN4;WFS1;PEX19
gsea,regulation of MAPK cascade (GO:0043408),0.4388037281209873,1.5630322951343767,0.023575638506876228,0.047412333143309816,0.995,9/34,15.41%,HMGB1;GSTP1;YWHAZ;LAMTOR1;TRAF7;MAP2K2;PAK2;MAPK1;PSMD10
gsea,response to amino acid starvation (GO:1990928),0.44550097241106573,1.5623649481949335,0.025974025974025976,0.04738448253442246,0.995,16/33,30.69%,SEC13;ATP6V1G1;LAMTOR4;LAMTOR1;ATP6V1C1;LAMTOR5;ATP6V1A;LAMTOR3;LAMTOR2;MAPK1;SH3GLB1;KPTN;MAPK3;SZT2;RRAGC;RHEB
gsea,cellular response to amino acid starvation (GO:0034198),0.44550097241106573,1.5623649481949335,0.025974025974025976,0.04738448253442246,0.995,16/33,30.69%,SEC13;ATP6V1G1;LAMTOR4;LAMTOR1;ATP6V1C1;LAMTOR5;ATP6V1A;LAMTOR3;LAMTOR2;MAPK1;SH3GLB1;KPTN;MAPK3;SZT2;RRAGC;RHEB
gsea,defense response to virus (GO:0051607),-0.5390905644433956,-1.5613167461792177,0.03795066413662239,0.06904319513605213,0.988,4/15,3.58%,PTPRC;BNIP3L;NLRC5;IRF2
gsea,phosphatidylcholine metabolic process (GO:0046470),0.48006600395839555,1.5600777446052685,0.034545454545454546,0.04807718476884782,0.996,14/23,33.95%,CSNK2A1;CSNK2B;CEPT1;LPCAT4;APOA2;ABCA3;PCYT1B;PEMT;PLB1;TMEM86B;PHOSPHO1;MBOAT7;LPCAT3;PLA2G4C
gsea,cytoplasmic translation (GO:0002181),-0.608584629727888,-1.5574894445795553,0.09551656920077972,0.0702317960379278,0.988,29/57,5.97%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;RPL27A;RPL27;RPL38;RPS10;UBA52;RPL23;RPS16;RPS14;RPL21;RPL36;RPS28
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3500195717278558,1.556977535470116,0.00927643784786642,0.04898915585307885,0.996,45/112,31.65%,EZH2;UBE2L3;MYB;RBM3;EDF1;TCF3;PPP2R1A;DRAP1;YAF2;MTPN;TCF7;MLF2;PPP2CA;MSL3;DAPK3;GLRX2;NSD1;UBE2V1;THAP7;RUNX3;MLX;SP3;SBNO1;CDK11B;CXXC1;REXO4;SAP30L;HCLS1;PQBP1;DVL2;ARNTL2;TCF7L1;PHF12;DNM2;ZFPL1;RNF20;RPL6;LDB1;ACTR8;GPBP1;SUFU;SPIN1;HMGA2;DVL1;WTIP
gsea,negative regulation of cell differentiation (GO:0045596),0.4255471690776102,1.5548781213403229,0.01694915254237288,0.04962717987873471,0.996,12/42,19.39%,MYB;MAD2L2;WDR61;PPP2CA;SRA1;YTHDF2;PAF1;CCDC85B;NELFB;SDHAF2;NPHP3;LRP5
gsea,regulation of neurogenesis (GO:0050767),0.5281849752469966,1.5531970410922962,0.03473491773308958,0.05001658291335413,0.997,3/17,7.98%,HMGB2;SNW1;YTHDF2
gsea,negative regulation of gene expression (GO:0010629),-0.3584773040818923,-1.552903561895745,0.010121457489878543,0.07165381717001912,0.991,88/88,99.99%,CD3E;SRGN;NDFIP1;RPL13A;RPS13;TGFB1;PHF1;PTPN22;CD28;TNRC6B;LGALS9;HIF1A;PAIP2;FOXP1;NPTN;TNRC6C;TMBIM6;DDX6;FLCN;ATP2B1;N4BP1;AGO3;EPC1;RNF139;RPS3;RPS6KA4;DGKQ;LGR4;VHL;ID2;STOX1;POU4F1;ESR1;NDFIP2;SLC2A10;CD46;CREBZF;SLC24A3;NUDT12;ATOH8;SFMBT2;ADAM10;TERT;EMILIN1;PDCD10;MECP2;GATA2;AGO4;BMPR1A;DDRGK1;TTBK1;SAMD4B;MAP2K1;OCLN;PCIF1;CPEB3;SMO;NCOR1;MAPT;CRKL;PSEN1;PPM1D;RBM4;SNX12;NUDT16L1;WWP2;FXR1;LSM14A;PTBP3;CNOT8;MPHOSPH8;DCP2;MAP2K2;DHX36;CNOT7;DAPK3;YY1;YTHDF2;RNH1;ERP29;PPP1R11;MALSU1;CNPY2;TRIM27;EIF4E2;LSM6;LSM5;EZH2
gsea,histone H4 acetylation (GO:0043967),0.5128735605486079,1.55092112117121,0.04068522483940043,0.05064800672379053,0.997,6/16,18.70%,MEAF6;MORF4L1;YEATS4;MSL3;LEF1;KANSL3
gsea,positive regulation of cellular metabolic process (GO:0031325),0.45436680358364606,1.5508124449001732,0.030120481927710843,0.05056038120692081,0.997,9/26,18.80%,ROMO1;CHCHD2;GHITM;GRB2;DHRS4;ATAD1;ARRB2;RAB1A;APOA2
gsea,regulation of gene expression (GO:0010468),0.31472764674196607,1.5489607765539788,0.0017889087656529517,0.05117527378921387,0.997,98/258,31.65%,EZH2;NUDT21;UBE2L3;PDCD5;MYB;HNRNPL;TRA2B;PABPN1;PCBP2;EDF1;RNF187;SNF8;TCF3;TRIM27;CNPY2;C1D;PPP2R1A;DRAP1;YAF2;DTNBP1;TCF7;ERP29;MLF2;PDCL3;PPP2CA;MSL3;GSK3A;YTHDF2;YY1;KRAS;DAPK3;NKAP;CNOT7;DHX36;PRKAG1;GLRX2;MAP2K2;MATR3;PTBP3;CGGBP1;FASTK;FAM50A;LAMTOR5;NSD1;UBE2V1;THAP7;RUNX3;MLX;SP3;SBNO1;CDK11B;LEF1;MAPK1;LIMS1;TAPBP;CXXC1;WWP2;REXO4;PUM1;SAP30L;SNX12;HCLS1;PQBP1;CIAO3;ADNP;DVL2;WNT16;CASP8;ARNTL2;PSEN1;LAMP3;TCF7L1;CRKL;PHF12;DHH;DNM2;ZFPL1;PIK3R3;RNF20;PCBP3;RPL6;MAPT;LDB1;EPHX2;CLK3;PRX;MAPK3;ACTR8;SMO;PRDM1;GPBP1;HNRNPH2;SUFU;SPIN1;FGF20;HMGA2;DVL1;WTIP
gsea,protein glycosylation (GO:0006486),0.4550862007730556,1.5483814949207981,0.015280135823429542,0.051264492272919085,0.997,11/34,20.47%,KRTCAP2;TMEM258;DAD1;TMEM165;MGAT2;ALG5;TUSC3;DPM1;ALG1;DPM3;MGAT3
gsea,second-messenger-mediated signaling (GO:0019932),0.553834538364107,1.5478920477176275,0.02702702702702703,0.05129283412440122,0.997,3/15,16.48%,PPP2R1A;PPP2CA;P2RY12
gsea,cilium organization (GO:0044782),0.364056668287709,1.546449448712671,0.014209591474245116,0.05168598202088067,0.997,44/82,34.30%,CFAP20;DYNLL1;ACTR3;ARL6;RAB8A;NUDCD3;ARL3;CCDC57;BBS5;WDPCP;RAB1A;BBS7;NPHP3;TTC26;SNAP29;TTC8;EXOC5;EXOC3;CEP131;TMEM17;PKD2;EXOC1;WDR35;TTC36;INTU;TCTN2;ATAT1;EXOC7;B9D2;IFT122;MKS1;TMEM67;FAM161B;PKD1;CCDC96;CDC14B;WDR19;CPLANE2;RAB11A;IFT52;IFT172;ARMC9;GALNT11;TXNDC15
gsea,positive regulation of interleukin-8 production (GO:0032757),0.5277667337136454,1.5461749355836452,0.039832285115303984,0.051619178426870124,0.997,5/15,18.80%,HMGB1;PYCARD;LAMTOR5;RAB1A;APOA2
gsea,regulation of tumor necrosis factor production (GO:0032680),0.44321722965278376,1.5454094969776282,0.03285420944558522,0.05173607873229218,0.997,10/27,33.53%,HMGB1;TRIM27;GSTP1;PYCARD;DDT;PSEN1;NFKBIL1;CYBA;TIRAP;LY96
gsea,carbohydrate homeostasis (GO:0033500),0.49729243546477,1.5449747910184148,0.02460456942003515,0.051770243897249435,0.997,10/22,26.63%,RPS6;SELENOT;PTPN2;ADIPOR2;CYB5R4;CRTC2;STK11;BAD;KCNB1;WFS1
gsea,positive regulation of protein kinase B signaling (GO:0051897),-0.41978782313680923,-1.544796779354365,0.020689655172413793,0.07512129065314888,0.993,13/33,26.95%,RAC2;TGFB1;FYN;CD28;RHOG;LCK;SRC;TGFBR1;IL18;INSR;FRS2;GAB2;AKT2
gsea,cellular response to DNA damage stimulus (GO:0006974),0.35362429866766776,1.5446482568718725,0.018648018648018648,0.05171120573810363,0.997,36/75,29.38%,DCUN1D5;RAD51B;SUMO1;UBE2A;NABP2;GRB2;INIP;OTUB1;XRCC3;YY1;ERCC1;FAAP20;BABAM2;USP16;ALKBH1;CEP63;ALKBH3;MNAT1;TOPORS;FNIP2;NSMCE3;PNKP;KIN;POLB;REXO4;RAD9B;BATF;SIRT7;STK11;PSEN1;CIB1;CASP2;ATRIP;MAPK3;IRF3;MACROD2
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.34515439267423115,1.5439344297620732,0.001841620626151013,0.05182687281726526,0.997,48/124,33.92%,POLR2J;AP2S1;POLR2K;RAC1;POLR2D;TIAL1;AP2M1;POLR2G;RHOA;POLR2I;CDC42;GRB2;ATP6V1G1;ACTR3;ARPC4;ARPC1A;GSK3A;AP2A1;ATP6V1C1;TYRO3;PAK2;PTPN2;WASF2;ATP6V1A;TIA1;NCF4;RAB14;PTK2;APPL1;MAPK1;CYFIP2;BRK1;FGFRL1;FIBP;ARPC5;PSEN1;AAMP;PIK3R3;VAV1;NCSTN;CHN1;CYBA;MAPK3;GIT1;FGF20;NCKAP1L;ARPC3;ANGPT2
gsea,regulation of angiogenesis (GO:0045765),-0.4387676928996654,-1.5439259281416287,0.02368421052631579,0.07485927980392071,0.994,13/32,28.21%,BTG1;SP100;ETS1;HIF1A;RRAS;ATF2;PPP1R16B;KRIT1;FOXC1;SASH1;NOS3;EPHA1;STIM1
gsea,regulation of phosphorylation (GO:0042325),0.42940553846885354,1.543580212391674,0.01348747591522158,0.051834602264734846,0.997,15/36,25.85%,TPR;SEC13;ILK;NDUFS4;DYNLL1;PPP2CA;NUP50;PRKAG1;PTK2;BTBD10;FNIP2;CDKN1C;PSEN1;JMJD8;LDB1
gsea,heart development (GO:0007507),-0.4101693274753878,-1.5416656920585792,0.023094688221709007,0.0753284547166184,0.996,17/39,26.00%,TGFB1;CDKN1B;BORCS8;TGFBR2;AKAP13;MEF2D;MEF2A;PDLIM2;CXADR;TCF25;TGFBR1;FOXC1;INSR;POU6F1;DAND5;ID2;CRELD1
gsea,protein import into nucleus (GO:0006606),0.5303953762792419,1.539396369545138,0.03903345724907063,0.05319267517784993,0.997,11/16,30.53%,TPR;SEC13;NUP50;APPL1;IPO13;RANBP17;KPNA4;NXT2;KPNA1;NUP62CL;FAM53A
gsea,regulation of actin filament polymerization (GO:0030833),0.4705671059434256,1.5374718803663525,0.029411764705882353,0.05371538266798992,0.998,15/23,39.30%,DBNL;PYCARD;MTPN;COTL1;ARF6;HCLS1;TWF2;KANK3;BAIAP2L2;TWF1;NCKAP1L;TENM1;DBN1;CARMIL1;ARHGAP18
gsea,regulation of nucleic acid-templated transcription (GO:1903506),0.3473289685084809,1.5370263356773064,0.01107011070110701,0.053692160966950286,0.998,44/107,31.65%,EZH2;UBE2L3;MYB;RALY;EDF1;TCF3;PPP2R1A;DRAP1;YAF2;TCF7;MLF2;PPP2CA;MSL3;DAPK3;GLRX2;NSD1;UBE2V1;THAP7;RUNX3;MLX;SP3;SBNO1;CDK11B;CXXC1;REXO4;SAP30L;HCLS1;PQBP1;DVL2;ARNTL2;TCF7L1;PHF12;DNM2;ZFPL1;RNF20;RPL6;LDB1;ACTR8;GPBP1;SUFU;SPIN1;HMGA2;DVL1;WTIP
gsea,ion transport (GO:0006811),-0.4495970775796114,-1.5367574589664381,0.03002309468822171,0.07706554014568555,0.996,14/25,28.24%,TSPO;SLC8B1;SLC36A1;LASP1;SLC17A5;LRRC8A;ATP11B;CTNS;SLC9A7;PANX1;SLC17A7;SLC9A6;SLC24A1;CHRNB2
gsea,cellular protein metabolic process (GO:0044267),-0.39041177860960435,-1.5367213034454366,0.05714285714285714,0.07642332731113816,0.996,146/146,99.87%,RPS27;SHISA5;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;UBL5;RPL27A;RPL27;RPL38;RPS10;UBA52;RPL23;RPS16;RPS14;UBA7;RPL21;PSENEN;PARP4;RPL36;RPS28;RPL22;RPS3;QSOX1;RPS9;RPL11;STK38;B4GALT7;APH1B;USP25;MANBA;FAM20C;RPS29;FBXL2;RABGGTA;APH1A;RAB12;FSTL3;SPPL3;AKT2;NUCB1;APLP2;IGFBP6;MXRA8;YES1;ADAM10;FUCA2;LAMB2;MRPL9;FGF23;RPL35A;MSRB3;MRPL24;PADI4;RPS4X;LIPT1;GGCX;CSNK1G3;ABL2;GALNT11;F2;RPL18;ARAF;MSRA;SIAH2;WFS1;FBXW2;RPS23;RPS6KB2;VWA1;RPL6;MRPL52;NCSTN;SPCS2;TMEM132A;MAN2B1;FBXO2;PSEN1;ABCA3;MBTPS1;UBE2D3;RPL32;EIF4EBP2;APOA2;MRPS16;UBE2G1;WWP2;CCDC59;RPL29;MSRB1;PNPLA2;TMEM208;RPS5;MRPL32;FBXO22;LCMT1;UBE2G2;DNAJC3;MRPL43;ATG3;MRPL41;RPS12;SEC11A;RPLP2;RPL26;LTA4H;SPCS1;PCMT1;MRPS11;MRPS21;MRPL10;NEDD8;MRPL36;RPL12;MRPL34;MRPS18C;RPL36A;RPS20;MRPS17;MRPL27;RPL35;MRPS33;UBL4A;RPS19;UBE2I;MRPS36;MRPS14;MRPS15;UBE2L3;RPL28;RPS6;MRPL23;SEC11C
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5074853971616252,1.5358059689351748,0.035650623885918005,0.054002051454664336,0.998,5/20,14.43%,YWHAB;CALM1;ZDHHC3;GRK6;FNTA
gsea,negative regulation of multicellular organismal process (GO:0051241),-0.372845074069886,-1.5340136840184972,0.024793388429752067,0.07714618452270025,0.997,26/52,29.72%,SRGN;TGFB1;IFNGR1;RBPJ;ARHGDIB;IP6K1;LNPEP;NPTN;FLCN;ATP2B1;N4BP1;PLCL2;NR1H2;IL17RD;IL15;NR1D1;SPX;RPS6KA4;LGR4;NOS3;LDLRAD4;AGER;GSK3B;ACOT11;TACSTD2;RAB11FIP5
gsea,protein localization to organelle (GO:0033365),0.3778674277350369,1.533215664957031,0.022727272727272728,0.05486491414510258,0.998,34/59,41.96%,SEC61B;EMD;SGTA;VAPA;WDR83OS;UBE2J2;TOR1A;ARL6;SEC61G;PAF1;ARF6;ARL3;TIA1;TOPORS;CNEP1R1;UBAC2;TTC26;LAMP3;WDR35;CROCC;RAB35;OBSL1;CYB5A;IFT122;TRAM2;DVL1;RAB11A;BBS2;TULP1;AUP1;TOR1B;TMEM30A;BBS1;STX1A
gsea,positive regulation of cellular catabolic process (GO:0031331),-0.3896345528036304,-1.5302617429240526,0.01949317738791423,0.0782893555232246,0.997,25/47,30.08%,LAPTM5;ZC3HAV1;TNFRSF1B;VGLL4;MSN;TMEM59;FOXO1;HIF1A;PTPN1;PTTG1IP;ORMDL3;FLCN;SNX33;RC3H1;PFKFB2;ITCH;TICAM1;INSR;GAPDHS;PRXL2C;PRKCD;LIN28B;AKT2;GSK3B;GPLD1
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),0.4838348212799951,1.5293949754577811,0.03441295546558704,0.05617795872929489,0.999,9/18,36.44%,HDAC3;KDM1A;GNAS;CNOT3;ADIPOR2;PEMT;THRA;PER2;ADIPOR1
gsea,phosphate-containing compound metabolic process (GO:0006796),0.3823928808621702,1.5287895260904063,0.015841584158415842,0.05624989938685391,0.999,30/59,41.48%,PPP1CA;CALM1;NT5C;GPX4;MINPP1;PANK2;IMPA1;IMPA2;NUDT3;PAK2;NUDT14;XYLB;PNKP;LPCAT4;GK5;TOP1;LIMK2;PLB1;EPHX2;MAPK3;ITPKA;THNSL2;PLA2G4C;PPM1A;PIP4P1;DUSP28;PLCB3;CLN8;THTPA;PLCD4
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5282750169149771,1.5276792830645713,0.04500978473581213,0.05641555340520589,0.999,8/15,34.67%,FOXM1;HDAC3;GSTP1;CYLD;NCOR1;GPS2;ZMYND11;TAOK3
gsea,apoptotic process (GO:0006915),0.3881484310688809,1.5269275510964968,0.02880658436213992,0.05655504244590906,0.999,28/56,31.89%,PPP2R1A;BNIP2;PYCARD;BAG6;PPP2CA;NUDT2;DAPK3;TRAF7;RFK;GLRX2;DIABLO;TRADD;CDK11B;FXR1;CYFIP2;CAPN3;DPF2;CASP8;STK11;RTN4;CIB1;CASP2;BAD;IRF3;RRAGC;TNFRSF19;RAF1;MAP3K10
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5153404185420999,1.5268114378827666,0.04384133611691023,0.05644178914812971,0.999,5/15,9.31%,ROMO1;GSTP1;GRB2;SOD1;DHRS4
gsea,regulation of cell cycle (GO:0051726),-0.35486215914089303,-1.526794840574998,0.011881188118811881,0.07936229375336476,0.998,37/83,33.80%,RPS15A;PTPRC;HBP1;TGFB1;CDKN1B;NR4A1;NOP53;RNF167;RPL23;SIRT2;UHRF2;STAT3;SIK1;FBXL17;PPP1R13B;EP300;ING4;CDK5;SRPK2;EVI2B;APC;FBXL3;CHMP1A;RPS6KA2;WHAMM;TGFBR1;ZBTB49;IRF6;FBXL22;SON;ID2;BIN1;AKT2;IL12A;POU4F1;SDCBP;DYNLT3
gsea,cell junction assembly (GO:0034329),0.4756344758046798,1.5246083936841124,0.04203152364273205,0.05709384416094552,0.999,13/26,31.32%,ILK;RHOA;DBNL;CDC42;LIMS1;CAPZA1;VMP1;TLN2;OBSL1;LIMS2;GRHL2;GJC1;TLN1
gsea,regulation of Ras protein signal transduction (GO:0046578),-0.4481101929070142,-1.5224663280316522,0.023148148148148147,0.08077140066058194,0.998,10/29,14.21%,SQSTM1;GABARAP;AKAP13;OGT;RASAL3;ARHGDIB;FLCN;ARHGAP17;RALGPS1;RASGRP4
gsea,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5129956277160403,1.5204812280134328,0.050505050505050504,0.058505035643142037,0.999,8/16,21.56%,UBE2L3;PDCD5;TOMM7;UBE2J2;GSK3A;SH3GLB1;UBE2D3;LEPROT
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5233204118554183,-1.5167989092633258,0.051111111111111114,0.08322006453732152,0.999,7/16,13.19%,PLD3;CD6;ADCY7;HIF1A;STAT3;TICAM1;NOD2
gsea,intrinsic apoptotic signaling pathway (GO:0097193),-0.4554890944538582,-1.5166309455515115,0.0408997955010225,0.0826755423119402,0.999,10/26,26.33%,MCL1;TNFRSF1B;DDX5;SELENOK;ARL6IP5;PPP1R13B;GSKIP;BCL2L2;PRKCD;ATP2A1
gsea,positive regulation of metabolic process (GO:0009893),0.4638463689985132,1.5152648704318927,0.049019607843137254,0.06056570240796604,0.999,9/20,36.44%,HDAC3;KDM1A;GNAS;CNOT3;ADIPOR2;PEMT;THRA;PER2;ADIPOR1
gsea,positive regulation of programmed cell death (GO:0043068),0.3513139296831511,1.5136174972789482,0.020793950850661626,0.060998504569413026,0.999,27/81,26.78%,HMGB1;RPS6;PDCD5;MTCH1;SAP18;PTPA;PYCARD;SOD1;CTNNBL1;DAPK3;SUDS3;PDCD2;DIABLO;DNM1L;TRADD;TFPT;UBE2Z;CTNNB1;CASP8;PSEN1;DNM2;CASP2;VAV1;NCSTN;BAD;HTATIP2;TIAM2
gsea,negative regulation of protein-containing complex assembly (GO:0031333),0.5043704234548637,1.5129975477882238,0.053604436229205174,0.06104540019693346,0.999,3/18,9.83%,HMGB1;CDC42;LCMT1
gsea,negative regulation of cellular protein metabolic process (GO:0032269),0.4521145013521246,1.5125500565132919,0.041304347826086954,0.06107433443297827,0.999,12/26,21.19%,EIF4E2;MALSU1;BAG6;DAPK3;CNOT7;DHX36;CDK5RAP3;CNOT8;LSM14A;FXR1;DNAJC1;RBM4
gsea,regulation of telomere maintenance via telomerase (GO:0032210),0.5010695374766497,1.5104120465844366,0.04500978473581213,0.06174965290383579,0.999,13/17,31.08%,DCP2;MAPK1;CTNNB1;PNKP;FBXO4;TERF1;SMG5;STN1;ACD;MAPK3;TNKS;TNKS2;MAP2K7
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4615964884750138,1.5103471248240985,0.048355899419729204,0.061596864973306804,0.999,12/21,27.41%,FOXM1;CNOT6;CNOT11;RPL26;CNOT7;CNOT8;CNOT3;TRIAP1;CNOT2;BATF;CASP2;KAT5
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.4013986635735666,-1.5079834659347797,0.02981651376146789,0.08661620818208111,0.999,16/37,23.40%,UBC;TGFB1;UBA52;TGFBR2;ZEB2;FLCN;EP300;SMAD4;IL17RD;RNF111;SMURF1;SMURF2;TGFBR1;DAND5;ZBTB7A;TGFB1I1
gsea,intra-Golgi vesicle-mediated transport (GO:0006891),0.4767199750140607,1.5047640664373265,0.04068522483940043,0.06393304262202842,0.999,12/20,31.73%,NAPA;COPB1;COPE;VTI1B;COG8;GOSR2;TRAPPC3;COPZ1;COG2;GOLGA5;VTI1A;TRAPPC10
gsea,regulation of protein catabolic process (GO:0042176),0.41247302660773044,1.504450574123142,0.023655913978494623,0.06385943550058858,0.999,10/36,18.14%,SNX3;MAD2L2;CSNK2A1;SNF8;OAZ1;GSK3A;SEC22B;CHMP6;WWP2;SNX12
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4977016696018042,1.5027082453020666,0.05807622504537205,0.06446092371541896,0.999,10/18,39.56%,DBNL;DTNBP1;SNX1;DNM2;MAP1S;NCKAP1L;TAOK3;DBN1;NBL1;CNTNAP1
gsea,negative regulation of protein ubiquitination (GO:0031397),-0.4962829374545733,-1.501882245786158,0.06439393939393939,0.08920002976880567,0.999,6/17,10.62%,SQSTM1;OGT;N4BP1;SVBP;VPS28;RPS3
gsea,cellular response to interleukin-12 (GO:0071349),0.49834656518125675,1.5007230051303049,0.07578947368421053,0.06523360026262705,0.999,9/18,16.84%,BOLA2;AIP;ARF1;CDC42;TALDO1;SOD1;PITPNA;PAK2;CAPZA1
gsea,positive regulation of signal transduction (GO:0009967),-0.36025380485213754,-1.4970853673997817,0.02278481012658228,0.09123166960174724,1.0,27/63,28.26%,PTPRC;CRLF2;ITGAV;RBPJ;ATP6V0C;HIF1A;SORL1;STAT3;MAML1;TSPAN14;NPTN;EP300;SRC;RPS3;ZRANB1;NOD2;CDKN2AIP;DSTYK;MBD5;TGFBR1;ZBTB7B;CRADD;DISC1;SASH1;NOS3;TREM2;IL7
gsea,organic anion transport (GO:0015711),0.5031376729000451,1.4963548244420177,0.052715654952076675,0.06701075926261235,0.999,7/20,22.18%,SLC25A4;SLC35B2;MFSD10;CYB5R4;SLC35B4;CYB5RL;SLCO5A1
gsea,cellular metal ion homeostasis (GO:0006875),-0.45613808173849135,-1.4956214461590578,0.05301204819277108,0.09145341258552087,1.0,9/23,28.21%,TPT1;NPTN;SLC8B1;ATP2B1;LETM2;TPCN2;ATP2A1;SLC24A1;STIM1
gsea,positive regulation of apoptotic process (GO:0043065),0.3411350818038599,1.493693048847986,0.020446096654275093,0.06798088662918483,1.0,30/91,31.89%,HMGB1;RPS6;PDCD5;MTCH1;SAP18;PTPA;PYCARD;SOD1;CTNNBL1;DAPK3;SUDS3;TRAF7;PDCD2;DIABLO;BRMS1;DNM1L;TRADD;TFPT;UBE2Z;CTNNB1;CASP8;PSEN1;DNM2;CASP2;VAV1;NCSTN;BAD;TIAM2;HMGA2;MAP3K10
gsea,cellular macromolecule catabolic process (GO:0044265),0.4855865155929771,1.4928403433198403,0.05595667870036101,0.06809491763687149,1.0,9/19,27.60%,RNASEH2C;XRN2;UBE2G2;SKIV2L;UBE2G1;FBXO2;FBXO17;DNASE1;SIAH2
gsea,negative regulation of neuron projection development (GO:0010977),-0.5047103215027674,-1.4912302692011286,0.044186046511627906,0.09321862522849654,1.0,5/15,9.74%,ITM2C;THY1;MYLIP;RTN4RL1;GDI1
gsea,positive regulation of protein localization to membrane (GO:1905477),0.4251958600192398,1.4901361704436256,0.03536345776031434,0.06915037641113177,1.0,13/34,26.29%,YWHAH;PDCD5;YWHAQ;YWHAB;YWHAZ;MFF;ARF6;PPP3R1;CASP8;MIEF1;CIB1;BAD;KCNB1
gsea,positive regulation of protein transport (GO:0051222),0.46325152119365853,1.4892681594868953,0.04296875,0.06936404721169039,1.0,9/23,24.35%,TPR;TMED10;OAZ1;IER3IP1;ARF6;DNM1L;CEP131;EXOC1;ATP2C1
gsea,negative regulation of inflammatory response (GO:0050728),-0.3740676769511876,-1.4878334719411113,0.015105740181268883,0.09443735950894956,1.0,46/46,98.79%,CD3G;TNFRSF1B;FYN;CD247;GNG2;ADCY7;GBA;SRC;HRH2;SHARPIN;PRKACB;NR1D1;PRKCD;PPARD;TREM2;VIPR1;AVPR2;GPBAR1;YES1;INSL3;MDK;GGT5;ADCY5;PTGIR;GPR176;MAPK14;GGT1;GPR45;POMC;OTULIN;ADCY3;GPR150;HTR6;GPS2;LPCAT3;GIT1;GPR25;PRKAR1A;ADCY9;FNDC4;PRKACA;PTPN2;TYRO3;GNB1;GSTP1;RPS19
gsea,cellular macromolecule biosynthetic process (GO:0034645),-0.42663911821440464,-1.487589447997333,0.09315589353612168,0.09388491735396111,1.0,43/109,26.30%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;PTMS;NR4A2;RPL37;RPL9;RPL27A;RPL27;RPL38;RPS10;RPL23;RPS16;RPS14;RPL21;RPL36;RPS28;GOLPH3;CREBL2;MEF2A;EPC1;EEF2;RPL22;ING4;GTPBP2;RPS3;RPS9;RPL11;RPS29;LARGE1
gsea,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5102515417908094,1.4855052021836483,0.06396588486140725,0.07103213691661361,1.0,9/15,26.17%,RAC1;ARF6;MTMR2;ANKRD13A;DLG4;PSEN1;UBQLN2;UNC119;LRPAP1
gsea,positive regulation of protein polymerization (GO:0032273),0.4736735954451874,1.4835892934925425,0.05272407732864675,0.0718219527656206,1.0,14/22,42.55%,MAPRE1;RAC1;PYCARD;ARF6;BAIAP2L2;SLAIN2;MAPT;NCKAP1L;OCLN;TENM1;CARMIL1;CDK5R1;TTBK1;AKAP9
gsea,interleukin-12-mediated signaling pathway (GO:0035722),0.5002109443920062,1.4809307892984713,0.06823027718550106,0.07276823392882262,1.0,9/17,16.84%,BOLA2;AIP;ARF1;CDC42;TALDO1;SOD1;PITPNA;PAK2;CAPZA1
gsea,fatty acid oxidation (GO:0019395),0.4671384971460678,1.4790263778717425,0.060215053763440864,0.07348143981243473,1.0,11/21,36.44%,ACAT1;ECHS1;HADHA;ADIPOR2;ACAA2;HADHB;AUH;ACADVL;ECI2;HSD17B4;ADIPOR1
gsea,erythrocyte differentiation (GO:0030218),0.5057299767416528,1.4769218822225285,0.05785123966942149,0.07416722227644751,1.0,7/15,18.15%,RPS19;CEBPG;ACIN1;CDK5RAP3;PTPN2;UBA5;HCLS1
gsea,intraciliary transport involved in cilium assembly (GO:0035735),0.5099394911260975,1.4755534196464144,0.055248618784530384,0.07463938706875169,1.0,11/15,38.29%,DYNLL1;DYNLRB1;TTC26;CEP131;WDR35;IFT122;WDR19;IFT52;IFT172;TTC30B;DYNC2LI1
gsea,negative regulation of protein phosphorylation (GO:0001933),0.3879778629126106,1.4714954101744973,0.036231884057971016,0.07630925185633712,1.0,19/47,36.69%,CALM3;CALM1;TRIM27;GSTP1;RTRAF;DTNBP1;FKBP8;DNAJC3;PAK2;CDK5RAP3;PPP1R15B;CRKL;CIB1;PPM1E;CAMK2N2;DVL1;ITGB1BP1;CADM4;OCLN
gsea,positive regulation of MAP kinase activity (GO:0043406),0.5300126046410665,1.4692577803710518,0.06393442622950819,0.07721870654242885,1.0,8/18,39.49%,EZH2;DVL2;MAP3K10;TAOK3;IRAK1;TENM1;EGF;TPD52L1
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4533014398398486,1.4679450810793722,0.058333333333333334,0.077558503252386,1.0,13/23,26.94%,CBFB;MED25;MED27;MED17;LEF1;MED31;MED6;CTNNB1;MED15;PPM1D;MED10;MED20;THRA
gsea,regulated exocytosis (GO:0045055),-0.38119113020675405,-1.466421430378062,0.024608501118568233,0.10568975956689798,1.0,19/45,32.10%,SRGN;CTSW;TGFB1;VAMP2;SNAPIN;LAMP2;TEX264;ARHGAP17;RAB31;CDK5;GTPBP2;QSOX1;PSAP;TMX3;RAB26;PROS1;APLP2;RAB11FIP5;ITGA2B
gsea,positive regulation of MAPK cascade (GO:0043410),0.39772766816757793,1.4621244898901002,0.03431372549019608,0.08020147900291716,1.0,22/47,39.95%,HMGB1;EZH2;PYCARD;KLHDC10;LAMTOR1;TRAF7;ARRB2;DDT;P2RY1;CRKL;CIB1;MAPK3;STK25;TIRAP;MAP2K7;TAOK3;IRAK1;IQGAP1;TENM1;EGF;TPD52L1;MAP2K1
gsea,cytoplasmic microtubule organization (GO:0031122),0.49511080401094343,1.4617416654410635,0.06545454545454546,0.08020745563872252,1.0,10/17,35.82%,RHOA;KATNAL2;VPS4B;LIMK2;SLAIN2;CIB1;SPAST;MAPT;RAB11A;KATNAL1
gsea,sodium ion transport (GO:0006814),0.5313050997175077,1.4563107394137473,0.061708860759493674,0.08286392632657745,1.0,9/16,38.02%,NDUFA9;ATP1B3;HCN2;PKD2;SLC5A6;SLC6A19;SLC5A2;HCN3;ASIC1
gsea,cellular transition metal ion homeostasis (GO:0046916),0.4242680688648066,1.45527954716383,0.048879837067209775,0.08319953140385428,1.0,11/28,20.04%,BOLA2;NEDD8;ARF1;ATP6V1G1;SOD1;ISCU;SLC30A5;ERFE;ATP6V1A;SLC30A9;IREB2
gsea,platelet degranulation (GO:0002576),-0.4278934176899081,-1.454348178375713,0.046357615894039736,0.11221435722817287,1.0,9/28,17.80%,SRGN;CTSW;TGFB1;LAMP2;TEX264;GTPBP2;QSOX1;PSAP;TMX3
gsea,regulation of signal transduction (GO:0009966),-0.33970726390493167,-1.4512802280834547,0.017391304347826087,0.11314547266938775,1.0,73/73,98.72%,CD3E;SP100;IRAK2;LFNG;TGFB1;FYN;RGS3;UBASH3B;OGT;UGCG;PTPN1;ELF1;FBXL17;CDC42SE2;PXN;NCK1;SRC;CASTOR2;CDKN2AIP;LLGL2;RASGRP4;GSKIP;SHARPIN;GRK3;RGS11;GRK4;ZDHHC17;TSPEAR;RGS14;DGKQ;MAPK8IP2;GNG7;TREM2;IGFBP6;CRK;ESR1;CD46;KAZALD1;PRAG1;GIT2;MPIG6B;ERBB3;ZFAND2B;YJEFN3;MFNG;BRAP;MGLL;IRAK1;GALNT11;ITGB1BP1;GIT1;ZDHHC7;INTU;TCF7L1;AMFR;VWA2;SENP2;RFNG;GRK6;PTPN2;ANKRD54;GLRX2;SYNJ2BP;CSK;ZDHHC3;SNW1;PPP2CA;DTNBP1;PPP2R1A;CBFB;ILK;SNX3;MTCH1
gsea,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5201963609762826,1.4498266206136345,0.06605504587155964,0.08595154529978331,1.0,5/15,12.39%,RHOA;CDC42;WDR1;SYNJ2BP;PDCD6IP
gsea,protein targeting to membrane (GO:0006612),0.383510397850258,1.4490022848003032,0.03648068669527897,0.08615520871168142,1.0,17/39,30.82%,SRP19;YIF1B;SSR1;SGTA;ZDHHC3;ARL6;ATG3;SEC63;ATAD1;PEX14;PEX16;PEX11B;ZDHHC4;ZDHHC7;NACA;PEX19;PXMP4
gsea,positive regulation of protein catabolic process (GO:0045732),-0.41266911436218495,-1.445484266282356,0.0412573673870334,0.11608459948934868,1.0,14/33,16.45%,TNFRSF1B;CDKN1B;VGLL4;MSN;FOXO1;SORL1;NDUFA13;PTTG1IP;SNX33;VPS28;ITCH;APC;SMURF1;SMURF2
gsea,regulation of cell motility (GO:2000145),0.3989103409724364,1.4415453795883382,0.0341726618705036,0.09002978086352637,1.0,25/39,43.40%,CFAP20;RAC1;RHOA;PHPT1;CCDC25;DAPK3;SPINT2;MGAT3;WAS;NTN1;BEX4;LDB1;NRG4;PKN2;RAF1;FGF20;TRIM32;CADM4;ABL2;EGF;ARHGAP18;PKN1;PLXNA3;PARD6B;MEAK7
gsea,protein-containing complex subunit organization (GO:0043933),-0.3960882005350329,-1.4396254348364605,0.050682261208576995,0.1197222306233315,1.0,35/35,99.02%,CD3E;CD3G;IL2RB;CD247;VAMP2;SLC9A3R1;WASL;APC;CARD10;RANBP9;IL1RAP;TEAD1;VAMP3;NAPG;PARD6B;SKAP2;SLC9A3R2;TEAD2;OCLN;NCKAP1L;WDR19;MAGI1;DET1;WAS;DLG4;CAPN3;CAPZA1;PEX14;TAPBP;MNAT1;DNM1L;PPP2R1A;GPAA1;ELOB;TPR
gsea,long-chain fatty acid metabolic process (GO:0001676),0.4784085740623879,1.4379489096825648,0.07308377896613191,0.0917685768040512,1.0,12/20,37.50%,GPX4;GSTP1;LTA4H;ELOVL1;ELOVL5;DAGLB;ACOT8;EPHX2;GSTM4;PLA2G4C;HSD17B4;MGLL
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.4711304284484472,1.436611737027394,0.06538461538461539,0.09231812960097528,1.0,5/17,44.08%,HMGB1;LY96;IRAK1;TAB2;TLR1
gsea,macroautophagy (GO:0016236),0.3440926647194482,1.4365625897415157,0.03333333333333333,0.09211370950027267,1.0,32/67,40.56%,CSNK2A1;TOMM6;VPS36;SNF8;DYNLL1;TSG101;TOMM22;TOMM7;PGAM5;CHMP2A;ATG3;VTA1;PRKAG1;CHMP6;CSNK2B;MVB12A;ATG4B;ATG5;VTI1B;ARL8B;WIPI2;VPS4A;SNAP29;VPS4B;BECN1;LIX1L;VPS39;VPS25;MTERF3;ATG16L1;CHMP4B;CHMP3
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),-0.448456660958374,-1.4351471834014016,0.07127429805615551,0.12179028442656575,1.0,5/20,9.64%,TPT1;NPTN;SLC8B1;ATP2B1;LCK
gsea,IRE1-mediated unfolded protein response (GO:0036498),0.4400332554933266,1.4339461351246925,0.05642023346303502,0.09325859518836732,1.0,12/23,26.63%,SSR1;GSK3A;PREB;DNAJC3;YIF1A;KLHDC3;CXXC1;GOSR2;ACADVL;VAPB;EXTL2;WFS1
gsea,sphingolipid biosynthetic process (GO:0030148),0.44425664037633306,1.4326889305642057,0.056818181818181816,0.09379392604031345,1.0,12/24,33.14%,SPTSSA;VAPA;CERS2;CSNK1G2;DEGS1;ELOVL1;ELOVL5;SPTLC1;VAPB;SPNS2;SGPP1;CERS5
gsea,cell-cell junction assembly (GO:0007043),0.4756732424453985,1.4317178855278343,0.06129032258064516,0.0941214750337136,1.0,13/22,39.56%,RHOA;WDR1;PAK2;TBCD;CTNNB1;TLN2;GJA5;PKN2;GJC1;TLN1;CLDN12;PATJ;CNTNAP1
gsea,regulation of cellular metabolic process (GO:0031323),0.47594087628990045,1.430541721458423,0.06031128404669261,0.09462934951915986,1.0,9/17,30.88%,FOXM1;PDK3;ARF1;PANK2;LAMTOR1;MKLN1;BCO2;MBOAT7;PM20D2
gsea,multivesicular body assembly (GO:0036258),0.4218315952245287,1.4275132093565843,0.05084745762711865,0.09603534405997048,1.0,11/25,23.13%,VPS36;SNF8;TSG101;CHMP2A;VTA1;CHMP6;PDCD6IP;MVB12A;VPS4A;CHMP7;VPS4B
gsea,multivesicular body organization (GO:0036257),0.4218315952245287,1.4275132093565843,0.05084745762711865,0.09603534405997048,1.0,11/25,23.13%,VPS36;SNF8;TSG101;CHMP2A;VTA1;CHMP6;PDCD6IP;MVB12A;VPS4A;CHMP7;VPS4B
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4331124060244819,1.4212302394573397,0.07758620689655173,0.09945354965587733,1.0,13/24,24.48%,CBFB;MED25;DHX36;MED27;MED17;LEF1;MED31;MED6;CTNNB1;MED15;PPM1D;MED10;MED20
gsea,monocarboxylic acid metabolic process (GO:0032787),0.41237867389417876,1.4199221922329268,0.08013937282229965,0.09999833085637516,1.0,12/28,34.83%,GLO1;PANK2;PDHB;AMACR;ACSF3;ACOT7;GPAM;ACOT6;SLC5A6;BCO2;CPT1C;PER2
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.45108914284266677,1.4190205174152615,0.09696969696969697,0.10020349014570026,1.0,13/19,28.06%,MAPRE1;SEC13;PTPA;DYNLL1;PAFAH1B1;EML4;PPP1CC;DCTN2;TUBG2;TBCE;B9D2;DYNC1LI1;TNKS
gsea,cellular response to insulin stimulus (GO:0032869),0.3767437598248166,1.417939293605058,0.03413654618473896,0.1005517429659857,1.0,12/45,25.98%,RPS6KB1;GRB2;ATP6V1G1;GSK3A;ATP6V1C1;RAB8A;PTPN2;RAB10;ATP6V1A;APPL1;PIK3R3;ZDHHC7
gsea,phospholipid transport (GO:0015914),-0.46154231795764655,-1.4146269083926168,0.0944206008583691,0.1360614878088503,1.0,8/17,24.24%,NPC2;PITPNC1;ATP11B;SCP2;ATP8A2;PITPNM1;ATP9A;ATP9B
gsea,peptide biosynthetic process (GO:0043043),-0.47748067752495565,-1.4137833405777045,0.1527777777777778,0.13575426744028132,1.0,32/79,11.35%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;RPL27A;RPL27;RPL38;RPS10;RPL23;RPS16;RPS14;RPL21;RPL36;RPS28;RPL22;RPS3;RPS9;RPL11
gsea,negative regulation of response to external stimulus (GO:0032102),0.42330685870410223,1.4108106635186537,0.0831758034026465,0.10468971847420082,1.0,12/27,32.77%,PCBP2;TYRO3;CERS2;NMI;PTPN2;RNF26;FNDC4;CD109;PPM1B;NFKBIL1;LPCAT3;GPS2
gsea,iron ion homeostasis (GO:0055072),-0.454457470133581,-1.4092937778545187,0.08687258687258688,0.13847094799974854,1.0,8/19,25.10%,B2M;NDFIP1;FTH1;ATP6V0D1;SMAD4;SLC22A17;ATP6AP1;TFR2
gsea,negative regulation of transport (GO:0051051),-0.4481883331469625,-1.4089646787138699,0.06722689075630252,0.13777359145018991,1.0,7/19,16.64%,NDFIP1;ITGAV;ARL6IP5;SNX33;CTTNBP2NL;NR1H2;LRSAM1
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.38277092761441794,-1.408665506163403,0.074,0.13703298466862898,1.0,14/32,25.41%,UBC;TGFB1;ZYX;UBA52;TGFBR2;NR3C1;PXN;SOX5;SRC;SMAD4;SMURF1;PDE2A;TGFBR1;ITGB5
gsea,positive regulation of cell differentiation (GO:0045597),0.3427362562082619,1.4075382393348463,0.03875968992248062,0.10638300244114038,1.0,28/68,48.95%,EZH2;NUDT21;TCF3;BNIP2;RHOA;CDC42;DHX36;SMAD2;LEF1;CTNNB1;LRP5;RBM4;ZC4H2;RPS6KA1;CTNNBIP1;ASXL2;TRIM32;BLOC1S6;SNAI1;ATRAID;MAPK9;PKDCC;NBL1;MAPK14;RAP1A;HGF;RARRES2;PPP1R13L
gsea,regulation of BMP signaling pathway (GO:0030510),-0.44571804119700964,-1.4058744927821034,0.08078602620087336,0.13822580333507237,1.0,10/19,21.69%,RBPJ;SORL1;LEMD2;UBE2D1;SMAD4;SMURF1;SMURF2;ACVR2A;FSTL3;DAND5
gsea,sulfur compound catabolic process (GO:0044273),0.4832434663689405,1.4017116196836414,0.10427350427350428,0.10976888896088222,1.0,8/16,34.60%,ACAT1;HEXB;MPST;OMD;CSPG5;OGN;NUDT7;FITM2
gsea,protein transport (GO:0015031),0.3004052022124633,1.4001506670067922,0.016771488469601678,0.1106809087575106,1.0,78/157,44.03%,YWHAH;SEC13;TMED10;VPS29;TMED9;ARF1;PDCD6;ERP29;SNX6;ATP6V1G1;TMED3;SAR1A;ARL6;SNX1;CHMP2A;SCFD1;AP2A1;PREB;ATP6V1C1;SAR1B;NAPA;RAB8A;SNX17;RAB10;TLK1;ARF6;ATP6V1A;RAB14;SNX8;TBC1D15;TMED7;RAB5C;TMED5;RAB21;RAB1A;VMP1;SNX4;GGA1;NEURL1B;COPZ1;STXBP2;STX12;TBC1D10A;SLC10A7;TANGO2;ARFIP1;DNM2;ARL5A;ARRDC1;AMN;UNC119;ACD;SCAMP5;VAMP4;SNX15;STXBP1;RAB18;ARHGAP1;VPS26C;RAB24;BBS2;GOLGA7;RAB1B;RAB11B;STX7;CHMP3;RAB3B;VPS26B;BBS1;BLZF1;STX1A;NAPG;SLU7;RILP;GOLPH3L;TMED4;SEL1L;TVP23A
gsea,negative regulation of apoptotic process (GO:0043066),-0.2969713933511694,-1.3948113960160442,0.038901601830663615,0.1460852378619306,1.0,128/128,98.46%,TPT1;SQSTM1;UBC;MCL1;NR4A2;CD27;IL2RB;BNIP3L;CD28;UBA52;PRKCH;FOXO1;ARF4;CFLAR;DNAJB6;HIGD2A;TMBIM6;GOLPH3;PPT1;TAX1BP1;PRDX5;SRC;EVI2B;IGBP1;ITCH;NRBP2;CPEB4;AGAP2;SEMA4D;IKBKB;KRT18;DSTYK;BRAF;SON;TAF9B;BCL2L2;VHL;CRLF1;MAPK8IP2;PRKCD;AKT2;GSK3B;TREM2;IL7;POU4F1;NTRK1;MYD88;MDK;UNC5B;TRAF6;ADAM10;FZD9;RNF144B;LTK;BFAR;IGF1R;PDCD10;XIAP;NOL3;RELA;HGF;ERBB3;HPN;ASAH2;DDRGK1;SIX1;OPN3;CITED1;TFAP2A;FZD3;CNTF;MAG;COMP;PRDM9;IRAK1;TMEM14A;CAT;NCKAP1L;HMGA2;FGF20;RAF1;ARAF;RPS6KA1;MAPK3;SIAH2;WFS1;ZFAND6;HTATIP2;CASP2;CIB1;MIEN1;LAMP3;PSEN1;CAPN3;HCLS1;MAP2K5;HYPK;CTNNB1;TOPORS;PSMD10;UBE2Z;MAPK1;LEF1;TRIAP1;PTK2;LAMTOR5;PAK2;BABAM2;TMBIM4;TYRO3;MAEA;DNAJC3;CIAPIN1;SOD1;SNX6;YWHAZ;RPS6KB1;UFM1;BNIP2;GLO1;GSTP1;TRIM27;HDAC3;NAA38;BAG1;CSNK2A1;PRDX2;BEX3
gsea,regulation of cilium assembly (GO:1902017),0.4128103835188296,1.394031071128527,0.06813627254509018,0.11445178889026623,1.0,11/26,23.62%,ATG3;ATG5;TBC1D15;CYLD;TBC1D19;ENTR1;CDK10;TBC1D10A;CROCC;TBC1D24;LIMK2
gsea,nervous system development (GO:0007399),0.32693257427878764,1.3928145557138782,0.03610675039246468,0.11503276418850945,1.0,48/100,36.92%,NDUFV2;COX7B;NDUFS2;GSTP1;ATXN10;DBNL;BTBD1;EIF2B2;TYRO3;SH3GL1;WDPCP;TAGLN3;ALDH5A1;NINJ2;DPF2;DLG4;DAGLB;MTF1;JRKL;PKD2;NRTN;INTU;ADAM22;CSPG5;OBSL1;SEMA6B;UNC119;MAB21L2;LDB1;NHEJ1;DPF3;PRX;SZT2;ZC4H2;SMO;PKD1;ESS2;MAP1S;GRHL2;RAPGEFL1;GFRA1;BTBD2;DVL1;ZIC5;JAG1;TENM1;VAX2;FUT10
gsea,negative regulation of cellular amide metabolic process (GO:0034249),0.42507872953353365,1.3918518199086385,0.08668076109936575,0.11542521391822771,1.0,12/24,22.71%,EIF4E2;MALSU1;ORMDL2;DAPK3;CNOT7;DHX36;CNOT8;LSM14A;ORMDL1;FXR1;RBM4;RTN4
gsea,regulation of osteoblast differentiation (GO:0045667),-0.4359419313145703,-1.3847239343733495,0.09933774834437085,0.1531852272916973,1.0,8/21,24.93%,DDX5;RUNX2;NBR1;SUCO;SEMA4D;TRPM4;ACVR2A;ATP6AP1
gsea,positive regulation of neuron projection development (GO:0010976),0.41186392243424136,1.381267242634054,0.07561436672967864,0.122283881198295,1.0,12/26,37.64%,SNX3;DBNL;DHX36;TWF2;CAPRIN2;SCARB2;TWF1;TOX;CBFA2T2;STYXL1;ABL2;DBN1
gsea,cellular iron ion homeostasis (GO:0006879),0.4526537586761017,1.3765088255821718,0.07723577235772358,0.1253401032659512,1.0,8/18,20.04%,BOLA2;NEDD8;ATP6V1G1;SOD1;ISCU;ERFE;ATP6V1A;IREB2
gsea,actin filament organization (GO:0007015),0.39063287846991324,1.375090355765524,0.08834586466165413,0.12601200199509055,1.0,10/34,22.13%,MAD2L2;RAC1;RHOA;CDC42;ARPC4;TMOD3;MYO19;RND1;WAS;BAIAP2L2
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3891701639328311,-1.374837443182727,0.08577878103837472,0.16020214717935138,1.0,12/28,23.40%,TGFB1;RBPJ;ZEB2;FLCN;EP300;SMAD4;SH2B1;RNF111;ACVR1B;TGFBR1;ACVR2A;TGFB1I1
gsea,membrane fusion (GO:0061025),0.4787477327604852,1.3744175997950772,0.10700389105058365,0.12615359303096677,1.0,8/15,28.74%,VAPA;NAPA;DNM1L;VTI1B;SNAP29;DNM2;RABEP1;UBXN2A
gsea,protein autoubiquitination (GO:0051865),0.4023503270648344,1.374208098114507,0.09619686800894854,0.12598954587971284,1.0,11/28,25.00%,RNF187;UBE2A;RNF181;UBE3A;RNF4;RNF220;RNF10;WWP2;UBE2D3;AMFR;RNF115
gsea,positive regulation of developmental growth (GO:0048639),0.4800047182254549,1.3729607591014292,0.11516314779270634,0.12658382287989126,1.0,7/16,31.70%,PPIB;DBNL;TWF2;NTN1;MAPT;RASAL1;ACTN3
gsea,receptor metabolic process (GO:0043112),0.43862101100048256,1.3713255860932054,0.08365019011406843,0.12729923704639057,1.0,9/21,24.46%,AP2M1;PLEKHJ1;GRB2;SNX1;ARRB2;MVB12A;SH3GLB1;DNM2;BECN1
gsea,negative regulation of supramolecular fiber organization (GO:1902904),0.42982552592774026,1.3710822989816973,0.08596491228070176,0.1271367639921814,1.0,10/23,28.71%,MAPRE1;PFDN2;PFDN1;TBCD;TWF2;KANK3;CIB1;TWF1;EML2;TUBB4A
gsea,positive regulation of cell motility (GO:2000147),0.35964256020812607,1.368970782820235,0.051070840197693576,0.12836556213954142,1.0,25/50,45.19%,MAPRE1;CFAP20;PHPT1;CCDC25;FERMT3;TRADD;PTK2;LEF1;WASHC1;MIEN1;PIK3R3;NTN1;CIB1;SEMA6B;SMO;TRIM32;SNAI1;FAM89B;CARMIL1;EGF;CBLL1;SEMA4G;MYLK;SEMA6C;DDRGK1
gsea,positive regulation of multicellular organismal process (GO:0051240),0.3259623664366943,1.3671043624505412,0.05289256198347107,0.12931799036903746,1.0,30/76,39.81%,EZH2;RPS19;MAD2L2;HDAC3;PPIB;SOD1;KDM1A;GNAS;SMAD2;CNOT3;ADIPOR2;LEF1;CTNNB1;SNX4;BATF;RTN4;LURAP1;PEMT;BAD;LRPAP1;SCAMP5;THRA;SMO;BMP1;SYDE1;PER2;SNAI1;ADIPOR1;EGF;TAPT1
gsea,toll-like receptor signaling pathway (GO:0002224),0.3989946601396654,1.3663498201601065,0.10438413361169102,0.1294926459482463,1.0,9/25,44.08%,HMGB1;NMI;UBE2D3;CASP8;TIRAP;LY96;IRAK1;TAB2;TLR1
gsea,insulin receptor signaling pathway (GO:0008286),0.3904529310437727,1.3658418942034865,0.08946322067594434,0.12958076454809592,1.0,8/30,23.53%,GRB2;ATP6V1G1;GSK3A;ATP6V1C1;PTPN2;ATP6V1A;APPL1;PIK3R3
gsea,protein maturation (GO:0051604),0.4016660244133864,1.3631085799497455,0.08302583025830258,0.13121120573675182,1.0,10/29,44.47%,CIAO2A;BOLA2;NFU1;CIAO2B;PSEN1;ECE2;CASP2;NCSTN;ASPRV1;LIPT1
gsea,positive regulation of neurogenesis (GO:0050769),0.44550137702205106,1.3626663540810693,0.10231023102310231,0.1312370780520261,1.0,8/22,26.78%,RHOA;SNW1;KDM1A;CTNNB1;CAPRIN2;OBSL1;FAIM;TIAM2
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4041233945482202,1.3618644704795033,0.0913978494623656,0.1314817810049773,1.0,10/30,31.08%,HMGB1;PYCARD;ARRB2;DDT;P2RY1;CRKL;CIB1;MAPK3;TIRAP;MAP2K7
gsea,regulation of apoptotic signaling pathway (GO:2001233),0.46304489458467774,1.356877880229437,0.10830324909747292,0.13491413279583037,1.0,5/16,17.14%,CSNK2A1;PYCARD;BCL2L12;TRAF7;CYLD
gsea,positive regulation of catabolic process (GO:0009896),0.39638073444562016,1.3566368721879916,0.0945945945945946,0.13475281213634444,1.0,13/28,43.00%,CSNK2A1;SNF8;OAZ1;GSK3A;SEC22B;WWP2;APOA2;ACTN3;TRIM32;EGLN2;NKD1;NEDD4L;RILP
gsea,endomembrane system organization (GO:0010256),0.3302547288423577,1.3540278976749822,0.05942622950819672,0.13633793825590443,1.0,29/61,28.74%,TMED10;TMED9;CDC42;PLEKHJ1;VAPA;TMED3;TOR1A;CSNK1A1;SURF4;LAMTOR1;DNM1L;RAB2A;TMED7;USP50;RNF26;TMED5;RAB1A;VMP1;VPS4A;TJAP1;COG4;COG2;TANGO2;GOLGA5;OBSL1;SUN1;VAPB;ATL1;UBXN2A
gsea,negative regulation of binding (GO:0051100),0.404294425092214,1.3532900367463916,0.100990099009901,0.1366020340827286,1.0,15/25,32.13%,PPP1CA;SUMO1;KDM1A;WAPL;MITD1;LEF1;PEX14;LRPAP1;PEX19;SMO;CTNNBIP1;STYX;HMGA2;DVL1;ITGB1BP1
gsea,regulation of DNA metabolic process (GO:0051052),0.4626843465119006,1.3494654659233773,0.10040160642570281,0.13915599189594344,1.0,11/16,37.15%,CDK9;SMARCAD1;MPHOSPH8;WDR70;UBE2V1;SMG5;SIRT7;KPNA1;GRHL2;SMG1;HDAC8
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),0.4242428069115459,1.3492728108810839,0.11895161290322581,0.13899557042272262,1.0,9/20,25.71%,RHOA;DCTN3;MITD1;ARL3;PDCD6IP;VPS4A;RAB35;SPAST;UNC119
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3985334945167522,-1.3480854283804542,0.0988235294117647,0.1831121841395052,1.0,8/23,27.37%,MCL1;ITGAV;CFLAR;EYA2;SRC;TGFBR1;NOS3;GSK3B
gsea,regulation of protein ubiquitination (GO:0031396),0.3438162981591423,1.3471368174866158,0.07581967213114754,0.1402246776123319,1.0,23/45,42.06%,UBE2L3;CENPX;COMMD1;HDAC3;UBXN1;FKBP1A;GSK3A;UBE3A;DERL1;ARRB2;USP4;CDK5RAP3;PSMD10;NSMCE3;FBXO4;WASHC1;SENP2;SIRT7;WFS1;PER2;HDAC8;MINAR1;AMER1
gsea,positive regulation of cell projection organization (GO:0031346),0.3780117302036602,1.3458400380463573,0.0856610800744879,0.14091370590995939,1.0,16/36,38.05%,SNX3;RHOA;TWF2;DVL2;DLG4;CAPRIN2;OBSL1;SCARB2;TIAM2;TWF1;DVL1;TOX;CBFA2T2;STYXL1;ABL2;CARMIL1
gsea,regulation of Rho protein signal transduction (GO:0035023),-0.44964179547183525,-1.343465202741042,0.10905349794238683,0.18621099259946283,1.0,5/16,11.72%,P2RY10;AKAP13;ARHGDIB;FLCN;LPAR6
gsea,positive regulation of cellular protein localization (GO:1903829),-0.4060933086218047,-1.3427839726499045,0.08576998050682261,0.18567613829981766,1.0,7/24,12.96%,TGFB1;FYN;ORMDL3;SNX33;VPS28;MARK4;APC
gsea,regulation of cell growth (GO:0001558),0.3327253019009726,1.3377393982422985,0.06818181818181818,0.1467754387339614,1.0,23/55,32.59%,MAD2L2;CSNK2A1;NDUFS3;DCUN1D5;PPP2R1A;CDC42;MTPN;PPP2CA;LAMTOR1;CRLF3;LAMTOR2;CCDC85B;CDK11B;PSMD10;STK11;RTN4;DACT3;CAPRIN2;CIB1;RPS6KA1;LTBP4;TRIM32;EGLN2
gsea,Wnt signaling pathway (GO:0016055),0.3793584971218814,1.335717300701623,0.10467289719626169,0.14805624951331814,1.0,13/34,21.90%,RBX1;SNX3;VPS29;TCF7;CSNK1A1;ARL6;LEF1;CTNNB1;CSNK1G2;DVL2;LRP5;WNT16;TCF7L1
gsea,peptidyl-serine phosphorylation (GO:0018105),0.3321650970392316,1.334508488596653,0.08879492600422834,0.1486490704245473,1.0,28/59,42.27%,CSNK2A1;PDK3;RPS6KB1;CSNK1A1;MAP2K2;PAK2;TLK1;PRKACA;MAPK1;CSNK1G2;MORC3;UHMK1;TOP1;RPS6KB2;TNKS;PKN3;PKD1;RPS6KA1;PKN2;CAMK4;MAP3K10;SMG1;VRK2;MAPK9;CSNK1G3;CDK5R1;PKN1;TTBK1
gsea,regulation of protein-containing complex assembly (GO:0043254),0.3951864060707025,1.3322796466799738,0.12298387096774194,0.150076897829043,1.0,14/27,33.05%,SUMO1;CDC42;SAR1A;PREB;LCMT1;SAR1B;NAPA;SH3GLB1;BRK1;FNIP2;RIOK3;TIRAP;RAF1;STXBP1
gsea,regulation of insulin secretion (GO:0050796),0.42283039528441047,1.3302694175340888,0.11690363349131122,0.1513625415957225,1.0,13/23,47.18%,UQCC2;PSMD9;LRP5;BAD;KCNB1;ENSA;PER2;RAPGEF3;EIPR1;STX1A;SOX4;STXBP4;RAP1A
gsea,positive regulation of phosphorylation (GO:0042327),0.33666608837921685,1.3301159312539161,0.07537688442211055,0.15117206026699295,1.0,21/60,32.74%,RAC1;ILK;HDAC3;ERP29;KRAS;TYRO3;PTK2;FXR1;BTBD10;RALBP1;DVL2;P2RY1;PSEN1;CRKL;PIK3R3;LIMK2;CIB1;MAPK3;FGF20;NCKAP1L;F2
gsea,positive regulation of protein binding (GO:0032092),-0.4370070219608847,-1.327367844687135,0.11886792452830189,0.1993323136873835,1.0,6/17,27.37%,B2M;LRP1;RPL11;SPPL3;STK4;GSK3B
gsea,neuron differentiation (GO:0030182),-0.36498757619856925,-1.3269120724156007,0.10991957104557641,0.19846542949295734,1.0,13/34,24.92%,NR4A2;ITM2C;IER2;RUNX2;UGCG;PPT1;FZD5;CDK5;NRBP2;ATP8A2;TGFBR1;LHX6;ID2
gsea,negative regulation of defense response (GO:0031348),0.43115775925686795,1.3267930335011864,0.1245136186770428,0.15338755369324772,1.0,7/20,20.50%,PCBP2;TYRO3;NMI;PTPN2;RNF26;FNDC4;PPM1B
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.3136416125258611,-1.3253296178579919,0.0649895178197065,0.1987895143038323,1.0,70/70,96.16%,UBC;IRAK2;ARID5B;UBA52;LGALS9;PRKCH;PRKCQ;NOD1;CFLAR;STAT3;ATF2;BCL10;CRTC3;EP300;RPS3;TRIM13;TICAM1;RNF31;NOD2;IKBKB;TRIM62;IL18;CARD9;ZBTB7A;RPS6KA4;TRIM26;RNF25;AGER;ESR1;TLR6;LPAR5;NTRK1;CRTC1;MYD88;TSSK4;PTEN;TRAF6;STK36;ABRA;RTKN2;RELA;RIPK4;TRIM68;TNFRSF11A;FER;DDRGK1;IL1RAP;TAB2;IRAK1;TRIM32;TIRAP;SMO;CIB1;AIM2;CRTC2;DVL2;CAPN3;HCLS1;CTNNB1;TRADD;RBCK1;UBE2V1;LAMTOR5;KDM1A;CEBPG;MTPN;PYCARD;TAF12;TRIM27;TCF3
gsea,actin cytoskeleton reorganization (GO:0031532),0.4442381770579139,1.321652246508482,0.12777777777777777,0.15687241749460726,1.0,9/17,30.96%,RHOA;DTNBP1;GRB2;PARVG;MKLN1;ATP2C1;CDC42BPA;CDC42BPG;SYDE1
gsea,regulation of mitochondrion organization (GO:0010821),-0.4181192360726741,-1.3214242277154784,0.12625250501002003,0.20147820634365593,1.0,7/20,18.34%,SQSTM1;GOLPH3;FLCN;FZD5;EP300;PDE2A;FIS1
gsea,positive regulation of tumor necrosis factor production (GO:0032760),0.430624572765248,1.3212785961173499,0.1431578947368421,0.156899414764445,1.0,7/18,33.53%,HMGB1;PYCARD;DDT;PSEN1;CYBA;TIRAP;LY96
gsea,positive regulation of type I interferon production (GO:0032481),0.4549634131136407,1.3205163095194243,0.13656387665198239,0.15713952060397865,1.0,8/16,27.83%,POLR2K;DHX36;POLR3C;CRCP;CTNNB1;PQBP1;RIOK3;IRF3
gsea,regulation of myeloid cell differentiation (GO:0045637),-0.467957419948267,-1.3199728239032678,0.14225941422594143,0.20169331196952786,1.0,9/15,17.27%,KMT2E;NR4A3;TNRC6B;PRKCQ;TNRC6C;AGO3;EP300;CNOT4;NFE2
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4223815792980167,1.3196660356866994,0.13389121338912133,0.15752138742673094,1.0,7/19,33.53%,HMGB1;PYCARD;DDT;PSEN1;CYBA;TIRAP;LY96
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3943065755393565,1.3188878003204603,0.12962962962962962,0.15779980102410315,1.0,14/24,31.71%,RAC1;RHOA;CDC42;PDCD6;PAK2;WASF2;NCF4;PTK2;CYFIP2;BRK1;AAMP;VAV1;CYBA;NCKAP1L
gsea,positive regulation of developmental process (GO:0051094),0.3473323300074258,1.3186062989146845,0.09913043478260869,0.15770556769151137,1.0,16/46,31.55%,MAD2L2;ANAPC2;MFF;DNM1L;RALBP1;DVL2;DLG4;PSEN1;RTN4;MIEF1;BMP1;TMEM79;RPS6KA1;CPEB3;SYDE1;DVL1
gsea,water-soluble vitamin metabolic process (GO:0006767),0.45307254935797975,1.3132293802402888,0.14744801512287334,0.16177260377231556,1.0,8/16,27.10%,PANK2;RFK;CYB5R3;GSTO2;AMN;CYB5A;FLAD1;SLC5A6
gsea,regulation of macroautophagy (GO:0016241),0.33455418019699923,1.3131179109271998,0.11632653061224489,0.16151125341711903,1.0,24/52,41.70%,SNX6;ATP6V1G1;LAMTOR4;PAFAH1B2;LAMTOR1;ATP6V1C1;PRKAG1;LAMTOR5;PRKACA;ATP6V1A;LAMTOR3;LAMTOR2;SH3GLB1;EXOC1;UBQLN2;EXOC7;RRAGC;RHEB;GNAI3;RRAGA;SMG1;RRAGD;CDK5R1;VPS26B
gsea,cytosolic transport (GO:0016482),0.3315547123218229,1.3130820703085795,0.0995850622406639,0.1611962577617909,1.0,27/48,43.85%,SNF8;TRIM27;VPS29;PLEKHJ1;SNX6;SNX1;AP2A1;VPS13A;RAB14;VTI1B;YKT6;WASHC1;GOSR2;GGA1;TBC1D10A;BECN1;WDR91;VPS53;VTI1A;MON2;GOSR1;SORT1;VPS26B;SNX2;RILP;VPS51;VAMP3
gsea,cation transport (GO:0006812),-0.3507549148302801,-1.3122229918331199,0.08024691358024691,0.208367209334983,1.0,16/36,27.57%,NDFIP1;SLC8B1;TAF7;SLC36A1;SLC29A4;SLC25A29;SLC18A2;TRPM6;TRPM4;SLC36A3;SLC38A7;KCNIP2;PANX1;KCNH4;KCNA3;SCN3B
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.42882330652127154,1.3118134652022635,0.13963039014373715,0.1618923644077246,1.0,6/17,45.19%,CSNK2A1;SGTA;UBXN1;BAG6;PDCL3;DDRGK1
gsea,regulation of interleukin-8 production (GO:0032677),0.4129197203626541,1.3112410580767397,0.10975609756097561,0.16200848866298667,1.0,6/20,18.80%,HMGB1;PYCARD;LAMTOR5;RAB1A;MAP2K5;APOA2
gsea,ribonucleoprotein complex biogenesis (GO:0022613),0.48186994378520726,1.309425916512358,0.18181818181818182,0.16310086827692294,1.0,10/18,20.31%,RPS6;RPS19;MRPL36;PAK1IP1;MALSU1;RBIS;RPL26;TGS1;RRP36;METTL17
gsea,positive regulation of T cell proliferation (GO:0042102),0.4277888918673351,1.3068757905566943,0.14829659318637275,0.1651146283167622,1.0,17/17,99.81%,HMGB1;PNP;PYCARD;NCKAP1L;IL12RB1;CD46;AGER;IL18;IL15;JAK3;RPS3;IL27RA;NCK1;CD28;CD6;PTPRC;CD3E
gsea,fat cell differentiation (GO:0045444),-0.4040135204530889,-1.3051802938328045,0.14081632653061224,0.21412037631524816,1.0,10/22,26.95%,NR4A2;NR4A3;NR4A1;FOXO1;BSCL2;CEBPA;EP300;FAM120B;ZBTB7A;AKT2
gsea,protein homooligomerization (GO:0051260),0.39603495331985517,1.3042264453004202,0.11557788944723618,0.16701708792395437,1.0,14/29,27.36%,ELAVL1;G3BP2;SSBP1;PYCARD;CHMP2A;ACOT13;USP16;PDCD6IP;MPP2;MICU1;PRMT8;PKD2;SPAST;ATL1
gsea,Golgi to plasma membrane transport (GO:0006893),0.3782283501823109,1.3037293632906448,0.1125,0.16710419326711176,1.0,18/27,43.83%,COMMD1;RAB10;ARL3;GGA1;EXOC5;EXOC1;GOPC;AMN;VAMP4;RABEP1;CCDC22;BBS2;GOLGA7;EXOC6;BBS1;BLZF1;GOLPH3L;VPS35L
gsea,regulation of organelle assembly (GO:1902115),0.3648425027790468,1.30319679695787,0.11462450592885376,0.16719092715891234,1.0,12/31,23.86%,TSG101;ATG3;RNF4;PDCD6IP;ATG5;TBC1D15;SENP6;CYLD;TBC1D19;TBC1D10A;TBC1D24;UBQLN2
gsea,negative regulation of protein kinase activity (GO:0006469),-0.3660434646866347,-1.301605985381623,0.1282565130260521,0.21655711448441542,1.0,31/31,96.05%,PTPRC;CDKN1B;THY1;UBASH3B;SORL1;PTPN1;DBNDD2;TAF7;INPP5K;GNAQ;GSKIP;EPHA1;TESK1;DBNDD1;SH3BP5L;CHP1;DEPTOR;ADARB1;ITGB1BP1;DVL1;CAMK2N2;PPM1E;LRP5;CDKN1C;CDK5RAP3;PAK2;DTNBP1;PYCARD;RTRAF;GSTP1;TRIM27
gsea,purine ribonucleotide metabolic process (GO:0009150),0.4349210766729769,1.2991594670842888,0.15021459227467812,0.17014804428309335,1.0,8/16,24.84%,ACAT1;ACOT13;ACBD6;GTPBP1;ACOT7;ACOT6;ACOT8;BAD
gsea,regulation of cellular localization (GO:0060341),0.4529117936946996,1.2987607636774097,0.16873889875666073,0.17011765945742052,1.0,11/16,46.62%,KDM1A;LRP5;STXBP2;UNC13D;PARD6G;DVL1;PARD6A;GOSR1;PARD6B;STXBP4;FER
gsea,positive regulation of mRNA catabolic process (GO:0061014),0.4374526969803222,1.2984830244830001,0.14906832298136646,0.16995759582625034,1.0,8/15,17.53%,POLR2G;YTHDF2;CNOT7;DHX36;CNOT8;GTPBP1;YTHDF1;PUM1
gsea,autophagosome maturation (GO:0097352),-0.4204848085713181,-1.2978652013485075,0.14901960784313725,0.21933659039089523,1.0,18/18,98.47%,GABARAP;MAP1LC3B;GABARAPL2;MAP1LC3A;LAMP2;RUBCNL;GABARAPL1;EPG5;VIPAS39;UVRAG;CHMP3;LIX1L;SNAP29;VMP1;WIPI2;VTI1B;TSG101;CALM1
gsea,transport across blood-brain barrier (GO:0150104),-0.42138566016024454,-1.296466068278953,0.14054054054054055,0.21814230128723971,1.0,9/16,32.90%,SLC9A3R1;SLC28A2;LRP1;SLC29A4;INSR;AGER;ABCC3;SLC2A10;SLC24A3
gsea,vascular transport (GO:0010232),-0.42138566016024454,-1.296466068278953,0.14054054054054055,0.21814230128723971,1.0,9/16,32.90%,SLC9A3R1;SLC28A2;LRP1;SLC29A4;INSR;AGER;ABCC3;SLC2A10;SLC24A3
gsea,protein phosphorylation (GO:0006468),0.2758606100650457,1.29179761147587,0.06601941747572816,0.17535405347775518,1.0,71/164,42.85%,GTF2H5;CSNK2A1;CCNH;PDK3;ILK;CTBP1;RPS6KB1;YWHAZ;CDK9;CSNK1A1;CSK;GSK3A;STK16;PRPF4B;DAPK3;COPS8;TYRO3;PRKAG1;SMAD2;PAK2;CSNK2B;FASTK;TLK1;PRKACA;RUNX3;PTK2;GRK6;CDK11B;MAPK1;CSNK1G2;FNIP2;MORC3;UHMK1;CDK10;TOP1;EIF2AK1;STK26;STK11;LIMK2;CDC42BPA;RPS6KB2;HTATIP2;CLK3;MAPK3;TNKS;PKN3;STK19;STK25;PKD1;RPS6KA1;PKN2;CDC42BPG;CAMK4;MAP3K10;TAOK3;SMG1;IRAK1;CDC42BPB;ABL2;VRK2;MAPK9;MAP3K9;PKDCC;MAP2K1;CSNK1G3;CDK5R1;PKN1;RSKR;TTBK1;CDK13;TESK2
gsea,positive regulation of GTPase activity (GO:0043547),-0.31754483722185695,-1.2897051579463548,0.10845986984815618,0.22396299541747322,1.0,34/57,33.46%,ARHGAP45;THY1;RABGAP1L;TBC1D10C;DOCK10;SNX18;NDEL1;FLCN;RHOG;RAPGEF6;SIPA1L3;PIP5K1A;RAP1GAP2;RIC1;TBC1D20;TBC1D2;SEMA4D;RUNDC1;RAP1GAP;TBC1D12;TBC1D22A;TBC1D17;SIPA1L2;AGRN;DVL3;EPHA1;GMIP;MAPRE2;ARHGEF10;GSK3B;TBC1D16;FOXJ1;NTRK1;APC2
gsea,sodium ion transmembrane transport (GO:0035725),0.4743566653090042,1.288978351477011,0.1558641975308642,0.17742037526864682,1.0,8/17,38.02%,ATP1B3;SLC9A5;HCN2;PKD2;SLC6A19;SLC5A2;HCN3;ASIC1
gsea,positive regulation of cellular protein metabolic process (GO:0032270),0.35508297713145814,1.28764111455297,0.13305613305613306,0.178238593036255,1.0,18/36,33.40%,RBM3;AURKAIP1;ELAVL1;RPS6KB1;RPL26;YTHDF1;FXR1;CYFIP2;UPF3A;CAPN3;CASP8;TBC1D10A;POLDIP3;BAD;CPEB3;ASPSCR1;TRIM32;PCIF1
gsea,organonitrogen compound catabolic process (GO:1901565),-0.44029673899344196,-1.2856357916239531,0.1484375,0.22680382202422106,1.0,7/15,24.34%,USE1;TPP1;LNPEP;PPT1;GNPDA2;LRSAM1;AMDHD2
gsea,ERBB signaling pathway (GO:0038127),-0.4203535885913797,-1.2838906338224794,0.15898617511520738,0.22720404438565706,1.0,15/15,97.75%,PTPN18;TGFB1;SRC;BRAF;NRG2;ERBB3;EGF;IQGAP1;NRG4;PTPRR;AAMP;MAPK1;PTK2;GRB2;CDC37
gsea,regulation of protein kinase activity (GO:0045859),0.3588289402294704,1.28382136396049,0.12055335968379446,0.18132270491541674,1.0,18/36,47.18%,TRIM27;GSTP1;RTRAF;DTNBP1;SOD1;PRKAG1;PAK2;ANKRD54;PTK2;PPM1E;CAMK2N2;DVL1;ITGB1BP1;IQGAP1;TAB2;CACUL1;UVRAG;RAP1A
gsea,regulation of interferon-gamma production (GO:0032649),0.443864214660384,1.2835776620119363,0.19,0.18113803611508486,1.0,4/15,6.93%,HMGB1;TRIM27;PYCARD;CEBPG
gsea,protein dephosphorylation (GO:0006470),0.32409639845427646,1.2831576816148476,0.1308411214953271,0.18113804779844747,1.0,27/57,35.80%,PPP1CA;SSU72;ILKAP;PPP2R1A;PHPT1;PPP2CA;PPP1CC;PPP2R2A;PPP6C;PPP2R2D;PPP2R5C;PTPN2;PTPRA;SDHAF2;MTMR2;PTPRU;PPP2R5E;PPP1R15B;PPM1B;PPM1D;STK11;PPM1E;PTPRR;CDC14B;PTPN14;PPM1A;PP2D1
gsea,regulation of protein binding (GO:0043393),0.3397261752321745,1.2807492554113675,0.13655462184873948,0.18292046550125676,1.0,20/38,32.13%,PPP1CA;BTBD1;NMD3;PPP2CA;FKBP1A;KDM1A;DERL1;MITD1;PRKACA;PEX14;AMFR;PRMT8;PSEN1;CAPRIN2;LRPAP1;PKD1;CTNNBIP1;STYX;DVL1;ITGB1BP1
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.39447874862980037,-1.2806088321056164,0.17115384615384616,0.229348237538875,1.0,7/21,11.35%,SQSTM1;OGT;N4BP1;SVBP;VPS28;RPS3;RPL11
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3988431392932421,1.2805415434448502,0.1718146718146718,0.18270864836826559,1.0,11/23,22.31%,RAC1;CDC42;ACTR3;WASF2;BRK1;P2RY12;WASHC1;TWF2;ENTR1;MIEN1;CROCC
gsea,translation (GO:0006412),-0.41819306630774433,-1.2801750196413104,0.22868217054263565,0.22844656174868397,1.0,87/87,99.75%,RPS27;RPS24;RPS15A;RPL34;RPL37A;RPL30;RPL18A;RPL39;RPS21;RPL19;RPS11;RPS7;RPL13A;RPL24;RPL17;RPS13;RPL37;RPL9;RPL27A;RPL27;RPL38;RPS10;UBA52;RPL23;RPS16;RPS14;RPL21;RPL36;RPS28;EEF2;RPL22;GTPBP2;RPS3;RPS9;RPL11;RPS29;MRPL9;RPL35A;MRPL24;RPS4X;RPL18;RPS23;RPS6KB2;RPL6;MRPL52;APEH;RPL32;EIF4EBP2;MRPS16;RPL29;GTPBP1;RPS5;MRPS34;MRPL32;MRPL43;AIMP1;MRPL41;RPS12;NDUFA7;RPLP2;RPL26;MRPS11;MRPS21;MRPL10;MRPL36;ZC3H15;RPL12;MRPL34;TRMT112;MRPS18C;RPL36A;RPS20;MRPS17;MRPL27;RPL35;MRPS24;MRPS33;TMA7;MRPL57;RWDD1;RPS19;MRPS36;MRPS14;MRPS15;RPL28;RPS6;MRPL23
gsea,tight junction assembly (GO:0120192),0.4468885898493137,1.2800634818837033,0.15357766143106458,0.18273308569939603,1.0,11/16,42.23%,PAK2;TBCD;PDCD6IP;PARD6G;GRHL2;CLDN12;OCLN;PARD6A;CLDN7;PATJ;PARD6B
gsea,Notch signaling pathway (GO:0007219),-0.4060250323899889,-1.2800244083817185,0.1394335511982571,0.2272758169988765,1.0,8/20,19.81%,RBPJ;DTX3;PSENEN;MAML1;EP300;ITCH;APH1B;APH1A
gsea,determination of left/right symmetry (GO:0007368),0.46188934409958915,1.2793987081771652,0.15357766143106458,0.18292045973224288,1.0,7/15,34.04%,ARL6;BBS7;NPHP3;PKD2;DNAH11;SMO;GALNT11
gsea,regulation of innate immune response (GO:0045088),0.4344747272600804,1.2787063702918697,0.17357001972386588,0.18318702934518313,1.0,8/16,29.78%,CDC37;TYRO3;NMI;POLR3C;APPL1;CASP8;RIOK3;TIRAP
gsea,protein-containing complex disassembly (GO:0032984),-0.36254652133210097,-1.276311769483136,0.1295238095238095,0.22996037047619342,1.0,29/29,98.87%,GABARAP;MAP1LC3B;RPL23;GABARAPL2;MAP1LC3A;LAMP2;FRAT1;FZD5;APC;RUBCNL;DVL3;GSK3B;GABARAPL1;EPG5;VIPAS39;UVRAG;AMER1;CHMP3;DVL1;LIX1L;SNAP29;DVL2;VPS4A;CTNNB1;WIPI2;VTI1B;CSNK1A1;TSG101;PPP1CA
gsea,glycerophospholipid biosynthetic process (GO:0046474),0.32229897765620275,1.2759214527903164,0.1065891472868217,0.1854311414410089,1.0,26/58,40.64%,CSNK2A1;ARF1;IMPA1;ABHD8;CSNK2B;RAB14;MTMR2;CEPT1;MTMR9;LPCAT4;PTDSS1;APOA2;PCYT1B;GPAM;PIK3R3;PEMT;ABHD5;DGKZ;PHOSPHO1;MBOAT7;LPCAT3;PLA2G4C;PLEKHA4;CDS2;PIK3C2B;ETNK1
gsea,positive regulation of response to external stimulus (GO:0032103),-0.35835137806127104,-1.2749889514431516,0.14705882352941177,0.23013968499694817,1.0,31/31,88.50%,TGFB1;ETS1;GPSM3;CEBPA;IL15;PDE2A;LRSAM1;IL18;SASH1;TREM2;IFI35;THBD;MDK;USF1;STX3;CD47;RARRES2;SETD4;CNTF;NAPEPLD;LY96;F2;ZCCHC3;CYBA;RIOK3;PUM1;P2RY12;TRADD;DDT;POLR3C;NMI
gsea,Ras protein signal transduction (GO:0007265),0.3475813983507564,1.2743316675748804,0.13725490196078433,0.18659770249125185,1.0,23/43,48.90%,RAC1;G3BP2;GNB1;RHOA;DBNL;GRB2;KRAS;USP50;BRK1;WAS;CRKL;CTNNAL1;NTN1;ARHGAP29;ARHGAP1;USP28;RAPGEF3;BRAP;RASSF1;MAPK14;ARHGEF1;RAP1A;RHOD
gsea,regulation of lipid metabolic process (GO:0019216),0.39091554983409393,1.2723689879553783,0.16917293233082706,0.18805270857320489,1.0,13/26,36.44%,EDF1;HDAC3;PANK2;TGS1;CERS2;SIN3B;SREBF1;GPAM;ZFP69;NCOR1;MBOAT7;GPS2;ADIPOR1
gsea,regulation of stress-activated MAPK cascade (GO:0032872),0.397481229662657,1.2714052822950386,0.14615384615384616,0.18856090394135552,1.0,10/22,40.77%,FOXM1;GSTP1;KLHDC10;MAP2K2;MAPK1;MAPK3;STK25;TAOK3;MAP2K1;MAPK8IP3
gsea,DNA replication (GO:0006260),-0.42576889759411807,-1.2666343547971648,0.18352059925093633,0.23797308187801186,1.0,16/16,87.38%,POLD4;PTMS;ING4;RBMS1;TREX1;KAT5;ATRIP;RMI1;TOP1;RAD9B;POLL;POLB;KIN;PNKP;NT5M;ORC4
gsea,skeletal system development (GO:0001501),0.3787691560048915,1.2641798578018162,0.15789473684210525,0.1946049325030151,1.0,16/32,47.14%,PPIB;EBP;GNAS;DEAF1;PAPSS1;UFD1;SLC10A7;BMP1;PKD1;SUFU;COMP;PKDCC;COL11A2;SOX4;DDRGK1;EXT1
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4400411008519227,1.2633314550433934,0.15949820788530467,0.19509492633117786,1.0,8/16,37.18%,GSTP1;PYCARD;CASP8;PPM1B;RIOK3;ZMYND11;PPM1A;CCDC22
gsea,negative regulation of kinase activity (GO:0033673),-0.37426983285455573,-1.262096741703594,0.1728395061728395,0.24175629184961303,1.0,26/26,96.05%,PTPRC;CDKN1B;THY1;UBASH3B;DBNDD2;TAF7;INPP5K;GNAQ;PPP2R5A;GSKIP;EPHA1;DBNDD1;CHP1;DEPTOR;NPRL2;ITGB1BP1;DVL1;MAPT;CAMK2N2;PPM1E;CDKN1C;PAK2;DTNBP1;RTRAF;GSTP1;TRIM27
gsea,positive regulation of cell-substrate adhesion (GO:0010811),-0.3823524987544069,-1.2580023364384838,0.17598343685300208,0.2450404567315022,1.0,22/22,97.04%,CD3E;SKAP1;RREB1;PLEKHA2;RAC3;EPHA1;GSK3B;CRK;TESK1;MDK;ARHGEF7;ECM2;RELL2;CARMIL1;LIMS2;CIB1;CSPG5;CRKL;LIMS1;CDC42;ILK;RAC1
gsea,visual perception (GO:0007601),0.4021801434893686,1.2563903879455067,0.16806722689075632,0.2014679132660238,1.0,11/25,39.07%,DNAJC19;PITPNA;CABP4;UNC119;WFS1;EML2;GNAT2;BBS2;TULP1;CABP1;MYO7A
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.3703633500797864,-1.2559853863563406,0.15288220551378445,0.24609277745240377,1.0,24/24,100.00%,CD52;P2RY10;NPTN;LPAR6;TRPM4;FIS1;CCR10;SPPL3;ACKR4;GPR157;ESR1;XCR1;PTGER1;ADCY5;PTGIR;LPAR2;ABL2;PTGER3;DLG4;P2RY1;TAC4;SELENOT;BCAP31;HMGB1
gsea,cellular response to starvation (GO:0009267),-0.31069854604360553,-1.2536375598491871,0.1431261770244821,0.2472673771844834,1.0,59/59,98.41%,GABARAP;MAP1LC3B;ATP6V0C;GABARAPL2;FOXO1;MAP1LC3A;ATP6V0D1;SIK1;BMT2;LAMP2;FLCN;ATP6V0B;ATF2;ATP6V1E1;ATP6V1F;CASTOR2;CPEB4;WDR45;ATP6V1H;ATP6V1G2;ATP6V1D;CLEC16A;ATP6V1B2;PIK3C3;GABARAPL1;BRSK2;WIPI1;BMPR2;ZFYVE1;WDR59;NPRL2;VPS41;STK24;NIM1K;WDR45B;RRAGD;RRAGA;RHEB;RRAGC;SZT2;MAPK3;KPTN;BECN1;STK26;SREBF1;WIPI2;SH3GLB1;MAPK1;ATG5;LAMTOR2;LAMTOR3;ATP6V1A;LAMTOR5;PRKAG1;ATP6V1C1;LAMTOR1;LAMTOR4;ATP6V1G1;SEC13
gsea,positive regulation of cellular component organization (GO:0051130),0.38114503241340364,1.2445840579571141,0.18729641693811075,0.21289855104642033,1.0,14/29,41.25%,TMED9;SUMO1;ANAPC2;SURF4;SH3GLB1;BRK1;FNIP2;TIRAP;HAS3;CALY;TMEM30A;RAPGEF3;CBLL1;NEDD4L
gsea,response to reactive oxygen species (GO:0000302),0.37234140393216736,1.2445199227967025,0.19206680584551147,0.2125064382918938,1.0,14/24,38.58%,ROMO1;GSTP1;SOD1;GLRX2;MAPK1;AGAP3;STK26;PKD2;MAPT;MAPK3;STK25;CAT;MAPK9;PTPRN
gsea,positive regulation of proteolysis (GO:0045862),-0.4205792065304385,-1.2437122358230666,0.19056603773584907,0.25703670230799097,1.0,9/16,30.08%,TNFRSF1B;OGT;CTSC;NDUFA13;GBA;SNX33;IST1;FBXW11;GPLD1
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4220400118667113,1.2423728343267335,0.19922630560928434,0.21427997842634128,1.0,9/16,29.89%,BEX3;CSNK2A1;LAMTOR5;TRIAP1;MAP2K5;LAMP3;SIAH2;RPS6KA1;RAF1
gsea,canonical Wnt signaling pathway (GO:0060070),0.39835391944372084,1.2400230099593235,0.16845878136200718,0.2161191364883312,1.0,11/23,31.90%,PPP1CA;TCF7;CSNK1A1;LEF1;CTNNB1;DVL2;LRP5;WNT16;TCF7L1;DVL1;BCL9
gsea,regulation of cell death (GO:0010941),-0.3601845651252793,-1.2399188886901222,0.1799163179916318,0.25993780922222803,1.0,12/28,26.91%,TNFRSF1B;CDKN1B;BNIP3L;NCK1;LRP1;TRIM13;APC;SARM1;RAB29;PDE8A;TBK1;PARP16
gsea,ribosomal small subunit biogenesis (GO:0042274),-0.4778446971736991,-1.2385971362247012,0.23954372623574144,0.25999775131094827,1.0,6/15,5.97%,RPS27;RPS24;RPS7;RPS16;RPS14;RPS28
gsea,cellular response to reactive oxygen species (GO:0034614),0.41923014845665046,1.236721533827841,0.22172949002217296,0.21899757882666873,1.0,6/15,27.73%,ROMO1;MAPK1;AGAP3;PKD2;MAPT;MAPK3
gsea,fatty acid catabolic process (GO:0009062),0.35311857372101013,1.2346101067451642,0.19066937119675456,0.22063183446188156,1.0,13/30,38.54%,ACAT1;ECHS1;HADHA;ACAA2;HADHB;AUH;ACOT8;ACADVL;NUDT7;ECI2;HSD17B4;MMAA;PCCB
gsea,regulation of cation channel activity (GO:2001257),0.4158061442985611,1.2341192920251607,0.1736111111111111,0.22070245888044543,1.0,6/19,34.48%,CALM1;FKBP1A;PRKACA;DLG4;CNIH3;DLG3
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.33776307232810693,1.2305457548350935,0.17777777777777778,0.22380041865309036,1.0,18/34,47.81%,RBX1;ELOB;SUMO1;DDA1;CSNK1A1;GSK3A;FBXO22;CDK5RAP3;PTK2;PSMD10;BBS7;DET1;DVL1;HECTD1;CCDC22;DDRGK1;CSNK1D;RNF14
gsea,phosphorylation (GO:0016310),-0.2651280805442795,-1.2304358188039954,0.10860655737704918,0.26816240215799436,1.0,139/139,97.88%,HCST;GMFG;STK17B;TGFB1;FYN;TGFBR2;PRKCH;CDK17;JAK1;ZAP70;STAT3;MAML1;SIK1;GNPTG;SIK3;DYRK1B;LCK;CDK5;SRPK2;JAK3;STK38;NEK3;MARK4;MKNK1;NRBP2;IKBKB;SHPK;GRK3;PRKACB;TSSK6;ACVR1B;FAM20C;GRK4;TGFBR1;MAP4K3;BRAF;MAP4K5;INSR;ACVR2A;NRBP1;RPS6KA4;DGKQ;STK4;CDK20;GLYCTK;PRKCD;CCNT1;TBK1;GSK3B;FGFR1;LIPE;SGK3;TOLLIP;NTRK1;ACVR2B;BRSK2;MARK2;STRADB;TSSK4;BMPR2;PRAG1;AKT3;STK36;ADAM10;CDKL4;MAP3K12;CAMK2B;DMPK;LTK;PRKAB1;MKNK2;MARK3;NEK11;MAP3K6;PXK;LIMD1;MAP4K2;BMPR1A;CDKL5;STK24;CSNK1D;FER;NIM1K;TESK2;CDK13;TTBK1;RSKR;PKN1;MAP2K1;MAP3K9;MAPK9;VRK2;CDC42BPB;FGGY;IRAK1;TAOK3;CAMK4;CDC42BPG;PKN2;DGKZ;STK25;STK19;PKN3;MAPK3;CLK3;CDC42BPA;LIMK2;STK11;STK26;TOP1;CDK10;GK5;MORC3;PNKP;FNIP2;CSNK1G2;MAPK1;CDK11B;GRK6;RUNX3;PRKACA;XYLB;TLK1;FASTK;PAK2;PRKAG1;COPS8;DAPK3;PRPF4B;GSK3A;CSK;CSNK1A1;CDK9;PANK2;YWHAZ;CTBP1;ILK;PDK3;CSNK2A1
gsea,regulation of type I interferon production (GO:0032479),0.35017314099074104,1.2299913839111356,0.16632016632016633,0.2238857638613843,1.0,15/32,38.88%,PCBP2;POLR2K;DHX36;POLR3C;CRCP;RNF26;CTNNB1;UFD1;CYLD;PQBP1;IRF3;TIRAP;TRIM32;IRAK1;LRRFIP1
gsea,negative regulation of protein binding (GO:0032091),-0.3975564259594191,-1.2291718624821204,0.1926605504587156,0.26822892178016516,1.0,19/19,98.87%,B2M;SORL1;TMBIM6;DISC1;PRKCD;GSK3B;ADAM15;DACT1;TTBK1;ITGB1BP1;DVL1;STYX;CTNNBIP1;LRPAP1;PEX14;MITD1;ARRB2;KDM1A;PPP1CA
gsea,regulation of cellular catabolic process (GO:0031329),0.3691016730850271,1.2265578467161378,0.1885245901639344,0.22688504888169927,1.0,12/26,40.25%,VPS29;DAPK3;RAB8A;CISD2;LAMP3;SCARB2;MAPT;RRAGC;WDR91;RRAGA;ABL2;RRAGD
gsea,inositol lipid-mediated signaling (GO:0048017),0.4371475342105757,1.2261158046048197,0.203125,0.22685489549807408,1.0,7/15,41.48%,RHOA;RPS6KB1;EXOC1;KCNH1;PLCB3;PIK3C2B;PLCD4
gsea,cellular response to growth factor stimulus (GO:0071363),-0.3151679054582558,-1.2246017919955101,0.1940928270042194,0.27228857632615955,1.0,44/44,99.42%,TGFB1;NR4A1;EHD1;TGFBR2;SIRT2;NR3C1;RUNX2;INPP5K;SOX5;SMAD4;ACVR1B;PDE2A;DSTYK;SYAP1;TGFBR1;FOXC1;ACVR2A;CORO1B;PDE8A;NTRK1;ACVR2B;BMPR2;HYAL1;ACAP2;RELA;BMPR1A;HGF;RAP1A;MAGI2;MAPK14;IQGAP1;ITGB1BP1;MAPT;CIB1;RAB35;CRKL;TWF2;MAP2K5;CTNNB1;LIMS1;APPL1;RPS6KB1;EMD;PDCD5
gsea,sensory perception of light stimulus (GO:0050953),0.38896610536748816,1.224153843514669,0.2071917808219178,0.22841151395262946,1.0,12/26,39.07%,DNAJC19;PITPNA;WHRN;CABP4;UNC119;WFS1;EML2;GNAT2;BBS2;TULP1;CABP1;MYO7A
gsea,potassium ion transmembrane transport (GO:0071805),0.3853054853159833,1.2230600311111712,0.19648093841642228,0.2290828107735637,1.0,11/31,37.11%,ATP1B3;SLC9A5;HCN2;PKD2;KCNK3;KCNB1;KCNA7;SLC12A8;KCNH1;HCN3;KCNK12
gsea,regulation of Notch signaling pathway (GO:0008593),-0.32998237450826756,-1.2181076415549792,0.18266978922716628,0.2787502975354404,1.0,33/33,92.86%,LFNG;RBPJ;STAT3;MAML1;TSPAN14;EP300;BEND6;SRC;NOD2;LLGL2;TSPEAR;ZBTB7A;NOS3;HIF1AN;CD46;PRAG1;PDCD10;NOTCH4;HEY1;GATA2;YJEFN3;MFNG;EGF;JAG1;GALNT11;ITGB1BP1;ARRDC1;WWP2;RFNG;TM2D3;YTHDF2;SYNJ2BP;SNW1
gsea,inorganic cation import across plasma membrane (GO:0098659),0.45636273282495154,1.2165767059444195,0.22189349112426035,0.23528797332690285,1.0,6/15,39.22%,ATP1B3;SLC9A5;HCN2;SLC12A8;SLC5A2;SLC39A8
gsea,positive regulation of protein secretion (GO:0050714),0.43119132618167294,1.2164278428148199,0.22324723247232472,0.2349908566605711,1.0,7/16,24.84%,TMED10;PSMD9;IER3IP1;ARF6;DNM1L;EXOC1;BAD
gsea,bicellular tight junction assembly (GO:0070830),0.4398641141180907,1.2157456390937424,0.2158273381294964,0.23526348885813617,1.0,10/15,42.23%,PAK2;TBCD;PDCD6IP;PARD6G;GRHL2;OCLN;PARD6A;CLDN7;PATJ;PARD6B
gsea,regulation of GTPase activity (GO:0043087),0.3241903214903046,1.2142716968884553,0.1801125703564728,0.23643351289847606,1.0,15/45,47.18%,EZH2;ZC3H15;SOD1;PTK2;TBC1D15;LIMS1;RALBP1;VAV1;CHN1;ITGB1BP1;RAPGEF3;RAB11FIP2;PLXNA3;FGD1;RAP1A
gsea,cellular protein catabolic process (GO:0044257),-0.38930387316920484,-1.2117456227633157,0.20920502092050208,0.2851448700368364,1.0,10/20,31.78%,CTSW;BNIP3L;CTSC;MYLIP;CTSB;CTSO;AFG1L;RNF123;RAB12;CTSF
gsea,regulation of hydrolase activity (GO:0051336),0.3900192696536279,1.2104973184760994,0.19672131147540983,0.24001634628058255,1.0,9/23,24.67%,SOD1;PAFAH1B1;CDK5RAP3;PTK2;TBC1D15;RALBP1;SCARB2;VAV1;CHN1
gsea,cellular calcium ion homeostasis (GO:0006874),-0.3511899227534101,-1.2086354978295057,0.19772727272727272,0.28747213719599535,1.0,28/28,97.33%,TPT1;SELENOK;NPTN;SLC8B1;ATP2B1;TPCN2;ATP2A1;SLC24A1;STIM1;SLC24A3;FKBP1B;GCM2;FZD9;DMPK;F2;WFS1;VAPB;ATP2C1;SLC10A7;PSEN1;MICU1;ANXA6;PRKACA;MAIP1;MICU2;TMEM165;TMCO1;SMDT1
gsea,glucose homeostasis (GO:0042593),0.370081110753471,1.2072012723778787,0.19410745233968804,0.2430067944947065,1.0,10/27,26.63%,RPS6;SELENOT;PTPN2;ADIPOR2;CYB5R4;CRTC2;STK11;BAD;KCNB1;WFS1
gsea,peptidyl-serine modification (GO:0018209),0.29994187327405375,1.2058445852150268,0.18004338394793926,0.24392754006934045,1.0,27/60,42.27%,CSNK2A1;PDK3;RPS6KB1;CSNK1A1;PAK2;TLK1;PRKACA;MAPK1;CSNK1G2;MORC3;UHMK1;TOP1;RPS6KB2;TNKS;PKN3;PKD1;RPS6KA1;PKN2;CAMK4;MAP3K10;SMG1;VRK2;MAPK9;CSNK1G3;CDK5R1;PKN1;TTBK1
gsea,axon guidance (GO:0007411),-0.30400288989229446,-1.2047281731358341,0.17177914110429449,0.2907768762327918,1.0,24/49,36.37%,RAC2;FYN;PRKCQ;VASP;NPTN;RHOG;FEZ2;SRC;DOK1;DOK4;SEMA4D;RAP1GAP;SH3KBP1;EPHB6;SPTBN4;EFNB1;FRS2;SEMA4F;GAB2;EPHA1;SPTBN2;EFNA2;SEMA3E;UNC5B
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3628086506816856,-1.2040508670875332,0.22743682310469315,0.29011859008121493,1.0,27/27,97.75%,PTPRC;IRAK2;IFNGR1;CFLAR;JAK1;PTPN1;ELF1;TAX1BP1;RNF31;IKBKB;SHARPIN;PIAS1;IL7;OTULIN;VRK2;IRAK1;PALM3;CASP8;CYLD;SPPL2A;TRADD;RBCK1;PTPN2;PYCARD;SUMO1;CBFB;CDC37
gsea,cellular response to organic substance (GO:0071310),-0.32552808697094376,-1.2017556507356968,0.2039045553145336,0.2914477638589966,1.0,36/36,97.26%,PTPN18;TGFB1;TGFBR2;ARL6IP5;STAT3;PTPN4;INPP5K;LDLRAP1;IL18BP;ACVR1B;TGFBR1;IL18;ACVR2A;TBK1;MME;POU4F1;ACVR2B;SLC1A1;BMPR2;TRAF6;BMPR1A;IL1RL2;ASAH2;PTPN14;CIB1;TWF2;HCLS1;MAP2K5;CTNNB1;LEF1;PTPN2;CDK9;RPS6KB1;RHOA;EMD;DCPS
gsea,positive regulation of intracellular transport (GO:0032388),0.39820518670108906,1.2007315903912437,0.22709923664122136,0.2489760368255118,1.0,7/17,41.29%,TPR;OAZ1;CEP131;STK11;TENM1;STX18;EIPR1
gsea,positive regulation of protein metabolic process (GO:0051247),0.3141683447380347,1.1980142058816299,0.1887966804979253,0.25155425437275813,1.0,18/42,43.00%,CSNK2A1;SNF8;MTPN;OAZ1;GSK3A;SEC22B;WWP2;RAB1A;MAP2K5;PSEN1;LDB1;WFS1;TRIM32;EGLN2;RAB1B;NKD1;NEDD4L;RILP
gsea,regulation of protein targeting to mitochondrion (GO:1903214),0.399344960283867,1.1978866901463718,0.2286282306163022,0.25120409924327863,1.0,8/17,21.56%,UBE2L3;TOMM7;UBE2J2;GSK3A;SH3GLB1;SREBF1;UBE2D3;LEPROT
gsea,negative regulation of intracellular signal transduction (GO:1902532),-0.28914948129298346,-1.1974232715919295,0.15450643776824036,0.29519221005175567,1.0,63/63,97.73%,MCL1;VGLL4;UBE2B;NOP53;PDE4D;SLC9A3R1;NDUFA13;CARD19;FLCN;INPP5K;PPM1N;SRC;SLA2;PDE2A;EPM2A;NR1D1;PPP2R5B;BCL2L2;OTUD3;TREM2;PPEF2;ESR1;NLRX1;PRDM15;IFI35;WWC2;CD22;PDE11A;PTEN;MAPKBP1;RHOH;MARK3;RFFL;RTKN2;RELA;DEPTOR;NPRL2;LIMD1;MUL1;MAGI2;MAPK14;MINAR1;UBR2;CCDC22;ADIPOR1;RNF34;PPM1A;ZMYND11;WTIP;RIOK3;CIB1;PPM1B;CASP8;CYLD;PSMD10;PPP2R5C;NMI;ARRB2;GSK3A;PDCD6;PYCARD;GSTP1;NDUFS3
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3901020936841947,-1.1948505553013036,0.20470588235294118,0.296987984849075,1.0,10/16,27.90%,RBPJ;IP6K1;LNPEP;FLCN;PLCL2;NR1H2;IL15;NR1D1;LGR4;ACOT11
gsea,negative regulation of MAPK cascade (GO:0043409),-0.3492934061890019,-1.193517905198607,0.2224334600760456,0.29707314195871687,1.0,28/28,99.03%,PTPRC;FOXO1;SLC9A3R1;SORL1;PTPN1;GBA;FLCN;INPP5K;STK38;SMAD4;IGBP1;DLG1;RGS14;PRKCD;PPEF2;PRDM15;PTEN;EMILIN1;DUSP9;RANBP9;ITGB1BP1;PTPRR;PSMD10;PTPN2;CDK5RAP3;SYNJ2BP;GSTP1;FOXM1
gsea,regulation of ion transport (GO:0043269),0.3950784895655475,1.192896065308456,0.23985239852398524,0.2563074434883605,1.0,10/19,43.85%,YWHAH;DTNBP1;SNX6;TOR1A;WWP2;FGF20;PDZK1;RAB11B;NEDD4L;VAMP3
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),0.3614019201001937,1.1916227387925646,0.2332155477031802,0.2571882507064066,1.0,10/27,33.50%,CSNK2A1;NDUFS3;GHITM;GSTP1;TRIAP1;ACAA2;PSMD10;SIAH2;ZMYND11;TMEM14A
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),0.36392866108759503,1.1911299422008017,0.2257001647446458,0.2572370543644316,1.0,10/27,36.52%,HMGB1;BCAP31;SELENOT;PRKACA;TAC4;P2RY1;DLG4;F2;PTGER3;ABL2
gsea,cellular component assembly (GO:0022607),0.28316833885514625,1.1907529753650532,0.1786339754816112,0.25714139737053826,1.0,54/86,44.84%,RAD21;ELOB;RAC1;ILK;GPAA1;PPP2R1A;RHOA;CDC42;YWHAZ;BAG6;YTHDF2;DNM1L;PARVG;YTHDF1;MNAT1;LIMS1;TAPBP;PEX14;CAPZA1;VMP1;CAPN3;TTC26;DLG4;AIF1L;ABCA3;WAS;BAIAP2L2;RTN4;DET1;BSN;ACD;MAGI1;LIMS2;STK25;GRHL2;RSPH1;WDR19;DVL1;NCKAP1L;HAS3;OCLN;TEAD2;REC8;SPEF1;STAG3;SLC9A3R2;STX7;SKAP2;PARD6B;NAPG;RSPH4A;VAMP3;TEAD1;IL1RAP
gsea,negative regulation of cellular component organization (GO:0051129),-0.3685363992490339,-1.189068714053161,0.22406639004149378,0.30114837412870216,1.0,11/21,28.51%,NOP53;SORL1;GBA;DNAJB6;WASL;SNX33;EP300;SRC;LRSAM1;GSK3B;RUBCN
gsea,cell junction organization (GO:0034330),0.37609409936801147,1.1867846490867175,0.2235494880546075,0.2610933510651298,1.0,12/23,31.55%,ILK;RHOA;CDC42;LIMS1;SNCB;CAPZA1;VMP1;PSEN1;MAPT;LIMS2;GRHL2;DVL1
gsea,regulation of inflammatory response (GO:0050727),-0.30234426802271896,-1.185795587916932,0.1748768472906404,0.3037816673469815,1.0,45/45,93.72%,TNFRSF1B;ETS1;GPSM3;VAMP2;FOXP1;GBA;CEBPA;NR1D2;NOD2;IL15;SHARPIN;SHPK;PDE2A;IL18;NR1D1;PRKCD;PPARD;IFI35;MYD88;MDK;CD47;XIAP;RELA;IL1RL2;DAGLA;GGT1;VAMP3;OTULIN;SETD4;NAPEPLD;BCL6B;MGLL;GPS2;LPCAT3;DNASE1;DAGLB;CYLD;FNDC4;TRADD;DDT;PTPN2;NMI;TYRO3;BRD4;SNX6
gsea,potassium ion transport (GO:0006813),0.3828919549253171,1.185115484681708,0.2118003025718608,0.2624483222439682,1.0,10/28,37.11%,ATP1B3;SLC9A5;HCN2;PKD2;KCNK3;KCNB1;KCNA7;KCNH1;HCN3;KCNK12
gsea,dephosphorylation (GO:0016311),0.29185631967611875,1.184809707779993,0.1947069943289225,0.26228428278888083,1.0,31/59,42.94%,PPP1CA;NT5C;ILKAP;PPP2R1A;PHPT1;PPP2CA;PPP1CC;PPP2R2A;PPP6C;PPP2R5C;PTPRA;SDHAF2;MTMR2;PNKP;PTPRU;PPP2R5E;PPM1B;PPM1D;STK11;PPM1E;PTPRR;EPHX2;CDC14B;PTPN14;SGPP1;THNSL2;PPM1A;PP2D1;DUSP28;THTPA;PLPPR2
gsea,regulation of intracellular signal transduction (GO:1902531),-0.2532117180572043,-1.1837165496686255,0.16488222698072805,0.30487036420206026,1.0,137/137,98.36%,SQSTM1;RAC2;ARHGAP45;PTPN22;ITGAV;ARHGAP15;NOP53;AKAP13;GNA13;ARHGDIB;GBA;RRAS;FLCN;RHOG;ARHGAP17;TAF7;PPP1R16B;ARHGAP9;LIME1;PPP1R13B;EP300;ARHGAP4;CDK5;PIP5K1A;FAM13B;RPL11;PIP4K2A;RAC3;CASTOR2;GPAT3;ARHGAP30;PDE2A;PPP2R5B;RASGRF2;FBXL2;ARHGEF4;FGD4;DLG1;RHOV;TRIO;TAF9B;STK4;FBXO9;GMIP;AGER;TREM2;ARAP3;PIP5K1B;CRK;POU4F1;PRKAB2;NTRK1;MAPK11;OCRL;WWC2;RHOU;PRDM11;PTEN;PLEKHG5;TRAF6;RHOH;ARHGEF7;PRKAB1;ARHGEF6;GNA12;XIAP;ULK4;RNF41;STARD8;RFFL;RELA;PIP4K2C;PPP1R13L;RHOD;TCP11;ARHGEF1;ARHGEF16;FGD1;MAPK14;MCF2L;MOB3B;ING2;ARHGAP23;CDK5R1;STARD13;ARHGAP18;TAF4;VRK2;RNF34;PIP4P1;ARHGAP1;STYXL1;TAOK3;ARHGAP29;SYDE1;ARAF;RRAGC;ATP6AP2;PRDM1;MAPK3;PRKAR1A;KAT5;TAF13;TIAM2;ZFAND6;ATRIP;MAPT;CHN1;VAV1;TTC5;STK11;RMI1;RAD9B;CAPN3;RALBP1;CYLD;RHOT1;MAPK1;DEPDC7;PPP2R5C;CSNK2B;ANKRD54;PAK2;PRKAG1;TMBIM4;ARHGAP33;MAPKAP1;TAF11;PYCARD;CDC42;TAF12;RHOA;PAK1IP1;MEAF6;RAC1;CSNK2A1;TAF10
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.3525879571085675,-1.1822686762787795,0.22580645161290322,0.30513251784198575,1.0,24/24,97.75%,SERTAD1;CDKN1B;CNPPD1;CCNI;MAPRE3;CEBPA;APC;CCNT1;CCNJ;INCA1;PTEN;HEXIM2;CCNYL1;CCNY;CDK5R1;PKD1;PKD2;CCNT2;CDKN1C;PSMD10;MNAT1;CDK5RAP3;CCNH;CDC37
gsea,phagosome maturation (GO:0090382),-0.38870530870771564,-1.1758924636141348,0.25298804780876494,0.3121677573999178,1.0,12/17,27.15%,ATP6V0C;RAB43;ATP6V0D1;ATP6V0B;ATP6V1E1;RAB31;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1D;ATP6V0A1;ATP6V1B2
gsea,positive regulation of transport (GO:0051050),-0.36412106757524,-1.175149488475326,0.22850678733031674,0.31167699240150526,1.0,11/22,31.89%,IL2RG;IL2RB;INPP5K;LRP1;IL15;TFR2;AKT2;GSK3B;TREM2;GPLD1;KCTD7
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3982860802147943,-1.1731275381601456,0.27692307692307694,0.3128357109389475,1.0,17/17,98.61%,LAPTM5;RPS7;RPL23;RNF139;RPL11;SMURF1;PTEN;GNA12;CCDC22;ARAF;PTK2;CDK5RAP3;UBE3A;PDCL3;SGTA;CSNK2A1;COMMD1
gsea,lipid transport (GO:0006869),-0.3438370585738821,-1.1725300609915605,0.25925925925925924,0.31201608231563016,1.0,23/23,99.48%,NPC2;PITPNC1;UGCG;SCP2;ABCA5;PITPNM1;MFSD2B;PPARD;ABCC3;SLC27A4;OSBPL8;MTTP;SLC10A1;PLEKHA3;SLC51A;SLC10A3;CLN8;SPNS2;PEX19;ABCA3;TRIAP1;PITPNA;GLTP
gsea,negative regulation of developmental process (GO:0051093),-0.3962961282892623,-1.1725256487226876,0.2175226586102719,0.31045135440889643,1.0,7/15,23.78%,TGFB1;THY1;RC3H1;ARPIN;FOXC1;HYAL3;NOS3
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3413727258666963,1.1721854157376947,0.25103734439834025,0.2757903460968208,1.0,17/30,33.36%,RAC1;CDC42;GRB2;ACTR3;ARPC4;ARPC1A;WASF2;PTK2;MAPK1;CYFIP2;BRK1;ARPC5;WAS;VAV1;MAPK3;NCKAP1L;ARPC3
gsea,Fc-gamma receptor signaling pathway (GO:0038094),0.3413727258666963,1.1721854157376947,0.25103734439834025,0.2757903460968208,1.0,17/30,33.36%,RAC1;CDC42;GRB2;ACTR3;ARPC4;ARPC1A;WASF2;PTK2;MAPK1;CYFIP2;BRK1;ARPC5;WAS;VAV1;MAPK3;NCKAP1L;ARPC3
gsea,amide biosynthetic process (GO:0043604),0.3841475121248655,1.1665998585558794,0.2732793522267207,0.28159163968760687,1.0,10/17,46.78%,SPTSSA;CERS2;DEGS1;SPTLC1;CERS5;PAM;CLN8;ASAH1;ASAH2;SPTLC2
gsea,negative regulation of neuron apoptotic process (GO:0043524),0.3800606140279132,1.1654863281884975,0.24713584288052373,0.28237348011444474,1.0,10/21,47.93%,SNX6;SOD1;TYRO3;WFS1;FGF20;MAG;CNTF;CITED1;SIX1;ERBB3
gsea,calcium-mediated signaling (GO:0019722),-0.37548787511686516,-1.1653117449154593,0.23311546840958605,0.31844023534867544,1.0,9/18,26.24%,PTPRC;PPP3CA;TRPM4;FIS1;PPP3CC;CCR10;NMUR1;ACKR4;TPCN2
gsea,phosphatidylinositol-mediated signaling (GO:0048015),0.3725197438047076,1.1636469517806776,0.2692967409948542,0.283946431083335,1.0,8/22,41.48%,RHOA;RPS6KB1;TYRO3;EXOC1;KCNH1;PLCB3;PIK3C2B;PLCD4
gsea,positive regulation of interleukin-1 beta production (GO:0032731),-0.4003610821932153,-1.162973512641631,0.252,0.3198804035010156,1.0,9/15,31.48%,EGR1;LGALS9;STAT3;FZD5;NOD2;PANX1;AGER;TRIM16;TLR6
gsea,positive regulation of lamellipodium organization (GO:1902745),0.4064383160957782,1.161883622123955,0.28087649402390436,0.2854703538116681,1.0,6/15,18.40%,RAC1;CDC42;ACTR3;WASF2;BRK1;TWF2
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),0.37231992048422907,1.1600776731238223,0.27565392354124746,0.2870845342502208,1.0,8/20,24.84%,PYCARD;BCAP31;TRAF7;PAK2;DNM1L;CYLD;BECN1;BAD
gsea,protein secretion (GO:0009306),0.37821736232979564,1.1592860014532371,0.2660377358490566,0.2875221090583,1.0,9/19,44.03%,PREB;RAB8A;RAB10;CYB5R4;TANGO2;PTPRN;RAB3B;SEL1L;TVP23A
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.35298219631742117,-1.1579226084213843,0.25165562913907286,0.32508938353982636,1.0,22/22,99.15%,UBC;POLD4;UBA52;XPA;PNRC2;DNASE1L1;DNASE1L2;DCP1B;SPO11;RNASE4;SETMAR;TREX1;FAN1;EXD2;DNASE1;REXO4;PDE12;EDC3;ERCC1;XRN2;RBX1;GTF2H5
gsea,positive regulation of kinase activity (GO:0033674),-0.3275018711222645,-1.157043843688907,0.25059101654846333,0.32476467416895655,1.0,14/28,33.34%,PTPRC;MAPRE3;INSRR;DDR1;AGAP2;DSTYK;EPHB6;INSR;JTB;EPHA1;TREM2;CAMKK1;FGFR1;NTRK1
gsea,cholesterol metabolic process (GO:0008203),0.3740359418180883,1.156443358479824,0.2622309197651663,0.2903021403684087,1.0,7/18,26.82%,EBP;SNX17;OSBPL1A;ACAA2;APOA2;ARV1;SOAT2
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.39609826564798584,-1.153983029141501,0.27450980392156865,0.3273234752328462,1.0,7/16,20.65%,PTPRC;SLC9A3R1;PTPN1;FLCN;SMAD4;DLG1;RGS14
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.39672049820991784,-1.1534361305636986,0.2554027504911591,0.3265696156178999,1.0,7/15,27.63%,IP6K1;ITPKC;TMEM150A;PIP4K2A;SLA2;PIK3C3;PI4K2A
gsea,regulation of actin filament-based process (GO:0032970),-0.3583188445007259,-1.1533052687072003,0.24796747967479674,0.325150842528898,1.0,12/23,34.43%,RAC2;CNN2;ABRACL;RHOG;ARHGAP17;LRP1;RAC3;RND2;CELSR1;PRKCD;CRK;TESK1
gsea,establishment of protein localization to membrane (GO:0090150),0.3373398788207922,1.152993668201623,0.2595573440643863,0.2937703203751821,1.0,14/27,44.65%,YIF1B;ZDHHC3;ARL6;ATG3;SEC63;RAB10;ZDHHC4;ZDHHC7;NACA;RAB11A;AQP11;GOLGA7;RAB11B;NECTIN3
gsea,negative regulation of signal transduction (GO:0009968),0.28266631431552264,1.1506095506028058,0.2269170579029734,0.29616691025063324,1.0,32/79,42.52%,EZH2;YWHAB;CSNK2A1;RPS6KB1;PDCD6;GSK3A;YTHDF2;TYRO3;PTPN2;APPL1;MTMR2;WWP2;LEPROT;DACT3;NTN1;ARRDC1;LRPAP1;KCTD6;NFKBIL1;IFT122;SIAH2;CTNNBIP1;SUFU;GPS2;PALM3;CADM4;APCDD1;EGF;BRAP;NKD1;CITED1;MOSMO
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),0.3975567095402636,1.1479132045300464,0.30185185185185187,0.2988774604123545,1.0,7/15,34.67%,BABAM1;BABAM2;CDK5RAP3;RAD9B;CDC14B;HMGA2;TAOK3
gsea,glycosaminoglycan catabolic process (GO:0006027),-0.38144282807150665,-1.1477245862556897,0.26666666666666666,0.3310033440148771,1.0,6/16,23.82%,TGFB1;IDS;IDUA;HYAL3;SGSH;AGRN
gsea,B cell activation (GO:0042113),-0.38942057797980034,-1.1460082156254536,0.2816593886462882,0.33169941653326673,1.0,15/15,96.16%,PTPRC;DNAJB9;ZAP70;JAK3;ZBTB7A;CHRNB2;IL11;CD22;GPS2;NHEJ1;CASP8;FCRL1;PTPN2;CEBPG;TCF3
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.379514856194356,1.1389177479949066,0.310838445807771,0.309257101692039,1.0,6/16,26.55%,CBFB;UFM1;KDM1A;UBA5;GPAM;KCTD6
gsea,synapse organization (GO:0050808),0.3478480123883521,1.1384836105996883,0.26161790017211706,0.309249155604306,1.0,9/26,35.72%,DBNL;CDC42;SNCB;PSEN1;OBSL1;MAPT;ZC4H2;DVL1;LRFN4
gsea,negative regulation of cell death (GO:0060548),-0.3309570954311042,-1.136976497768602,0.2708757637474542,0.34255249008055094,1.0,27/27,97.26%,TNFRSF1B;BNIP3L;FYN;SORL1;GBA;NCK1;INPP5A;CDK5;PDE8A;PARP16;GSK3B;POU4F1;SOX4;CHMP4B;SPEF1;WFS1;LRPAP1;BECN1;VPS4B;WNT16;PDE12;BTBD10;ATG5;TXNDC12;NENF;CHMP2A;DCPS
gsea,neuron projection morphogenesis (GO:0048812),0.30883051574586795,1.1365585385863013,0.2654424040066778,0.3112105163521822,1.0,18/41,42.23%,DBNL;CDC42;DTNBP1;RAB8A;RAB10;CTNNB1;DLG4;DNM2;ATL1;MAP1S;DVL1;NCKAP1L;TAOK3;IQGAP1;DBN1;NBL1;CNTNAP1;PARD6B
gsea,regulation of kinase activity (GO:0043549),-0.3447368353584461,-1.1333378508032648,0.26054590570719605,0.3459970689529845,1.0,12/23,33.34%,CDKN1B;NLRC5;SLC9A3R1;INSRR;DDR1;DSTYK;EPHB6;INSR;EPHA1;TREM2;FGFR1;NTRK1
gsea,endosome organization (GO:0007032),-0.3875112214669449,-1.1273729781439776,0.3162217659137577,0.35269051188552114,1.0,15/15,98.34%,SQSTM1;SNX33;RAB22A;PI4K2A;CLCN3;CHMP2B;PHETA1;TMCC1;PHETA2;RILP;RNF26;USP50;LAMTOR1;PLEKHJ1;SNX3
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.38919391978473244,-1.1260350128811134,0.29518072289156627,0.35278274589131464,1.0,15/15,97.75%,SERTAD1;CDKN1B;CNPPD1;CCNI;CCNT1;STOX1;CCNJ;TTBK1;CDK5R1;CCNT2;CDKN1C;MNAT1;CDK5RAP3;CCNH;CDC37
gsea,positive regulation of cell migration (GO:0030335),-0.2731623602568006,-1.1219171835746033,0.2544529262086514,0.3568524956345095,1.0,64/64,98.80%,PTPRC;TGFB1;HIF1A;STAT3;RREB1;PPP3CA;SPAG9;SRC;NSMF;APC;SEMA4D;ACVR1B;FAM83H;SMURF2;NUMB;TGFBR1;CAPN7;INSR;SEMA4F;EPHA1;TRIP6;AKT2;SDCBP;INSL3;SEMA3E;MDK;BMPR2;PODXL;ADAM10;HYAL1;ARHGEF7;PTP4A1;IGF1R;NIPBL;PDCD10;RHOD;HGF;FER;DDRGK1;SEMA6C;MYLK;SEMA4G;CBLL1;EGF;CARMIL1;FAM89B;SNAI1;TRIM32;RAB11A;NCKAP1L;SYDE1;SMO;SEMA6B;CIB1;PIK3R3;RTN4;MIEN1;CRKL;WASHC1;LEF1;PTK2;TRADD;FERMT3;MAPRE1
gsea,regulation of endothelial cell migration (GO:0010594),-0.36620148391694785,-1.1216483522067355,0.29398148148148145,0.35556491058985973,1.0,18/18,97.04%,SP100;ETS1;FOXP1;RRAS;SVBP;KRIT1;SASH1;GPLD1;BMPR2;ATOH8;EGF;ITGB1BP1;AAMP;EMC10;PTK2;SYNJ2BP;PDCD6;RAC1
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3660108451103644,-1.1186641242853956,0.30039525691699603,0.35774908453795956,1.0,10/20,25.65%,CDKN1B;SORL1;PTPN1;GBA;INPP5K;CEBPA;STK38;APC;RGS14;PRKCD
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3485616136784842,-1.116942961910504,0.2975708502024291,0.35861316815772354,1.0,10/19,21.69%,SORL1;PTPN1;LEMD2;UBE2D1;SMAD4;SMURF1;SMURF2;ACVR2A;FSTL3;DAND5
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3629630833324075,1.1135630929283191,0.3030927835051546,0.3403102581235054,1.0,10/18,25.41%,MTCH1;BEX3;PYCARD;PDCD2;DIABLO;TRADD;CASP8;CASP2;BAD;MAPT
gsea,peptidyl-threonine phosphorylation (GO:0018107),0.3399378161258012,1.1108521222586836,0.3477366255144033,0.3432630935999767,1.0,13/24,42.27%,CSNK2A1;GSK3A;CSNK2B;MAPK1;CDK10;CDC42BPA;TNKS;CDC42BPG;MAP3K10;CDC42BPB;MAP2K1;CDK5R1;TTBK1
gsea,integrin-mediated signaling pathway (GO:0007229),0.36505320927738943,1.1093634506407193,0.29642857142857143,0.34467000440825574,1.0,7/21,32.13%,ILK;CDC42;CCM2;FERMT3;PTPRA;PTK2;ITGB1BP1
gsea,positive regulation of inflammatory response (GO:0050729),0.37643286309624097,1.1069271978062019,0.33206831119544594,0.3473665662252062,1.0,5/16,18.47%,RPS19;NMI;DDT;TRADD;SNX4
gsea,regulation of protein targeting to membrane (GO:0090313),-0.382958442138103,-1.1047907494817066,0.33271719038817005,0.374348865637122,1.0,6/15,26.95%,FYN;ITGB2;INPP5K;GDI1;FIS1;AKT2
gsea,regulation of organelle organization (GO:0033043),0.29679775045853213,1.1043141550848932,0.3210633946830266,0.35023813221894,1.0,21/39,42.55%,TMED9;SAR1A;PREB;SURF4;MFF;SAR1B;PAK2;DNM1L;PTK2;MAPK1;RHOT1;SIRT7;SCARB2;MAPT;MAPK3;SYDE1;CPLANE2;STX18;SPEF1;MIEF2;AKAP9
gsea,glycosphingolipid metabolic process (GO:0006687),-0.36794343259615164,-1.1034242201062157,0.3361884368308351,0.37460437519289314,1.0,10/18,35.44%,CTSA;ESYT2;UGCG;GBA;ARSA;PSAP;B4GALT6;LARGE1;NEU3;SMPD2
gsea,cell-cell junction organization (GO:0045216),-0.3373674108725768,-1.102884632985039,0.3064516129032258,0.3735522865151443,1.0,20/20,92.40%,TGFB1;FLCN;TJP3;CXADR;CDH24;NECTIN1;ARVCF;CDH11;CDH15;ANG;NECTIN3;PARD6B;PARD6A;OCLN;TLN1;GJC1;LIMS2;TLN2;LIMS1;CSK
gsea,peroxisome organization (GO:0007031),0.377986259235107,1.1025682489572168,0.3362255965292842,0.3518410038536452,1.0,7/15,28.08%,MFF;DNM1L;PEX14;PEX16;PEX11B;ACOT8;PEX19
gsea,protein tetramerization (GO:0051262),0.3711454547707529,1.101967458328542,0.3422562141491396,0.3520347563688044,1.0,8/16,29.14%,NUDT21;SSBP1;ACOT13;USP16;CPSF7;PKD2;CUTC;PKD1
gsea,lipid homeostasis (GO:0055088),0.37534655046788745,1.0976410930086384,0.3463587921847247,0.3574427142389734,1.0,9/19,40.83%,ORMDL2;ABHD8;PNPLA2;ORMDL1;USF2;ABHD5;FITM2;RBP1;CLN8
gsea,response to insulin (GO:0032868),-0.32891348373113716,-1.0951417834575172,0.3104166666666667,0.382970826899802,1.0,14/25,30.08%,FOXO1;OGT;VAMP2;RAB8B;INPP5K;RAB31;INSIG2;SYAP1;ZBTB7B;INSR;RAB12;AKT2;KHK;GPLD1
gsea,muscle contraction (GO:0006936),0.337679945040886,1.091848506333925,0.33476394849785407,0.36451040339296503,1.0,15/33,43.14%,CALM1;PABPN1;EMD;TMOD3;MYL4;GJC1;TLN1;ACTN3;TNNI1;GNAO1;MYBPC1;MYL1;SNTA1;TMOD2;MYLK
gsea,positive regulation of immune response (GO:0050778),0.36567761347010114,1.0871094754971597,0.33473684210526317,0.370293535394467,1.0,7/16,32.17%,MYB;PYCARD;NMI;POLR3C;RIOK3;CYBA;SASH3
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3295271596048188,-1.0858432930083044,0.3397312859884837,0.3947875603512787,1.0,31/31,97.04%,CD3G;NR4A3;FYN;ABI1;CD247;WASL;ARPC1B;NCK1;SRC;ARPC2;WIPF2;PRKCD;CRK;YES1;ARPC3;NCKAP1L;MAPK3;VAV1;WAS;ARPC5;BRK1;CYFIP2;MAPK1;PTK2;WASF2;ARPC1A;ARPC4;ACTR3;GRB2;CDC42;RAC1
gsea,regulation of response to external stimulus (GO:0032101),0.3221360534949544,1.0788471370418011,0.3391304347826087,0.38160034815023214,1.0,17/30,51.62%,CALM1;BRD4;APPL1;FNTA;P2RY12;CYLD;CASP8;DAGLB;TIRAP;F2;MGLL;BCL6B;GGT1;RNF135;STK24;IL1RL2;RELA
gsea,mitotic cytokinesis (GO:0000281),0.37157078568694074,1.0787077281324895,0.3736951983298539,0.3811096980859291,1.0,6/15,25.71%,MITD1;ARL3;PDCD6IP;RAB35;SPAST;UNC119
gsea,regulation of actin cytoskeleton organization (GO:0032956),0.32058019750939026,1.0760572599999765,0.36065573770491804,0.38431769690522866,1.0,12/29,39.73%,RAC1;RHOA;PHPT1;DAPK3;TWF2;CDK10;RND1;TWF1;IQGAP1;ABL2;ARHGAP18;RAPGEF3
gsea,regulation of insulin receptor signaling pathway (GO:0046626),-0.3512679929785862,-1.0738384317594774,0.38144329896907214,0.41054956687021493,1.0,18/18,94.73%,PRKCQ;OGT;SORL1;PTPN1;INPP5K;NCK1;PIP4K2A;ZBTB7B;PRKCD;SLC27A4;GRB14;TNS2;PIP4K2C;VWA2;PTPN2;ERFE;GSK3A;RPS6KB1
gsea,negative regulation of proteasomal protein catabolic process (GO:1901799),0.35745107846671936,1.073626991743045,0.34419551934826886,0.38709186461862016,1.0,17/17,97.22%,PSMF1;UBXN1;BAG6;LAMP3;AQP11;DDRGK1;FHIT;SDCBP;RYBP;USP25;WAC;RPL11;EIF3H;N4BP1;OGT;GABARAPL2;NOP53
gsea,cognition (GO:0050890),0.3665022548972393,1.0713116185905533,0.37593984962406013,0.3894999536439085,1.0,7/15,34.08%,RP9;SETD5;TUSC3;TTC8;MGAT3;LINS1;SOBP
gsea,cytoskeleton organization (GO:0007010),-0.28932892974142427,-1.0702375955807644,0.36729857819905215,0.41417207546470086,1.0,39/39,97.04%,RAC2;THY1;CNN2;RHOG;SIPA1L3;ARHGAP4;RAC3;ZRANB1;RND2;RANBP10;SH3KBP1;FGD6;FGD4;BIN1;ZMYM6;ARAP3;RHOU;LRCH3;MDK;RHOBTB2;SIPA1;RHOH;CFAP410;LIMD1;RHOD;RANBP9;FGD1;CNTNAP1;CDC42BPB;FITM2;WTIP;STRIP2;OBSL1;CSPG5;RND1;WDPCP;CAPZB;RHOA;RAC1
gsea,activation of protein kinase activity (GO:0032147),0.31378383442781793,1.069683473521067,0.366,0.39120311629209564,1.0,12/29,35.05%,MAPKAP1;COPS8;PAK2;PRKACA;STK11;ADCY9;PRRC1;PRKAR1A;TIRAP;ITGB1BP1;TAOK3;IRAK1
gsea,positive regulation of epithelial cell migration (GO:0010634),-0.3316388841198975,-1.0686053021544344,0.37185929648241206,0.41477893319158865,1.0,23/23,97.04%,ETS1;HIF1A;FOXP1;RRAS;RREB1;SRC;CAPN7;SASH1;MAPRE2;GPLD1;INSL3;BMPR2;ATOH8;HYAL1;EGF;RAB11A;ITGB1BP1;RTN4;AAMP;EMC10;ARF6;PDCD6;RAC1
gsea,protein lipidation (GO:0006497),-0.31776775236127686,-1.0675267316603074,0.3302238805970149,0.4145814198640122,1.0,26/26,92.43%,SELENOK;ZDHHC18;UGCG;ATG12;ZDHHC20;ZDHHC9;WDR45;ZDHHC17;MPPE1;PIK3C3;GPLD1;ZDHHC1;ZDHHC23;WIPI1;WDR45B;PIGM;PIGW;PIGO;PIGP;ZDHHC7;DPM3;WIPI2;ATG5;DPM1;DPM2;ZDHHC3
gsea,glycolipid metabolic process (GO:0006664),-0.35047566738629377,-1.0647521680677927,0.3826429980276134,0.41713175449279244,1.0,19/19,99.48%,CTSA;ESYT2;UGCG;GBA;ARSA;PSAP;NEU3;SMPD2;NEU4;SUMF1;ASAH1;GLB1;ST3GAL2;PIGW;FUCA1;B4GALNT1;ESYT1;HEXB;GLTP
gsea,plasma membrane bounded cell projection assembly (GO:0120031),0.24231015736405825,1.0630371602118445,0.347008547008547,0.39986865527928467,1.0,62/103,45.72%,CFAP20;RAC1;DYNLL1;ACTR3;ARL6;RAB8A;ARF6;NUDCD3;ARL3;CCDC57;BBS5;WDPCP;RAB1A;P2RY12;BBS7;NPHP3;TTC26;SNAP29;TTC8;AIF1L;EXOC5;EXOC3;CEP131;STK26;TMEM17;EXOC1;WDR35;TTC36;INTU;NTN1;TCTN2;ATAT1;EXOC7;B9D2;IFT122;MKS1;TMEM67;PKD1;CCDC96;CDC14B;WDR19;CPLANE2;RAB11A;IFT52;IFT172;ARMC9;GALNT11;TXNDC15;BBIP1;BBS2;SPEF1;CARMIL1;EXOC6;RILPL1;BBS1;TCTN1;RILP;MYLK;SSTR3;CFAP43;FGD1;BBS9
gsea,negative regulation of type I interferon production (GO:0032480),0.3356422976913647,1.0578220044065754,0.3736951983298539,0.4068313076132768,1.0,7/19,27.83%,PCBP2;PYCARD;YY1;UFD1;CYLD;PPM1B;IRF3
gsea,regulation of smoothened signaling pathway (GO:0008589),0.3785762672572699,1.0566643584682054,0.40398550724637683,0.4077702928306164,1.0,7/15,34.30%,INTU;KCTD6;IFT122;SMO;SUFU;ARMC9;TXNDC15
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.37482651729093236,1.0537400153721144,0.3904761904761905,0.4114249685400691,1.0,6/15,33.11%,GSTP1;YTHDF2;CNOT7;PTPN2;GPS2;PALM3
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.315039133689184,-1.0513452540627912,0.36886993603411516,0.4357698070409164,1.0,23/23,95.92%,SP100;ITGAV;CFLAR;DEDD2;BCL10;TNFRSF12A;SRC;TGFBR1;FGFR1;PELI3;BCL2L14;NOL3;RELA;DEPTOR;ZMYND11;SIAH2;CASP8;CYLD;TRADD;PAK2;BCL2L12;PYCARD;GSTP1
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3444603760943899,1.0505671698402839,0.3793103448275862,0.4153252197791633,1.0,8/17,34.74%,NDUFS3;PYCARD;BCAP31;DNM1L;CYLD;BECN1;BAD;STYXL1
gsea,protein autophosphorylation (GO:0046777),-0.27109114256580796,-1.0472239354109023,0.376940133037694,0.44039470675655384,1.0,46/46,91.83%,STK17B;ITK;PRKX;SIK1;INSRR;SRC;DDR1;MKNK1;ACVR1B;INSR;STK4;EPHA1;GSK3B;FGFR1;NTRK1;FGFR3;MARK2;ULK3;MAP3K12;CAMK2B;MKNK2;IGF1R;MARK3;CDKL5;STK24;FER;MAP3K9;VRK2;IRAK1;SMG1;TAOK3;MAP3K10;CAMK4;STK25;MAPK3;HTATIP2;STK11;STK26;EIF2AK1;UHMK1;PTK2;PAK2;MAP2K2;TYRO3;DAPK3;STK16
gsea,cell-matrix adhesion (GO:0007160),-0.2889343285324514,-1.046948372090608,0.34877384196185285,0.4388294221198661,1.0,35/35,97.04%,ZYX;THY1;ITGAV;ITGAL;ITGB2;ITGA2;SRC;PIP5K1A;DDR1;WHAMM;ITGB5;TRIP6;THBS3;ADAM15;ARHGEF7;EMILIN1;CD96;NID2;RHOD;TMEM8B;ECM2;TESK2;SGCE;STRC;ITGB1BP1;ACTN3;PKD1;THSD1;VWA2;MKLN1;PARVG;FERMT3;TIMM10B;ILK;RAC1
gsea,cell projection organization (GO:0030030),0.3685432535750013,1.0469185204484601,0.3992673992673993,0.4200340640218117,1.0,7/15,31.71%,RAC1;CDC42;PARVG;P2RY12;NPHP1;CSPG5;NCKAP1L
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3338569965566667,1.0451173044658701,0.4078674948240166,0.42196667445627756,1.0,9/19,19.95%,UBE2K;GSTP1;PYCARD;PTPN2;RBCK1;TRADD;SPPL2A;CYLD;CASP8
gsea,anterograde trans-synaptic signaling (GO:0098916),0.2849089348313735,1.0437180770501084,0.3765112262521589,0.4231823209185061,1.0,17/43,37.20%,CALM1;PAFAH1B1;SYNJ2BP;PRKACA;MAPK1;SNCB;DLG4;KCNK3;BSN;UNC119;PRKAR1A;RPS6KA1;GALR3;CAMK4;HTR6;CHRM4;KIF5A
gsea,establishment of protein localization to extracellular region (GO:0035592),0.34879554042548533,1.042140619539801,0.38715953307393,0.42470996115336695,1.0,7/17,44.03%,PREB;RAB8A;RAB10;TANGO2;RAB3B;SEL1L;TVP23A
gsea,cholesterol homeostasis (GO:0042632),-0.33196938057310094,-1.041299469999037,0.4132420091324201,0.4435547496964226,1.0,18/18,99.35%,NPC2;EHD1;TTC39B;LDLRAP1;NR1H2;ABCA5;IL18;NR1D1;MTTP;DGAT2;LCAT;CYP39A1;SOAT2;EPHX2;LRP5;APOA2;LAMTOR1;RALY
gsea,sterol homeostasis (GO:0055092),-0.33196938057310094,-1.041299469999037,0.4132420091324201,0.4435547496964226,1.0,18/18,99.35%,NPC2;EHD1;TTC39B;LDLRAP1;NR1H2;ABCA5;IL18;NR1D1;MTTP;DGAT2;LCAT;CYP39A1;SOAT2;EPHX2;LRP5;APOA2;LAMTOR1;RALY
gsea,protein catabolic process (GO:0030163),-0.310444350716014,-1.0366337985715723,0.38961038961038963,0.4492272895057891,1.0,22/22,93.54%,USE1;TPP1;FBXO6;LAMP2;PPT1;MANBA;LRSAM1;NR1D1;RAB12;NGLY1;RNF41;NEU4;FBXO27;CLN8;SIAH2;FBXO17;FBXO2;CAPN3;UBE2G1;ATE1;UBE2G2;BAG6
gsea,negative regulation of cell migration (GO:0030336),-0.28421748937916524,-1.036457477817051,0.4,0.44756917950227265,1.0,30/30,97.04%,THY1;ARHGDIB;FLCN;LRP1;ARHGAP4;RECK;ARPIN;ADORA3;EPHA1;LDLRAD4;TACSTD2;NDRG4;PIP5KL1;PTEN;ADAM15;RNF41;ATP1B2;MCC;BMPR1A;ADARB1;STK24;MAGI2;ADIPOR1;JAG1;ITGB1BP1;PTPRR;RNF20;STK26;PTPRU;RAC1
gsea,regulation of interleukin-1 beta production (GO:0032651),-0.33865584694466205,-1.0363499418181967,0.38193018480492813,0.4458302285131165,1.0,18/18,95.92%,EGR1;LGALS9;FOXP1;STAT3;FZD5;NOD2;PANX1;AGER;TRIM16;TLR6;MYD88;GSDMD;GIT1;AIM2;CASP8;USP50;PYCARD;GSTP1
gsea,regulation of vesicle-mediated transport (GO:0060627),-0.2862522130141366,-1.0330834433838696,0.3996101364522417,0.44915276779103364,1.0,37/37,97.78%,PTPRC;ITGAV;VAMP2;PTPN1;BET1L;RAB5A;RAB8B;RNF139;SRC;RAB33B;ATP9A;RAB12;RAB26;PLD1;CD22;RAB3A;ARFGAP1;RAB3B;CHMP3;RAB11B;MAP2K1;ABL2;RAB11A;CPLANE2;RAB4B;MAPK3;MBTPS1;SNX12;RAB21;RAB5C;MAPK1;RAB10;SNX17;RAB8A;MAP2K2;SCFD1;AP2S1
gsea,inorganic cation transmembrane transport (GO:0098662),0.2744688119939327,1.0314547881392013,0.42653352353780316,0.44021394699646377,1.0,31/64,47.66%,TMCO1;ATP1B3;TMEM165;FKBP1A;SLC30A5;SLC9A5;ATP6V1A;HCN2;PKD2;SLC25A27;ATP2C1;KCNK3;KCNB1;TRPM7;KCNA7;PKD1;UCP3;KCNH1;SLC6A19;HCN3;KCNK12;SLC39A2;ASIC1;SLC39A8;TMEM175;SLC11A2;MCOLN1;NNT;RYR3;TRPC4AP;HPN
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.35950348410242927,1.0261199263500826,0.41710296684118675,0.4475952882767521,1.0,9/17,40.24%,CALM1;GNB1;LEF1;CTNNB1;PPP3R1;GNAT2;GNAO1;PLCB3;FZD3
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.3310639840666026,-1.025964101377631,0.4109947643979058,0.4582422676225762,1.0,18/18,95.76%,GNA13;GNG2;ADCY7;GNAQ;ADGRB2;LGR4;LGR5;ADGRD1;PTGER1;ADCY5;PTGIR;GNAL;LPAR2;ADCY3;PTGER3;ADCY9;GNAS;GNB1
gsea,gland development (GO:0048732),-0.34419966275340996,-1.0258621819568532,0.39416058394160586,0.45648297483478195,1.0,15/15,93.12%,MSN;ARID5B;SLC9A3R1;CEBPA;TGFBR1;MDK;GCM2;DKK3;NOTCH4;SIX1;PKD2;HESX1;CDK5RAP3;CEBPG;SOD1
gsea,negative regulation of neuron death (GO:1901215),-0.2881405765335029,-1.0240685976098516,0.4073170731707317,0.45719397259802425,1.0,30/30,93.72%,TNFRSF1B;SORL1;GBA;PPT1;INPP5A;CDK5;NRBP2;CPEB4;AGAP2;CRLF1;GSK3B;POU4F1;NTRK1;MDK;UNC5B;FZD9;ERBB3;SIX1;CITED1;CHMP4B;CNTF;MAG;FGF20;WFS1;BTBD10;FBXO7;TYRO3;NENF;SOD1;SNX6
gsea,positive regulation of Ras protein signal transduction (GO:0046579),0.3555889423063445,1.0227673514308355,0.41025641025641024,0.45190563952531093,1.0,5/15,28.41%,RAC1;GRB2;CRKL;VAV1;STK19
gsea,protein localization to plasma membrane (GO:0072659),-0.2620323014891655,-1.0227028621170149,0.3950892857142857,0.45743655270484596,1.0,46/46,94.03%,EHD1;FCHO2;SLC9A3R1;TSPAN14;RAB8B;TMEM150A;RAPGEF6;INPP5K;PIP5K1A;IKBKB;SMURF1;TMEM88;TSPAN17;DLG1;RAB12;SPTBN4;SCN3B;GORASP1;ZDHHC23;PRAM1;CRB3;ANK3;ZFYVE27;RAB3A;F11R;RAB40C;RAP1A;NECTIN3;ASB3;RAB3B;SLC9A3R2;PDZK1;PIGW;KCNIP3;STXBP1;RAB11A;ITGB1BP1;KCNB1;EFR3A;EFR3B;PPIL2;P2RY1;RAB10;RAB8A;ZDHHC3;ATP1B3
gsea,negative regulation of cell motility (GO:2000146),-0.30245497848496394,-1.021827332890309,0.38875305623471884,0.45687248806832453,1.0,11/24,34.76%,THY1;FLCN;ARHGAP4;RECK;ARPIN;ADORA3;EPHA1;LDLRAD4;TACSTD2;CRK;PIP5KL1
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.29814448658141157,-1.019125956122002,0.432183908045977,0.45900162501855085,1.0,26/26,98.20%,TGFB1;PDE4D;INPP5K;CREBL2;NCK1;BRAF;DMD;SPTBN4;STK4;TBK1;STOX1;MTCP1;IL11;PTEN;MLXIPL;PDCD10;AKAP9;RAPGEF3;TENM1;RAF1;ARAF;CAPRIN2;HCLS1;FNIP2;NSD1;MAD2L2
gsea,protein processing (GO:0016485),0.3097261650098813,1.0186947504067427,0.4511545293072824,0.457364971133385,1.0,10/27,24.57%,SEC11C;SPCS1;SEC11A;TMEM208;RCE1;PSEN1;ECE2;CASP2;SPCS2;NCSTN
gsea,peptidyl-threonine modification (GO:0018210),0.2984845910170903,1.0186486495160079,0.43380855397148677,0.4566544869584485,1.0,14/27,42.27%,CSNK2A1;GSK3A;CSNK2B;MAPK1;CDK10;CDC42BPA;TNKS;CDC42BPG;MAP3K10;GALNT11;CDC42BPB;MAP2K1;CDK5R1;TTBK1
gsea,regulation of cellular component movement (GO:0051270),0.3274062562109459,1.0165304569476878,0.41208791208791207,0.4590739799671645,1.0,12/21,40.93%,RPS19;RHOA;DAPK3;YTHDF1;NRG4;PKN2;RAF1;CADM4;ABL2;EGF;ARHGAP18;PKN1
gsea,protein localization to membrane (GO:0072657),0.24613182588203297,1.0147817724883812,0.4329159212880143,0.4609869298995758,1.0,33/70,41.18%,ATP1B3;TM9SF1;ABHD17A;ZDHHC3;SYNJ2BP;TM9SF3;TM9SF2;RAB8A;RAB10;ARL3;SH3GLB1;CAPN3;P2RY1;DLG4;PPIL2;ARL5A;EFR3B;EFR3A;KCNB1;RABEP1;WDR19;DVL1;ITGB1BP1;LIN7B;RAB11A;STXBP1;DLG3;KCNIP3;PIGW;PDZK1;SLC9A3R2;RAB11B;RAB3B
gsea,iron ion transport (GO:0006826),-0.3066016674416791,-1.0061109310558922,0.4415841584158416,0.4775897428711363,1.0,13/23,27.15%,ATP6V0C;FTH1;ATP6V0D1;ATP6V0B;ATP6V1E1;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1D;ATP6V0A1;ATP6AP1;TFR2;ATP6V1B2
gsea,myeloid cell differentiation (GO:0030099),0.34416448084628515,1.002860508130419,0.4582560296846011,0.47866301321078814,1.0,6/17,29.78%,RPS19;ACIN1;PTPN2;UBA5;HCLS1;TIRAP
gsea,positive regulation of defense response (GO:0031349),-0.32284049491681177,-1.0004585033998576,0.44468085106382976,0.4847841965225928,1.0,9/18,36.32%,ETS1;GPSM3;CEBPA;IL15;PDE2A;LRSAM1;IL18;IFI35;MDK
gsea,regulation of intracellular protein transport (GO:0033157),0.3367720543001307,1.0004228244691633,0.4334677419354839,0.4816373481126551,1.0,7/16,36.73%,TPR;OAZ1;UHMK1;CEP131;SIRT7;PTPN14;TENM1
gsea,negative regulation of phosphorylation (GO:0042326),-0.3111775379002883,-0.9966464135842366,0.45751633986928103,0.4890663560962491,1.0,22/22,96.12%,TGFB1;CDKN1B;INPP5K;TESK1;PIP5KL1;PTEN;STAP1;CHP1;NPRL2;OCLN;CADM4;ACTN3;GIT1;NCOR1;MAPT;CIB1;CRKL;PPP1R15B;CDKN1C;CDK5RAP3;FKBP8;DYNLL1
gsea,intracellular pH reduction (GO:0051452),-0.3409110364857593,-0.9964349304405925,0.4633663366336634,0.4874020415655683,1.0,11/15,28.45%,ATP6V0C;ATP6V0D1;ATP6V0B;ATP6V1E1;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1D;ATP6V0A1;ATP6V1B2;CLCN3
gsea,cellular response to organonitrogen compound (GO:0071417),0.28761066352587794,0.9944745834811068,0.4718045112781955,0.48996405131375353,1.0,19/28,47.21%,LAMTOR4;LAMTOR1;LAMTOR5;LAMTOR3;LAMTOR2;CTNNB1;P2RY12;HCN2;P2RY1;PKD2;RRAGC;CPEB3;RRAGA;HCN3;RAPGEF3;RRAGD;AKAP9;RAP1A;RYR3
gsea,protein K63-linked ubiquitination (GO:0070534),-0.3403002918727406,-0.9940723311829756,0.47925311203319504,0.48917529662079995,1.0,16/16,96.05%,PELI1;UBE2B;ARIH2;ITCH;PELI3;TRAF6;BFAR;TRAF3IP2;RNF135;HECTD1;RNF115;UBE2G1;WWP2;UBE2V1;RNF4;TRIM27
gsea,positive regulation of secretion by cell (GO:1903532),0.3324497483839419,0.9930062683473925,0.4855595667870036,0.49151092421510534,1.0,11/19,43.11%,TMED10;DTNBP1;IER3IP1;ARF6;DNM1L;UNC13D;EXOC1;KCNB1;RAB27B;STX1A;GOLPH3L
gsea,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3213999161436798,0.9915782950128872,0.44420600858369097,0.492859117689878,1.0,11/19,43.00%,CHMP2A;VTA1;CHMP6;MVB12A;CHMP7;LEPROT;VPS4B;SORT1;CHMP4B;CHMP3;RILP
gsea,Rho protein signal transduction (GO:0007266),0.32965836677952515,0.9897638531282357,0.4600694444444444,0.494786054879185,1.0,7/19,35.09%,RHOA;CDC42;WAS;CTNNAL1;NTN1;ARHGAP29;ARHGAP1
gsea,regulation of endocytosis (GO:0030100),0.31635470452366,0.9830550729741621,0.49391304347826087,0.5048696216407234,1.0,12/22,41.25%,AP2S1;SNX17;MTMR2;RAB5C;SNX12;LRPAP1;SCAMP5;RAB4B;CALY;ABL2;CBLL1;NEDD4L
gsea,phospholipid metabolic process (GO:0006644),0.3073782083951728,0.9783717585304811,0.503690036900369,0.511693666020415,1.0,11/22,42.94%,GPX4;LPCAT4;APOA2;GPAM;ABHD12;PLB1;PLA2G4C;FITM2;PIP4P1;CLN8;PLPPR2
gsea,neurotransmitter transport (GO:0006836),-0.3078826073721477,-0.9728240804652806,0.48009367681498827,0.5219755396057151,1.0,20/20,83.42%,VAMP2;SNAPIN;SLC28A2;LIN7C;SLC29A4;SLC18A2;SLC17A7;SLC1A1;RAB3A;NRXN2;CASK;STX1A;SNPH;STXBP1;LIN7B;TSPOAP1;DVL1;STXBP2;SLC29A2;DNAJC5
gsea,regulation of defense response (GO:0031347),-0.29548506011603237,-0.9682802115809586,0.5066964285714286,0.5274448793057345,1.0,21/21,90.61%,PTPN22;FOXP1;N4BP1;NR1D2;NOD2;SHPK;TREM2;MYD88;XIAP;RELA;IL1RL2;RNF135;GGT1;BCL6B;MGLL;TIRAP;DAGLB;CASP8;CYLD;APPL1;BRD4
gsea,regulation of epithelial cell migration (GO:0010632),-0.3208123616528267,-0.9677263603606495,0.4961636828644501,0.526209314292317,1.0,8/15,36.69%,HIF1A;RREB1;SRC;CAPN7;SASH1;TACSTD2;INSL3;BMPR2
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3151805212787282,0.9601935615675296,0.5161839863713799,0.5404987479193042,1.0,7/20,42.23%,RAB8A;TBCD;RAB10;ATL1;MAP1S;DVL1;PARD6B
gsea,cortical cytoskeleton organization (GO:0030865),-0.32431569257581533,-0.9529410069446685,0.5119047619047619,0.549018153536993,1.0,16/16,97.04%,RAC2;RHOG;FMNL1;RAC3;LLGL2;IKBKB;RND2;DLG1;RHOBTB2;RHOH;RHOD;NCKAP1L;RND1;ARF6;RHOA;RAC1
gsea,protein localization to cilium (GO:0061512),0.30809712886496776,0.94232814966608,0.5377176015473888,0.569815707650102,1.0,14/19,47.50%,ARL6;ARL3;TTC26;WDR35;NPHP4;TCTN2;RABEP1;IFT122;WDR19;TULP1;BBS1;TCTN1;BBS9;CSNK1D
gsea,chemical synaptic transmission (GO:0007268),0.237954525137383,0.9413057088666287,0.5530179445350734,0.5705673786481487,1.0,34/66,48.56%,CALM1;PAFAH1B1;SYNJ2BP;NAPA;PRKACA;MAPK1;SNCB;DNAJC5;DLG4;STXBP2;TBC1D24;KCNK3;BSN;UNC119;PRKAR1A;RPS6KA1;GALR3;CAMK4;DVL1;TSPOAP1;LIN7B;HTR6;STXBP1;CHRM4;NQO1;KIF5A;SNPH;STX1A;AKAP9;CACNB4;STAC3;CHRNB1;GPR176;PLP1
gsea,regulation of neuron apoptotic process (GO:0043523),0.2733054217684597,0.9243746558960056,0.5681444991789819,0.5981323526625012,1.0,15/31,45.02%,SNX6;SOD1;TYRO3;CTNNB1;TRIM2;KCNB1;WFS1;FGF20;EGLN2;MAG;CNTF;CDK5R1;TFAP2A;CITED1;SIX1
gsea,myeloid leukocyte differentiation (GO:0002573),-0.285652480913277,-0.9181474363453772,0.5807860262008734,0.606294326875829,1.0,20/20,95.56%,TGFBR2;LGALS9;FOXP1;CEBPA;EP300;OSTM1;IL15;GAB2;TREM2;EFNA2;PDE1B;TNFRSF11A;MAPK14;PIR;CAMK4;CASP8;BATF;LEF1;CDC42;GLO1
gsea,protein localization to cell periphery (GO:1990778),-0.23102108629534576,-0.9149523756168896,0.6004366812227074,0.6092954046985698,1.0,49/49,94.03%,EHD1;FCHO2;SLC9A3R1;TSPAN14;RAB8B;TMEM150A;RAPGEF6;INPP5K;PIP5K1A;LIN7C;IKBKB;SMURF1;TMEM88;TSPAN17;RAB29;DLG1;RAB12;SPTBN4;SCN3B;ZDHHC23;PRAM1;CRB3;ANK3;ZFYVE27;RAB3A;F11R;RAB40C;RAP1A;RAB3B;SLC9A3R2;PDZK1;PIGW;KCNIP3;STXBP1;RAB11A;LIN7B;ITGB1BP1;WDR19;RABEP1;KCNB1;EFR3A;EFR3B;PPIL2;P2RY1;ARL3;RAB10;RAB8A;ZDHHC3;ATP1B3
gsea,regulation of secretion by cell (GO:1903530),0.31161216582587103,0.9139837457273766,0.5871743486973948,0.6146872695975475,1.0,8/15,43.85%,RAB8A;RAB10;RAB21;DNAJC1;ARFIP1;CPLANE2;RAB3B;VAMP3
gsea,transferrin transport (GO:0033572),-0.2862383491163386,-0.9060484514666772,0.5991983967935872,0.6225293196804615,1.0,12/20,27.15%,ATP6V0C;ATP6V0D1;ATP6V0B;ATP6V1E1;ATP6V1F;ATP6V1H;ATP6V1G2;ATP6V1D;ATP6V0A1;ATP6AP1;TFR2;ATP6V1B2
gsea,phosphatidylinositol metabolic process (GO:0046488),-0.24084276801163906,-0.8904606709333988,0.651356993736952,0.6467980440405067,1.0,38/38,95.18%,INPP5D;RAB5A;PLAAT3;INPP5K;PLEKHA2;INPP4A;PLCD1;PIP5K1A;PIP4K2A;MTMR6;PITPNM1;MTM1;ARF3;MTMR10;INPP5E;PIK3C3;PI4K2A;PIP5K1B;MTMR11;OCRL;PTEN;MTMR7;PLEKHA3;PIP4K2C;PIK3C2B;PLCB3;PIGW;PIP4P1;PLEKHA4;PLA2G4C;PIP4P2;MBOAT7;PIK3R3;MTMR9;MTMR2;RAB14;IMPA1;ARF1
gsea,fatty acid metabolic process (GO:0006631),0.27033780872412316,0.890459883513917,0.6166365280289331,0.6532573207243297,1.0,14/26,47.05%,GPX4;ADIPOR2;ACSF3;ACOT7;GPAM;ACOT6;ACOT8;CPT1C;PER2;ADIPOR1;PON2;GGT1;LPIN3;AASDH
gsea,regulation of exocytosis (GO:0017157),0.30337697167462585,0.8892637617409118,0.6227436823104693,0.6542197580966772,1.0,9/16,41.18%,RAB8A;CHMP6;RAB10;RAB21;UNC13D;CPLANE2;RAB27B;CHMP3;RAB3B
gsea,sterol metabolic process (GO:0016125),0.29765346269946624,0.8889846345507623,0.5919540229885057,0.6535522383387135,1.0,8/16,45.56%,EBP;OSBPL1A;APOA2;ARV1;SOAT2;PIP4P1;CLN8;CYP39A1
gsea,axonogenesis (GO:0007409),-0.21833223190866505,-0.8878867378105052,0.6470588235294118,0.6487181476265655,1.0,56/56,93.98%,FYN;PRKCQ;VASP;NPTN;FEZ2;CDK5;SRC;DOK1;DOK4;SEMA4D;RAP1GAP;SH3KBP1;NTNG2;EPHB6;ZDHHC17;B4GALT6;SPTBN4;EFNB1;FRS2;SEMA4F;GAB2;EPHA1;SLC9A6;SPTBN2;POU4F1;BRSK2;EFNA2;ANK3;SEMA3E;UNC5B;PTEN;MAP1B;RAB3A;NLGN3;RANBP9;SPTB;NTN3;EFNA4;SEMA6C;PARD6B;SEMA4G;CDK5R1;LYPLA2;KIF5A;GFRA1;MAP1S;MAPK3;ATL1;SEMA6B;NRTN;MAPK1;PTK2;PTPRA;RAB10;RAB8A;GRB2
gsea,epithelial cell differentiation (GO:0030855),0.3084366904498238,0.8859319738913906,0.6470588235294118,0.6577312462785934,1.0,9/16,45.02%,EDF1;RAB10;ACADVL;ZDHHC7;GRHL2;JAG1;CITED1;TST;SIX1
gsea,anion transmembrane transport (GO:0098656),0.29108235186243997,0.8844110939818782,0.6295620437956204,0.6590727129929198,1.0,9/19,45.13%,SLC25A4;PRAF2;SLC35B4;SLC25A11;SLC25A12;SLC5A6;MFSD12;SLC39A8;SLC25A42
gsea,regulation of neuron projection development (GO:0010975),-0.2184157803716711,-0.8804394480939193,0.6908665105386417,0.6589953684750159,1.0,49/49,98.34%,ITM2C;MYLIP;NPTN;NDEL1;RTN4RL1;EP300;CDK5;SERPINI1;RETREG3;NTNG2;DISC1;RAB29;GSK3B;NDRG4;NTRK1;BRSK2;MARK2;MDK;PTEN;PRAG1;GPC2;CAMK2B;LTK;ULK4;ATP1B2;CDKL5;RAP1A;LRRC4C;MAGI2;MINAR1;CDK5R1;DBN1;ABL2;MAG;STYXL1;CBFA2T2;TOX;TWF1;TBR1;LZTS3;CHN1;SCARB2;CIB1;PSEN1;TWF2;FBXO7;PAK2;GSK3A;SNX3
gsea,positive regulation of macroautophagy (GO:0016239),0.3029843622915762,0.8799289443559586,0.6421052631578947,0.665578249606205,1.0,8/15,49.52%,SLC25A4;PAFAH1B2;SH3GLB1;SPTLC1;GNAI3;UVRAG;SPTLC2;PIP4K2C
gsea,negative regulation of metabolic process (GO:0009892),0.2891273176090731,0.8780584757432789,0.6405693950177936,0.6676006483251908,1.0,7/19,31.70%,GSTP1;PGAM5;ACOT13;STK11;ZDHHC7;RHEB;ACTN3
gsea,regulation of axonogenesis (GO:0050770),0.31071943857963696,0.8771436840111347,0.6111111111111112,0.6681347264605659,1.0,8/17,46.52%,RHOA;PAK2;RTN4;CHN1;TIAM2;MAG;PLXNA3;LRRC4C
gsea,regulation of autophagosome assembly (GO:2000785),0.2983652267993784,0.8735249440253943,0.6463414634146342,0.6733977467883677,1.0,8/15,51.31%,SCFD1;SEC22B;SH3GLB1;UBQLN2;RAB1B;CHMP4B;PIP4K2C;NPRL2
gsea,chemical homeostasis (GO:0048878),0.30839241775037995,0.8698149230700509,0.6241935483870967,0.6786293812331468,1.0,10/18,41.25%,ABHD8;PNPLA2;USF2;ABHD5;AQP11;FITM2;RBP1;SLC4A3;CLN8;NEDD4L
gsea,phosphatidylinositol biosynthetic process (GO:0006661),0.22401404376332848,0.8685813539441765,0.6893787575150301,0.6796243795846119,1.0,20/46,41.57%,ARF1;IMPA1;DPM2;DPM1;RAB14;MTMR2;MTMR9;DPM3;EFR3B;PIK3R3;EFR3A;PIGP;ITPKA;MBOAT7;PIGO;SMG1;PLEKHA4;PIGW;PIK3C2B;PIGM
gsea,regulation of cell migration (GO:0030334),0.20889638282987888,0.8667948959876152,0.7357910906298003,0.6813157340880232,1.0,47/91,54.35%,MAPRE1;RAC1;RHOA;FERMT3;TRADD;PTK2;APPL1;LEF1;WASHC1;PTPRU;MGAT3;STK26;MIEN1;PIK3R3;RNF20;CIB1;SEMA6B;BEX4;LDB1;SMO;FGF20;TRIM32;SNAI1;JAG1;FAM89B;CARMIL1;EGF;CBLL1;PLXNA3;SEMA4G;NKD1;PARD6B;MYLK;MEAK7;SEMA6C;DDRGK1;MAGI2;FER;STK24;HGF;RHOD;ADARB1;RFFL;CAMSAP3;RNF41;ULK4;GNA12
gsea,plasma membrane organization (GO:0007009),-0.2909919547744694,-0.8636817565772346,0.6573604060913706,0.6852389372566683,1.0,16/16,87.09%,SLC9A3R1;UGCG;SNX33;BIN3;WHAMM;MYOF;BIN1;ANK3;RAB3A;BIN2;COL5A1;PLSCR2;ARV1;DEGS1;ARL8B;ANXA6
gsea,actomyosin structure organization (GO:0031032),0.2875788965730124,0.8566054205942802,0.6649916247906198,0.6968575864098355,1.0,9/20,35.52%,RHOA;WDR1;TMOD3;CAPN3;CDC42BPA;FAM171A1;CDC42BPG;EPB41L5;CDC42BPB
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.28858174752848936,0.8484915613310586,0.6913357400722022,0.7090307172157644,1.0,9/18,42.55%,MAD2L2;FNIP2;HCLS1;CAPRIN2;ARAF;RAF1;TENM1;RAPGEF3;AKAP9
gsea,kidney development (GO:0001822),0.29439263747382555,0.8481303789730852,0.6872909698996655,0.708318119060819,1.0,10/17,45.04%,BAG6;ARL3;NPHP3;WFS1;PKD1;VANGL2;TFAP2A;CITED1;SIX1;SOX4
gsea,organic acid transport (GO:0015849),0.27246659811979485,0.8117891699184634,0.7412698412698413,0.7652410650055086,1.0,9/19,49.55%,SLC25A11;SLC43A1;SLC7A7;SLC5A6;SLC25A47;SLC6A19;SLC10A3;SLC46A1;SLC51A
gsea,axon development (GO:0061564),0.2491129635664417,0.7931160185927119,0.7657807308970099,0.7921218308450397,1.0,9/23,42.23%,RAB8A;RAB10;RTN4;MAPT;ATL1;MAP1S;CDK5R1;MAPK8IP3;PARD6B
gsea,regulation of TORC1 signaling (GO:1903432),-0.256871745711928,-0.774191890081033,0.8031496062992126,0.8230399555910852,1.0,16/16,88.20%,BMT2;FLCN;SIK3;CASTOR2;GPR137;CLEC16A;DGKQ;GPR137C;RRAGD;PIP4P1;RRAGA;RRAGC;SZT2;KPTN;STK11;LAMTOR5
gsea,protein O-linked glycosylation (GO:0006493),-0.236309146791118,-0.7738432048287504,0.8009950248756219,0.8202815933599656,1.0,23/23,91.24%,OGT;GALNT2;POFUT2;B3GNT2;GXYLT2;GALNT9;C1GALT1C1;B3GNT8;LARGE1;ST6GALNAC2;TMTC3;GALNT4;C1GALT1;ST3GAL2;MUC4;CRPPA;B3GNT4;GALNT11;LARGE2;DPM3;DPM1;DPM2;GALNT12
gsea,glycerophospholipid metabolic process (GO:0006650),0.23867211430360136,0.7731429690792082,0.800711743772242,0.8194116145227375,1.0,12/25,41.57%,PAFAH1B1;PIGX;DPM2;ABCA3;ENPP6;ABHD12;GDPD1;PIGP;PLA2G4C;PIGW;PLCB3;PIGM
gsea,positive regulation of cell adhesion (GO:0045785),0.24538346158351731,0.741696936884371,0.825,0.8590958130268692,1.0,10/21,48.90%,RAC1;LIMS1;P2RY12;CIB1;MAGI1;NCKAP1L;RELL2;ZFHX3;ECM2;RHOD
gsea,phospholipid dephosphorylation (GO:0046839),0.2448619717463752,0.741372644351432,0.8589743589743589,0.8580480289070193,1.0,7/17,42.94%,MTMR2;MTMR9;EPHX2;SGPP1;PIP4P2;PIP4P1;PLPPR2
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.22464369895758354,0.7338941899546007,0.8700305810397554,0.8656890336568045,1.0,13/33,45.82%,GNAI2;GNAS;WASF2;P2RY12;ADCY9;GNAT2;GALR3;GNAI3;GNAO1;PTGER3;ADCY3;LPAR2;GNAL
gsea,glycoprotein metabolic process (GO:0009100),-0.2363467171451233,-0.7325411151545618,0.8436830835117773,0.8701853775849486,1.0,18/18,91.62%,HIF1A;FBXO6;GOLPH3;B4GALT7;MANBA;LARGE1;GAL3ST4;NGLY1;MAN2A2;NEU4;FBXO27;ST3GAL2;ENGASE;FBXO17;MAN2B1;FBXO2;ERP44;MAN1A2
gsea,response to tumor necrosis factor (GO:0034612),0.23095051640603892,0.7319818847397115,0.8558052434456929,0.8664834469454984,1.0,11/23,51.62%,PYCARD;TRADD;CASP8;CIB1;ZFAND6;MAP2K7;TRIM32;ASAH1;GGT1;TNFRSF11A;RELA
gsea,glycosaminoglycan biosynthetic process (GO:0006024),0.2147912290533706,0.7242066883999166,0.8551959114139693,0.8738288923577359,1.0,18/28,50.22%,B4GALT2;UGDH;EXT2;SLC10A7;OMD;CSPG5;OGN;NDST1;GLCE;CHST14;HAS3;B4GALT3;B3GNT4;ST3GAL2;HS3ST6;EXT1;NDST2;B3GAT3
gsea,Golgi to plasma membrane protein transport (GO:0043001),-0.23177767402149155,-0.7148744035395384,0.8755186721991701,0.8866261792586403,1.0,18/18,88.24%,VAMP2;GOLPH3;RAB31;KRT18;SYS1;RAB26;KIF13A;ANK3;ARFRP1;GOLPH3L;BLZF1;BBS1;GOLGA7;BBS2;VAMP4;AMN;GGA1;RAB10
gsea,glycoprotein biosynthetic process (GO:0009101),0.23090405132519734,0.6984515383144898,0.8771653543307086,0.8996207368539461,1.0,8/22,41.36%,DAD1;ALG5;ALG1;CANT1;B3GALT1;B3GNT4;FUT10;ST3GAL2
gsea,establishment of protein localization to plasma membrane (GO:0061951),-0.21459196446031253,-0.6782945963792475,0.9238683127572016,0.918637935655314,1.0,20/20,88.24%,VAMP2;GOLPH3;RAB31;SYS1;RAB26;KIF13A;GORASP1;ANK3;ARFRP1;NECTIN3;GOLPH3L;BLZF1;BBS1;RILPL1;GOLGA7;BBS2;VAMP4;AMN;GGA1;RAB10
gsea,glycosaminoglycan metabolic process (GO:0030203),0.21225656572797275,0.6441884498649213,0.9253731343283582,0.9424069521349377,1.0,10/18,50.22%,UGDH;EXT2;FUCA1;NDST1;GLB1;B3GAT2;HS3ST6;EXT1;NDST2;B3GAT3
gsea,modulation of chemical synaptic transmission (GO:0050804),-0.18868470554188974,-0.6024606549101351,0.9720812182741116,0.9643861225436207,1.0,20/20,81.20%,BTBD9;CDK5;GRIK5;MAPK8IP2;AGER;CHRNB2;BEGAIN;PTEN;LRRC4;NLGN3;NPAS4;PXK;RIMS3;DLGAP3;LRRC4C;AKAP9;DGKZ;NPTXR;DLG4;EIF4EBP2
gsea,aminoglycan biosynthetic process (GO:0006023),0.17888995055755896,0.5223936441184195,0.9888888888888889,0.989449992966662,1.0,10/18,52.58%,UGDH;EXT2;NDST1;B3GALT1;B3GNT4;HS3ST6;EXT1;NDST2;B3GAT3;B3GNT9
